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Abstract 
 
A series of lanthanide complexes based on asymmetrically substituted cyclen ligands 
were designed and synthesised in this project in order to develop ROS-responsive 
luminescent molecular sensors. A synthetic strategy involving the synthesis of an 
intermediate ligand was applied to the asymmetrically functionalisation of the cyclen ring. 
The intermediate ligand was called “the generic ligand” since it possesses a generic 
chemical structure that could be modified in many ways in order to produce different 
types of ligands. The generic ligand was designed and synthesised by exploiting an 
orthogonal protection strategy. The synthetic strategy involving the synthesis of the 
intermediate generic ligand proved to be very versatile and successfully applicable to the 
synthesis of different asymmetrically substituted cyclen-based ligands. Seven types of 
ligands (L1-L7) were synthesised in this project exploiting the synthetic strategy 
mentioned above. The ligands were complexed with trivalent lanthanide ions giving arise 
to eleven lanthanide complexes EuL1-EuL7.  
The photophysical properties of the lanthanide complexes were measured using 
absorption and emission spectroscopy. The photophysical properties of two Eu(III) 
based complexes were measured in presence of ROS species generated in situ by H2O2 
and Fe(II) perchlorate. The ROS response of these Eu(III)-based complexes was also 
measured in vitro by using a cellular ROS assay. In this assay H2O2 and tBHP were used 
to increase the ROS production within the cells.  
A mitochondrial stress test (MST) was performed on EuL1-TbL4 with the aim to identify 
compounds that exhibit a potential mitochondrial and/or cellular toxicity. A calcium 
loading capacity assay was performed on the same lanthanide complexes tested with 
the MST with the aim of investigating their effect on the mitochondrial capability to uptake 
and internalize Ca2+.   
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A - absorbance 
OAc - acetoxy 
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ATP - adenosine triphosphate 
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c - molar concentration 
CAT - catalase 
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δ - chemical shift 
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NMR - nuclear magnetic resonance 
1O2 - singlet oxygen 
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O-P-Thr – O-phosphorylated threonine 
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PET - photo-induced electron transfer  
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QH2 - ubiquinol 
ROS - reactive oxygen species 
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S1 S2 - electronic singlet excited states 
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SOD - superoxide dismutase 
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T1 - electronic triplet exited state 
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1. Introduction 
 
Luminescence is defined as the emission of light by a substance following excitation that 
in most cases is represented by the absorption of light [1]. Luminescence is a highly 
sensitive tool that can be applied for the detection of single molecules in complex 
biological systems, since it allows a real time detection of a target biomolecule in living 
cells [1]. For this reason it has received a great importance as a diagnostic tool in medical 
and biological fields. Over the last decades many research studies have focused their 
attention on the development of ever more efficient luminescent molecular probes [1], 
[2]. A molecular probe, also known as molecular sensor or chemosensor, is a molecular 
or supramolecular system that is able to transform probe-analyte interactions into a 
signal which allows analyte sensing [3]. In the case of luminescent molecular probes, an 
analyte can be detected through the changes of the photophysical properties of the 
probe, such as increasing or decreasing of the emission intensity, as consequence of 
analyte-probe interaction [4]. The use of lanthanide complexes for the detection of 
biological analytes such as anions, pH and metal ions has grown significantly over the 
last decade [5], [6]. Lanthanide ions-based complexes possess unique photophysical 
properties, such as large Stokes shift, narrow emission bands and long luminescence 
decay time, which make them ideal luminescent probes for biological systems [5], [6]. 
For example, their long luminescence lifetimes, ranging from microsecond to millisecond, 
contrarily to that of biological (i.e., organic) species that possess lifetimes in the order of 
nanoseconds, make lanthanide-based complexes particularly useful for the application 
in living cells [7]. In fact, using time-gating techniques it is possible to separate the signals 
coming from the lanthanide ions from the short-lived fluorescence of molecular 
background (autofluorescence), which is due to certain fluorescent molecules present 
within the cells, such as proteins [7]. The aim of this project is to develop novel 
luminescent lanthanide complexes capable of producing detectable changes of their 
18 
 
photophysical properties following the interaction with biological analytes, thus allowing 
analyte detection. The biological analytes that were analysed in this project are ROS 
(reactive oxygen species), such as hydrogen peroxide (H2O2) and the hydroxyl radical 
(OH●). ROS are a group of chemically reactive molecules and radicals containing 
oxygen, which are mainly produced within the mitochondria [8]. ROS play a key role in 
many physiological processes, such as signal transduction and inflammation, and for this 
reason ROS are very important for the cell survival [9]. However, increased 
concentrations of ROS may lead to oxidative damage to lipid, DNA and proteins that can 
be the cause of many cellular and/or cellular organelles dysfunctions [10]. Cells are 
continuously exposed to basal oxidative damage as consequence of an increased ROS 
production, such as that caused by the immune system response to the pathogens’ 
invasion [11], however, cells possess enzymatic and non-enzymatic antioxidants able to 
regulate ROS levels and prevent or repair oxidative damage [12]. When the 
overproduction of ROS is not balanced by the ability of the cellular antioxidants to 
neutralize the excess of ROS and repair the oxidative damage, there could be serious 
consequences for the cells and/or cellular organelles [10]. For example, mitochondrial 
dysfunction can be caused by increased production of superoxide radical (O2−•), which 
represents another type of ROS, occurring when the DNA lesions, previously caused by 
high ROS levels, are not repaired [9]. Moreover, increased ROS production is also 
observed following the administration of certain drugs, such as doxorubicin [13]. Because 
of the ROS involvement in many physiological and pathological processes, over the last 
decades many research studies were focused on the development of ever more sensitive 
probes to selectively monitor ROS in living cells [14]. This would help to further elucidate 
their biological roles. The lanthanide complexes synthetized in this project should be able 
to signal the presence of ROS species, such as H2O2 and OH●, and for this reason, they 
may represent new tools finalized to measure the level of oxidative stress and studying 
the effects on mitochondrial function. They can be also applied to the screening of drug 
candidates during the drug development phase, where they can be employed to measure 
19 
 
the drug induced oxidative stress via ROS detection. This may allow to identify potential 
toxic drugs. Drug-induced oxidative stress is involved as a mechanism of toxicity in many 
tissues and organ systems, such as liver, kidney, cardiovascular and nervous systems 
[15]. For example doxorubicin, which is an anthracycline antibiotic used in numerous 
chemotherapy protocols, is well known to cause a dose-dependent cardiotoxicity that is 
associated with an increase of ROS production [15]. 
  
1.1 Photophysical Overview 
In this section, some concepts of general photophysics and lanthanide photophysics will 
be described before introducing the concept of luminescent molecular sensors. In 
particular, the absorption process, fluorescence and phosphorescence, and the 
photophysical properties of trivalent lanthanide ions will be described in the following 
sections. This aids in the description of the systems studied in this work and 
understanding their photophysical behaviour.  
 
1.1.1 Absorption Process 
According to the quantum theory, molecules can only take discrete energy values [1], 
[16]. These discrete values are called “energy levels”. There are three types of energy 
levels: rotational, vibrational and electronic. The electrons in atoms or molecules can 
change their energy level by absorbing or emitting a photon, whose energy must be 
equal to the difference between the two energy levels. This phenomenon is called 
electronic transition [1], [16]. Molecules can also undergo to rotational and vibrational 
transitions. Rotational transitions occur after the absorption of radiations with 
wavelengths falling in the microwave region of the electromagnetic spectrum. Vibrational 
transitions take place in the near infra-red region, while electronic transitions of the 
bonding electrons occur after the absorption of a molecule in the UV and in the visible 
region [1], [16] (Figure 1).  
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Figure 1. Energy level diagram describing A - the rotational changes, B – the vibrational changes and C - 
the electronic changes of the molecules energy.  
 
 
When the bonding electrons of organic molecules are in the ground state, they occupy 
the lowest energy orbitals according to Pauli’s Exclusion Principle [1], [16]. Therefore, 
the bonding orbitals σ, π (for unsaturated molecules) and n (non-bonding orbital for 
molecules containing heteroatoms such as N and O) are fully occupied, while the 
antibonding orbitals of type σ* and π* are empty. An electronic transition consists of the 
passage of an electron from a lower energy molecular orbital to a higher energy 
molecular orbital. For this reason electronic transitions in organic molecules can occur 
mainly in three ways: from an orbital σ to an orbital σ* (σ→σ* transition), from an orbital 
of type π to an orbital of type π* (π→π* transition) and from an orbital n to an orbital π* 
(n→π* transition) (Figure 2) [1], [16]. 
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Figure 2. Diagram of electronic transitions. 
 
 
For organic molecules transitions involving σ bonds (σ→σ* transitions) occur after the 
absorption of electromagnetic radiations with wavelengths falling in the region of the far 
UV, below 190 nm, because the energy difference between the two levels is quite high. 
π→π* and n→π* transitions take place in molecules containing double bonds and/or 
heteroatoms [1], [16]. These types of transitions occur after the absorption of 
electromagnetic radiations with wavelengths falling in the region of UV-visible. In order 
for absorption to occur it is necessary that the energy of the absorbed photon is equal to 
or greater than the energy difference between the ground state and the excited state. 
When a photon is absorbed, its energy is transferred to the electron which is promoted 
to a higher energy electronic orbital, thus leading the molecule to the excited state [1], 
[16]. The molar absorption coefficient (ε) (also called molar extinction coefficient or molar 
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absorptivity) is a measure of how strongly a substance absorbs light at a certain 
wavelength and is usually measured in M-1cm-1. The relationship between the molar 
absorption coefficient and the absorbance of a chemical species is governed by Beer-
Lambert's law [1], [16]:  
A = ε.l.c 
Where A represents the absorbance value, ε is the molar absorption coefficient, l is the 
path length and c is the molar concentration of the chemical species [1], [16].  
 
1.1.2 Fluorescence and Phosphorescence 
Luminescence is defined as the radiation emitted by a molecule, or an atom, after it had 
absorbed energy to go to an exited state [1], [16]. The main types of luminescence are 
the fluorescence and phosphorescence. Electronic states of organic molecules can be 
grouped into two main categories, singlet states and triplet states. In a singlet state all of 
the electrons of the molecule have their spins paired. In a triplet states one set of electron 
spin have become unpaired [1], [16]. A triplet state has always a lower energy than its 
corresponding singlet state [1], [16]. Figure 3 shows a partial energy diagram for a 
photoluminescence system.  
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Figure 3. The Jablonski diagram provides a representation of ground and excited electronic states of a 
molecule and the processes related to the absorption and emission (radiative and nonradiative) of energy.  
 
S0 represents the electronic ground state, S1 and S2 are the two electronic excited singlet 
states, and T1 is the excited triplet state. When an electron in a molecule is excited to 
the singlet state after the absorption of electromagnetic radiation, it returns to the ground 
state through both radiative and non-radiative processes. An example of non-radiative 
process is the vibrational relaxation, which is indicated on the Jablonski diagram (Figure 
3) as a curved arrow between vibrational levels. Vibrational relaxation is a non-radiative 
process because the energy transferred to the electron by a photon is then converted 
into kinetic energy [1], [16]. The vibrational relaxation takes place between the vibrational 
levels of the same excited state; therefore the electrons do not change their electronic 
level through this pathway. In fact through this pathway a molecule, which has been 
previously excited to one of the many vibrational levels of a singlet state, is conducted to 
the lowest vibrational level of the same singlet excited state. This means that photon 
emission always occurs from the lowest vibrational level of an excited state. If a molecule 
is excited to a singlet state S2 and if the lowest vibrational level of S2 overlaps with the 
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higher vibrational levels of the S1 state, a transition of the molecule from the lowest 
vibrational level of the S2 state to a higher vibrational level of the S1 singlet state can 
occur through another non-radiative process called internal conversion. During this 
process part of the molecular energy is converted into heat [1], [16] Once the molecule 
has reached a higher vibrational levels of the S1 state, vibrational relaxation leads the 
molecule to the lowest vibrational level of this state. At this stage the molecule returns to 
the ground state S0 through two pathways. One of these pathways is represented by the 
non-radiative process of internal conversion, which causes the conversion of all energy 
into heat as mentioned above. The other pathway is a radiative pathway involving the 
emission of a photon from the lowest vibrational level of S1. This process is called 
fluorescence and occurs in 10-9 to 10-7 seconds [1], [16]. The energy of the photon 
emitted is equal to the difference of energy between the lowest vibrational level of the 
exited singlet state (S1) and the ground state (S0). This means that the energy of 
fluorescent photons is in most cases lower than that of the exciting photons. Since the 
energy of an electromagnetic radiation (or a photon) is given by the product of the 
Planck’s constant (h) and the frequency (ν) (which is the inverse of the wavelength), 
generally the radiation emitted during the fluorescence occurs at wavelength longer than 
the one absorbed. The difference in energy (or wavelength) between the absorbed 
photon (or absorbed radiation) and the emitted photon (or emitted radiation) is known as 
the Stokes shift [1], [16]. (Figure 4). 
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Figure 4. The absorption and emission bands of a molecule. The difference in wavelength between the 
peaks is known as the Stokes shift. 
 
 
The average time a molecule stays in its excited state before emitting a photon is known 
as lifetime. Although the direct absorption of photon from the ground state to the triplet 
states is not an efficient process, in some molecules a more efficient process allows the 
population of triplet states from the lowest excited singlet state. This process is known 
as intersystem crossing. This is a spin-dependent internal conversion process because 
it involves the change in the electron spin and is usually indicated by a horizontal, curved 
arrow from one column to another. The mechanism for intersystem crossing involves 
vibrational coupling between the excited singlet state and a triplet state [1], [16]. Once 
the intersystem crossing has occurred, the molecule undergoes the usual vibrational 
relaxation process and reaches the lowest vibrational level of the triplet state. Once a 
molecule reaches this state, a radiative transition can occur leading the molecule in the 
ground state. This radiative process is called phosphorescence and occurs in 10-4 - 10-1 
seconds [1], [16]. Now that some basic concepts of photophysics have been introduced, 
it is possible to introduce the photophysical properties of the lanthanide ions, which will 
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be described in details in the following section. This will help to understand the 
photophysical behaviour of the systems studied in this project. 
 
1.1.3 Photophysical properties of Lanthanide ions 
The lanthanides are the group of 15 elements ranging from lanthanum (atomic number 
57) to lutetium (atomic number 71). All lanthanides, with the exception of lanthanum, are 
called f-block elements because of the gradual filling of last electrons in f-orbitals. When 
moving from cerium to lutetium, the 4f orbitals are gradually filled. The electronic 
configuration of lanthanide atoms is usually reported as [Xe]4fn6s2, where [Xe] 
represents the electronic configuration of the noble gas xenon, and n represents the 
number of electrons from 0 to 14 (0 for La to 14 for Lu). In aqueous solutions the majority 
of the lanthanides exist in the oxidation state +3 (Ln3+ where Ln is referred to any 
lanthanide). The electronic configuration of all trivalent lanthanide ions is [Xe]4fn-1, 
indicating that the 6s electrons and one 4f electron are lost. These f orbitals are shielded 
by the filled 5s2 and 5p6 sub-shells. Although these sub-shells are lower in energy, they 
are spatially extended outside the 4f orbitals causing their shielding. The shielding of the 
4f orbitals by the filled 5p6 and 5s2 sub-shells results in the characteristic spectroscopic 
properties of lanthanide ions. According to the Laporte’s parity selection rule the 4f-4f 
transitions are forbidden. It states that the electronic transitions between states with the 
same parity are forbidden [17], [18], [19]. The 4f-5d transitions are parity allowed but 
require high energy to occur, their intensity is quite weak and their emission bands are 
very broad. As consequence direct excitation of lanthanide ions only produces low level 
of luminescence (for 4f-4f transitions the molar absorption coefficient is of the order of 1 
M-1 cm-1) [17], [18], [19]. Some lanthanide ions are luminescent and the luminescence of 
some of them is easier to observe. The efficiency of a lanthanide ion emission depends 
on two main factors. The first factor affecting the efficiency of lanthanides emission is the 
ease with which the non-radiative deactivation pathways are minimized. Lanthanides 
emission is highly influenced by interaction with molecular vibrational modes. Stretching 
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of O-H bonds represents the most efficient quenching process, but N-H, C-H and C=O 
stretching vibrations may also have a significant contribute [20]. The efficiency of 
luminescence quenching is inversely proportional to the energy gap between the excited 
emissive state and ground state. Therefore lanthanide ions having a relatively bigger 
energy gap between their lowest energy excited states (emissive states) and ground 
states are less efficiently quenched by the surrounding molecular environment (Figure 
5).  
 
 
Figure 5. This figure shows the partial energy diagrams of some lanthanide ions. The main 
luminescent levels are drawn in red, while the fundamental levels are indicated in blue. 
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Another important factor influencing the efficiency of lanthanides emission is the facility 
with which their exited states can be populated. Ln ions are photochemically inert 
because direct photoexcitation is difficult due to their low molar absorption coefficient, 
associated with 4f–4f transitions of lanthanide ions. For effective excitation of Ln ions, 
they must be sensitized using an organic chromophore, so-called ‘‘antenna’’ [20]. In 
these systems, the photoexcited antenna successfully transfers its energy to the Ln ion 
(energy transfer (ET) process), producing the metal ion excited state thus allowing the 
lanthanide ion to luminesce (Figure 6).  
 
 
 
Figure 6. Schematic representation of the antenna effect. 
 
 
1.1.4 Sensitized lanthanide emission 
In the lanthanide complexes bearing an organic chromophore as sensitizer antenna, the 
absorption of a photon by the antenna promotes it to a high vibrational level of its excited 
singlet state S1. From this level the vibrational relaxation takes place leading the 
chromophore to the lowest vibrational level of its excited singlet state. If an intersystem 
crossing takes place the organic chromophore passes from the lowest level of its S1 to 
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the triplet state T1. From the triplet state, three competing processes can occur: back 
energy transfer through intersystem crossing to the singlet state, chromophore 
phosphorescence or energy transfer process to the excited state of lanthanide ion. If the 
sensitizer has a high molar absorption coefficient and the intersystem crossing and the 
energy transfer processes occur efficiently, the excited states of lanthanide ion can be 
populated leading to an intense emission from lanthanide ion after the irradiation with 
conventional light sources (Figure 7). For an energy transfer process to occur it is 
necessary that the energy level of the lowest vibrational level of the sensitizer triplet state 
is higher (> 1700 cm⁻¹) than the energy level of the lanthanide ion excited state. This 
prevents the back energy transfer from the lanthanide ion excited state to the sensitizer 
triplet state [21]. 
 
 
 
Figure 7. Jablonski diagram showing the indirect excitation of a lanthanide ion via an organic chromophore. 
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Despite the good overlap between the chromophore antenna and lanthanide ion energy 
levels, for a sensitised lanthanide emission a radiative energy transfer is unlikely to occur 
because of the low molar absorption coefficient of Ln(III). The energy transfer process 
therefore takes place by a non-radiative mechanism [22]. The energy transfer process 
from the sensitizer antenna to the lanthanide (III) can occur through one of the two non-
radiative energy transfer mechanisms; the Dexter (exchange) mechanism and the 
Förster (dipole-dipole) mechanism [22]. The emission spectra of lanthanide ions and 
their complexes consist of very narrow bands because they arise from inner-shell 
electronic transitions that are unaffected by the environment and occur at well-defined 
wavelengths [20]. For europium complexes, five emission bands are observed, which 
arise from electronic transitions from the lowest excited state,5D0, to the ground state, 
7FJ, (ΔJ = 0 to 4), with a maximum emission peak at about 616 nm, corresponding to ΔJ 
= 2 emission band (Figure 8). For terbium complexes, four intense bands are observed, 
originating from transitions from the emissive 5D4 level to the 7F6, 7F5, 7F4 and 7F3 levels 
of the ground levels, with a maximum emission peak at 545 nm, corresponding to the ΔJ 
= 1 band [20], [23], [24]. 
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Figure 8. Jablonski diagram showing the energy transfer process involved in the luminescence of Eu 3+ 
complexes of organic ligands.  
 
Since the general photophysics concepts and the photophysical properties of the 
trivalent lanthanide ions have been described so far, it is now possible to introduce the 
concept of a molecular sensor. In the following sections, a brief introduction of the 
concept of molecular sensors is provided, followed by a more detailed description of 
luminescent molecular sensors. In particular, the attention will be focused on the 
luminescent molecular sensors based on luminescent lanthanide complexes, since they 
represent the object of study of this project. 
 
32 
 
1.2 Molecular sensor 
A molecular sensor, also known as a chemosensor or probe, is a molecular system that 
is able to interact with a molecule or ion (analytes) and transform this interaction into a 
detectable signal that allows analyte sensing [25]. The signalling can take place for 
example by a change in the electrochemical, luminescence or NMR properties. Although 
there are many variable properties to choose from, photoluminescence is particularly 
attractive since it allows high sensitivity, real-time detection and relatively low cost [25]. 
  
1.2.1 Luminescent molecular sensors 
A luminescent molecular sensor can be defined as a molecular system able to signal the 
presence of a specific analyte (such as an anion, a cation or a molecule) via changes in 
its photophysical properties, such as absorbance profile or an enhancement or 
quenching of the emission profile [25]. Although there are many types of luminescent 
molecular sensors based on different sensing mechanisms, such as photo-induced 
electron transfer (PET), metal-ligand charge transfer (MLCT) and fluorescence 
resonance energy transfer (FRET), in this chapter the attention will be focused on the 
luminescent lanthanide-based molecular sensors since they represent the type of 
molecular sensor studied in this project. In the following sections, several examples of 
molecular sensors based on luminescent lanthanide-complexes will be described to 
provide a clear evidence of how their unique photophysical properties can be exploited 
for analyte sensing. The following examples of luminescent lanthanide-complexes also 
show how the luminescence of the lanthanide ions can be controlled by opportunely 
modulating the chemical structure of the ligand used for the complexation. This may help 
to understand the rational design behind and the mechanism of action of the molecular 
systems that are the object of study of this project. 
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1.2.1.1 pH Responsive lanthanide complexes  
In lanthanide-based chemosensors, the lanthanide usually represents the signalling unit, 
while the ligand contains the receptor unit able to bind the analyte. In some cases the 
signalling unit may also act as receptor unit. The interaction of the analyte with the 
receptor or signalling unit can be transduced into a luminescent response form the 
lanthanide, allowing the analyte detection. McMahon and co-workers developed a bright 
pH-responsive europium luminescent probe that localises selectively in the endoplasmic 
reticulum of living cells [26]. The chemical structure of this complex is reported in Figure 
9.  
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Figure 9. Representation of pH dependent sulphonamide ligation. 
 
High quantum yields of 50% were achieved by using multiple aryl-alkynyl groups as 
sensitizer antennae compared to the azaxanthone used by the authors in previous 
studies [26], which exhibited quantum yields of 6%. The aryl-alkynyl groups in 
combination with the pyridyl groups selectively localise the complex within the 
endoplasmic reticulum. The sulfonamide moiety confers pH-sensitivity to the probe: in 
acidic conditions the sulfonamide is protonated and cannot take part in the Eu(III) 
coordination thus opening a coordination site for one molecule of water (1) (Figure 9). At 
higher pH the sulfonamide is deprotonated and can participate in the Eu(III) coordination 
through the nitrogen and displacement of the water molecule (2) (Figure 9). The Eu(III) 
35 
 
emission spectra of the europium complex as a function of pH (0.1 M NaCl, 298 K) 
showed substantial changes in the splitting of the ΔJ = 1 transition and also in the form 
of the ΔJ = 2 and ΔJ = 4 spectral bands. In particular, an 80% increase of ΔJ = 2/[ΔJ = 
0 + ΔJ = 1] emission intensity over the pH range 4-10 was observed, consistent with a 
change in the Eu(III) coordination environment. Other examples of pH responsive Eu(III) -
based complexes was reported by Mark P. Lowe et al [27]. The luminescent properties 
of two Eu(III)-based complexes of two ligands formed by DO3A (1,4,7-
tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane), containing a pendant arm of 
diphenylphosphinamide moiety (dpp), were studied. The dpp moiety was used as 
chromophore antenna to sensitise the Eu(III) emission. The europium(III)-based 
emission of these complexes was recorded at pH 5.5, 8.4 and 10.0 upon excitation of 
the antenna at 270 nm. An overall increase in the intensity of the Eu(III) spectra as the 
pH moved toward more basic media was observed and the most significant change was 
the increase of the hypersensitive ΔJ = 2 band at around 617 nm [27]. The increased 
europium emission intensity observed in basic media could be attributed to the closer 
proximity of the chromophore to the Eu(III) center, which made the energy transfer more 
efficient and the fact that the Eu(III) coordination by the dpp moiety in basic media 
displaced a quenching water molecule, which further increased the Eu(III) emission 
intensity [27].  
 
1.2.1.2 Modulation of lanthanide(III) sensitization by altering the antenna-
lanthanide(III) distance 
As discussed in the section 1.1.4, the sensitization of lanthanide complexes occurs via 
energy transfer from the triplet excited state of the antenna to the lanthanide(III) ion. 
Researchers have exploited the distance-dependence of the energy transfer process to 
modulate luminescence through altering the distance between the sensitizer antenna 
and the lanthanide(III) ion. While an obvious way to do this is to increase the number of 
bonds between the antenna and the Ln3+ [28], it has also been achieved reversibly 
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through complexation. Pierre et al. designed a water soluble Eu(III)-based probe (3) to 
signal the presence of K+ [29]. The chemical structure and mode of action of this complex 
(3) are reported in Figure 10.  
 
 
 
Figure 10. Structure and mode of action of the Eu(III)-probe (3). 
 
Complex (3) contains a phenanthridine group that acts as Eu(III) sensitizer antenna and, 
together with the crown ether, as K+ complexing group. The complexation of K+ by the 
crown ether and the phenanthridine group (via a cation-π interaction) caused a decrease 
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of the distance between the antenna and the Eu(III), which in turn caused an increase of 
the Eu(III)-based luminescence as consequence of an improved energy transfer process 
from the phenanthridine antenna to the lanthanide ion [29].  
 
Switch-off probes have been designed exploiting the reverse strategy where the analyte 
of interest causes the dissociation of a coordinating antenna thus preventing it to act as 
sensitizer [29]. Gunnlaugsson and co-workers have used the coordinating water soluble 
antenna 4,7-diphenyl-1,10-phenanthroline-disulfonate (BPS) to signal the presence of 
dicationic transition metals, such as Fe(II) [30]. The chemical structure and the mode of 
action of the Eu(III)-based luminescent probe (4) are reported in Figure 11. 
 
 
 
 
Figure 11. Structure and mode of action of the Eu(III)-probe (4). 
 
In absence of Fe(II), the BPS antenna coordinated the Eu(III) and sensitized its 
luminescence. In the presence of Fe(II), the BPS antenna, which has a high affinity for 
Fe(II), coordinated the Fe(II) forming a Fe(II)-BPS3 complex. The displacement of the 
BPS antenna on the Eu(III) complex induced by the Fe(II) prevented the antenna to act 
efficiently as sensitizer and consequently a very low Eu(III) emission was observed [30].  
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1.2.1.3 Lanthanide complexes based on analyte-triggered antenna formation.  
This section describes an example of luminescent lanthanide complexes containing pro-
antennae masked by reactive cages. Pershagen and co-workers reported examples of 
lanthanide complexes based on caged coumarin antennae [31]. The general chemical 
structure (5) and the mode of action of these complexes in illustrated in Figure 12.  
 
 
Figure 12. General chemical structure and mode of action of lanthanide complexes based on caged 
coumarin antennae.  
 
In these complexes, the pro-antenna was derivatised (caged) with either phenylboronic 
acid, triisopropylsilane, allyl, or galactose cages for the detection of hydrogen peroxide, 
fluoride, palladium, or β-galactosidase, respectively. In the presence of the analyte, the 
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cage was removed as consequence of the reaction with the analyte, triggering the 
formation of the coumarin antenna, which was then able to sensitize the Ln(III) 
luminescence. While selectivity for hydrogen peroxide, fluoride, and β-galactosidase was 
not tested, the palladium probe was selective over other transition metals [31]. Moreover 
the authors demonstrated that the hydrogen peroxide and fluoride probes were able to 
signal the presence of their respective analytes with no detectable cross interference 
[31].  
 
1.2.1.4 Other examples of luminescent molecular sensors based on lanthanide-
complexes 
An example of how the photophysical properties of luminescent lanthanide complexes 
can be exploited to selectively signal the presence of analytes, even in a complex 
biological environment, was reported by Bruce et al. [32]. In this study, the synthesis and 
the anion binding behaviour of a series of Eu(III) and Tb(III) complexes were reported. 
The chemical structure of one of the lanthanide complexes synthesised and tested in 
this study (6) is shown in Figure 13. Compound (6) is the triflate salt of an Eu(III)-based 
complex, whose ligand is formed by a trisubstituted cyclen containing three identical 
moieties of  phenyl ethyl amine derivatives.  
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6 
Figure 13. Chemical structure of the Eu(III)-based complex (6). 
 
 
The emission of (6) was recorded in presence of several anions, such as NaHCO3, 
Na2HPO4, sodium lactate and disodium malonate, and the related emission profiles were 
compared with the emission profile recorded in absence of added anions. Significant 
changes of the emission profile of the Eu(III) complex (6) were observed upon addition 
of each anion. These changes were particularly significant upon the addition of the 
NaHCO3, indicating that (6) was able to selectively sense HCO3- among a broad range 
of anions. This selectivity was particularly useful when the complex (6) was going to be 
tested in a complex biological environment. The comparison between the emission 
spectra of (6) recorded in absence and presence of HCO3- showed that in the latter case 
ΔJ = 0 emission band reduced in intensity by a factor of 4 and the ΔJ = 2/ΔJ = 1 ratio 
doubled. The changes of emission profiles observed with the complex (6) following the 
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addition of the anions were due to the changes of the coordination environment of Eu(III). 
These changes in turn were due to the replacement of two molecules of H2O, involved 
in the Eu(III) coordination, with the anion. The reversible replacement of two molecules 
of H2O with HCO3- anion is depicted is shown in Figure 14.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Reversible HCO3- binding to the Eu(III) core of complex 6.  
 
 
The bicarbonate signalling by luminescent lanthanide-based complexes was further 
investigated by Parker et al. [33]. In this study, a series of Eu and Tb complexes of four 
different ligands containing an azaxanthone as sensitizer antenna were evaluated as 
probes for the bicarbonate anion. The four ligands were complexed with Eu(III) and 
Tb(III), giving rise to two series of complexes: one including four Eu(III) complexes and 
the other comprising the Tb(III) complexes. Since similar results were obtained along the 
Eu(III)-series, and since the results were also similar for the complexes belonging to the 
Tb(III) series, in this section the photophysical behaviour of one Eu(III) and one Tb(III) 
complexes of the same ligand will be discussed as representative of the Eu(III) and 
Tb(III) series respectively. The structures of the Eu(III) and Tb(III) complexes (complexes 
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(7) and (8) respectively), whose photophysical properties are descried in this section, are 
shown in Figure 15. 
 
 
Figure 15. Chemical structures of two lanthanide complexes synthetized and tested by Parker et al. (7) is 
the Eu(III) complex, while (8) is the Tb(III) complex and both were obtained starting from the same ligand 
bearing an azaxanthone as sensitizer.  
 
The emission of (7) was recorded during the titration with sodium bicarbonate up to a 
final concentration of 30 mm. A large increase in emission intensity was observed across 
the Eu(III) emission spectrum, particularly with the ΔJ = 2 emissive band. The maximum 
of the ΔJ = 2 band shifted slightly upon bicarbonate binding from 614 to 616 nm and 
changes to the overall form of emission were observed, mainly within the ΔJ = 1 band. 
The emission of (8) was recorded upon incremental addition of sodium bicarbonate 
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solutions. Although the presence of bicarbonate induced an increase of the relative 
intensity of Tb(III) emission, this increase was less intense compared to the large 
increase observed with (7) upon bicarbonate addition. The effect of a protein background 
upon bicarbonate binding was also examined in this study. In this case, the emission of 
Eu(III) of (7) was monitored upon incremental additions of sodium bicarbonate to (7) 
dissolved in a fixed human serum albumin (HSA) solution. A significant increase of the 
Eu emission and a shift in the ΔJ = 2 maximum from 614 to 616 nm were observed upon 
addition of sodium bicarbonate and these results were consistent with those observed 
when protein was not present. The terbium analogue (8) showed a change of less than 
20% in spectral emission intensity following addition of the same concentration of 
bicarbonate. The different responses observed for (7) and (8)  to the presence of 
bicarbonate in a fixed background of protein was exploited by Parker et al. to measure 
bicarbonate concentrations in a biological medium by monitoring the europium to terbium 
emission intensities ratio. This was achieved using a lanthanide-tandem system formed 
by a mixture of Eu(III) and Tb(III) complexes of a common ligand, where the terbium 
complex served as an internal reference for the strong emission intensity achievable with 
the europium analogue. Incremental additions of sodium bicarbonate to a mixture of (7) 
and (8)  in 3:2 ratio, dissolved in a medium containing HSA, citrate, lactate, phosphate 
and ATP, were monitored by measuring the variation of the Eu/Tb emission intensities 
ratio. The higher proportion of the Eu(III) complex was essential to start at a point where 
the ratio of emission intensities was approximately unity, as terbium was the more 
emissive complex. An increase of the europium/terbium intensities ratio was observed 
upon bicarbonate addition, suggesting that this tandem system could be applied for 
bicarbonate concentration measurements in biological fluids. The tandem 
europium/terbium emission method was then tested in a human serum. Even in this case 
a significant increase of the europium/terbium emission intensities was observed upon 
addition of bicarbonate. The europium/terbium emission intensities ratio measured upon 
addition of bicarbonate allowed the estimation of unknown values of bicarbonate 
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concentration for real-life serum samples. The tandem europium/terbium emission 
method also proved to be effective for the calculation of mitochondrial levels of 
bicarbonate in several different cell types. In this assay the mitochondria were the target 
organelles since the Krebs cycle and glycolysis both produce mitochondrial CO2 that is 
converted into bicarbonate for transport [34].  
 
1.2.1.5 Examples of luminescent lanthanide complexes as cyanide and fluorine 
anions sensors 
Other examples of luminescent lanthanide-based complexes able to detect the presence 
of anions in aqueous solutions were recently reported by Routledge et al. [35]. In this 
study the synthesis and anion binding behaviour of three Eu(III) complexes were 
reported. In particular, the ability of these complexes of signalling the presence of 
cyanide and fluorine anions in aqueous solutions was examined. The chemical structures 
of the lanthanide complexes (9), (10) and (11) developed by Routledge et al. are shown 
in Figure 16.   
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Figure 16. Chemical structures of complexes (9), (10) and (11).  
 
Complexes (9) and (10) contain a phenacyl group that coordinates the Eu(III) through 
the carbonyl oxygen and in addition provides an antenna chromophore used for the 
sensitization of the lanthanide ion. The coordination of Eu(III) by the phenacyl group had 
two effects: it facilitated the energy transfer process from the chromophore to the 
lanthanide and in the meantime polarized the carbonyl group thus increasing its 
susceptibility to the attack by external nucleophiles. Such a binding event could cause a 
disruption of the chromophore antenna, thereby changing the effectiveness of energy 
transfer. The response of (9) and (10) to cyanide and fluoride ions was tested through 
emission and NMR spectroscopy and changes in emission and NMR spectra were 
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examined. A significant decrease in the relative intensity of the Eu(III) emission was 
observed for both complexes (9) and (10). However, the Eu(III) emission spectra of (9) 
and (10) obtained upon the addition of cyanide ion did not show any difference in the 
peak shapes compared  the Eu(III) emission spectra recorded before adding cyanide. 
This indicated that the coordination environment of the metal centre did not undergo any 
change, thus confirming that the water molecule was still involved in the lanthanide 
coordination and was not replaced by cyanide ion. Therefore, the decrease of the relative 
intensity of the Eu(III) emission could not be attributable to the perturbation of the 
coordination environment of Eu(III) caused by cyanide. It was rather the consequence of 
the nucleophilic attack by cyanide ion to the polarized carbonyl function of the phenacyl 
antenna, which was converted into its corresponding cyanohydrin form. This in turn 
caused a perturbation of the sensitizer antenna thus reducing the effectiveness of the 
energy transfer process from the antenna to the lanthanide ion, which resulted in a 
lowered intensity emission. This mechanism is illustrated in the Figure 17, which shows 
the reversible binding of the cyanide ion to (9) and (10) that led to the cyanohydrin 
formation. 
 
 
 
Figure 17. Cyanohydrin formation caused by the nucleophilic attack by cyanide ion to the carbonyl function 
of the antenna. X = F in complex (9) and X = Br in complex (10).  
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The changes in the NMR spectra recorded for (9) and (10) following cyanide addition 
showed the presence of a cyanohydrin derivative thus confirming the mechanism 
responsible for the lowered Eu(III) emission observed upon cyanide addition. While both 
complexes (9) and (10) were responsive to the presence of cyanide ion, they did not 
show any response to changes in fluoride ion concentration. Indeed, a completely 
inverse situation was observed for complex (11) that proved to be responsive to changes 
in fluoride concentration and unresponsive to cyanide.  
 
1.2.1.6 Examples of luminescent lanthanide complexes as phosphorylated amino 
acids and hexapeptides sensors 
Other examples of luminescent lanthanide complexes were recently developed by 
Parker et al. to signal phosphorylated amino-acids and O-phosphorylated hexapeptides 
[36]. The two Eu(III) complexes, (12) and (13), examined in this study were based on an 
achiral heptadentate triazacyclononane ligand bearing two strongly absorbing 
chromophores and their chemical structures are shown in Figures 18 and 19 
respectively.  
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Figure 18. Chemical structure of (12).  
 
Figure 19. Chemical structure of (13).  
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The two Eu(III) complexes were not coordinated by a solvent molecule since the steric 
hindrance caused by the benzylic substituent prevented solvent coordination. The anion 
binding properties of (12) and (13), towards hydrogenphosphate were examined before 
studying the phosphorylated amino acid and hexapeptide anions. The emission of (12) 
and (13), was monitored upon incremental addition of aqueous solutions containing 
hydrogen phosphate and the changes in the relative intensity and form of the Eu(III) 
emission spectrum were examined. Complex (13), showed no change in europium 
spectral form with added hydrogenphosphate while complex (12) exhibited a significant 
modulation. The differences in hydorgenphosphate response shown by (12) and (13) 
were due to the fact that in (12), the presence of the N-methyl ammonium group on the 
benzyl ring acting as hydrogen donor, favoured the hydrogen bonding with 
hydrogenphopshate, thus facilitating its incorporation into the coordination sphere of the 
metal centre, which in turn caused variation of the Eu(III) emission profile. The emission 
spectral changes of (12) were investigated following the addition of O-P-Ser, O-P-Thr 
and O-P-Tyr, which are O-phosphorylated amino acids. The Eu(III) emission spectra 
recorded upon the addition of the phopshorylated amino acids were all similar to that 
following the addition of hydrogenphosphate, and the changes that occurred were not 
significant, except in the ΔJ = 4 and ΔJ = 1 emissive bands. However, these changes 
were accompanied by a strong CPL signal upon addition of O-P-Ser or O-P-Thr to (12). 
CPL stands for circularly polarized luminescence.  No CPL signal was induced by 
addition of O-P-Tyr indeed, indicating that (12) was selective towards the O-
phopshorylated serine and threonine. Moreover, the response of (12) to a series of 
phosphorylated amino acids was also investigated. Three phosphorylated peptides, 
containing the same amino acid sequence and only varying for the type of 
phosphorylated amino acid and the number of phosphorylated sites, were selected for 
this study. In particular, one peptide containing a phosphorylated residue of serine, one 
peptide containing a phosphorylated residue of tyrosine, and another peptide containing 
phosphorylated residues of serine and tyrosine were tested. The corresponding non-
50 
 
phosphorylated peptide was also studied as a control. The addition of the non-
phosphorylated control peptide resulted in no induced CPL indeed, providing further 
evidence that the peptide binds to the Eu(III) centre via the phosphate group. The 
induced CPL spectral response of the O-P-Ser peptide was opposite in sign and form to 
that of O-P-Tyr peptide, suggesting that the chiral structure of the entire peptide when 
bound to the lanthanide centre could be associated with the induced CPL response. The 
di-phosphorylated peptide, containing both a phosphorylated serine and tyrosine 
residue, induced a CPL signal much less intense than for the other two peptides, and 
seemed to be the result of an additive sum of the two separate spectra. This could be 
explained considering that (12) had no preferential binding site, as the calculated affinity 
constants for the O-P-amino acids were the same. Therefore, the emission spectrum 
observed was a combination of (12) bound to the O-P-Ser of the peptide and the O-P-
Tyr residue.  
The ligands used in the systems examined so far were almost symmetric since they were 
based on trisubstituted cyclen ligands containing two identical pendant arms or on 
tetrasubstituted cyclen ligands bearing three identical pendant arms. The luminescent 
lanthanide complexes that will be examined in the next section represent examples of 
more sophisticated systems whose ligands are based on asymmetrically substituted 
cyclen ligands, containing three different pendant arms [37], [38]. These examples will 
show how the use of asymmetrically substituted cyclen-based ligands allow a major 
control on the sensitization of the lanthanide ions and how this feature is particularly 
useful in sensing analytes difficult to be accurately detected in complex biological 
environments. 
 
1.2.1.6 Examples of luminescent lanthanide complexes based on asymmetrically 
substituted cyclen ligands. 
Most luminescent lanthanide complexes reported in the literature, some of which have 
been examined in the previous section, are able to signal the presence of substrates by 
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an increase or decrease in luminescence intensity or changes in the emission spectral 
form. This makes the analyte detection sometimes ambiguous. Bruce et al. reported a 
series of lanthanide-based luminescent sensors that were non-emissive in absence of 
the analytes of interest, and became emissive upon analyte binding [37]. This was be 
achieved by using unsymmetrical cyclen-based ligands incorporating an antenna and a 
quencher. The general chemical structures of these systems are shown in Figures 20 
and 21. 
 
Figure 20. General chemical structure of Eu(III) and Tb(III) complex developed in this study. Base is 
represented by uridine (U) or adenosine (A). The trivalent lanthanide ions (Ln) used in this system are Eu(III) 
and Tb(III). The sensitizer antenna is coumarin 2.  
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Figure 21. General chemical structure of Nd(III) and Yb(III) complex developed in this study.  Base is 
represented by uridine (U) or adenosine (A). The trivalent lanthanide ions (Ln) used in this system are Nd(III) 
and Yb(III). The sensitizer antenna is rhodamine.  
  
In their systems, Eu(III) and Tb (III) were sensitised with coumarin 2, while Nd(III) and 
Yb(III) with rhodamine [37]. Both antennae were paired with nucleoside (uridine and 
adenosine) quenchers. The interaction between the quencher and the antenna could be 
regulated by the addition of the complementary base or DNA to the complexes, resulting 
in changes in the lanthanide luminescence intensity. In the absence of substrates, the 
quencher could disrupt the energy transfer from the antenna to lanthanide ion resulting 
in the inhibition of its luminescence. As the complementary base or DNA was added to 
the solution containing the complex, a strong luminescence from the lanthanide could be 
detected as consequence on quencher-complementary base or DNA interaction. Among 
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the systems developed in this study, the Nd (III)-based complex containing rhodamine 
as sensitizer and adenosine as base showed the desired switch off-on luminescence 
upon addition of DNA or the complementary base uridine. Quenching of the rhodamine 
antenna by the adenosine quencher was almost complete since only a very weak Nd(III) -
based luminescence was observed in absence of substrate following excitation of the 
rhodamine antenna at 355 nm. Upon addition of substrate the non-luminescent probe 
was turned on and a strong Nd(III) based luminescent was observed upon excitation at 
355 nm. The switching off-on property of the Nd(III)-based complex developed by Bruce 
et al. provides a valid example of how the use of asymmetrically substituted cyclen-based 
ligands can allow a tighter control the luminescence of lanthanide ion compared to the 
control achievable when more symmetric substituted cyclen-based ligands are 
employed. Other examples of how asymmetrically substituted cyclen-based ligands 
could be exploited to develop luminescent lanthanide-based sensors possessing a tight 
control of the lanthanide ion sensitization were reported by Bruce et al. [38]. In this study, 
the synthesis, characterization and photophysical properties of two asymmetrically 
substituted cyclen-based near IR-emitting lanthanide complexes were reported. Their 
chemical structures are shown in Figure 22. These systems possessed a common ligand 
based on an symmetrically substituted cyclen complexed with the near IR-emitting Nd(III) 
and Yb(III) in complex (14) and (15) respectively (Figure 22).    
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Figure 22. Chemical structures of compound (14) and (15) that were developed in this study.  
 
The Nd(III) and Yb(III) were sensitised by rhodamine, which in turn is excited by energy 
transfer from a coumarin 2 moiety. An energy transfer cascade consisting of two 
processes occurred in these systems allowing the sensitization of Nd(III) and Yb(III): one 
energy transfer process from coumarin 2 to rhodamine and another from rhodamine to 
Nd(III) and Yb(III) in (14) and (15) respectively (Figure 23). The energy transfer cascade 
covered the UV-visible-near IR region of the spectrum, resulting in large Stokes shifts. 
Excitation of the coumarin 2 moiety at 355 nm resulted in the direct excitation of the 
rhodamine moiety and consequent emission from the lanthanide ion.  
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Figure 23. The energy transfer cascade initiated by excitation of the coumarin 2 moiety proceeds through 
the rhodamine antenna, resulting in lanthanide emission. The cascade can be disrupted by intercalative 
quenching of the coumarin 2 by DNA. 
 
 
Both compounds (14) and (15) in methanol showed the characteristic near IR emission. 
(14) had an emission band at 890 nm and one at 1064 nm, while (15) emitted at 980 nm. 
The total emission intensity of (14) at 1065 nm showed a significant decrease upon 
treatment with 1 equiv. of dsDNA, due to quenching of the coumarin 2 moiety by the 
DNA-strands. This quenching effect resulted from an intercalation effect exerted by DNA 
on the coumarin 2. Changes similar to (14) emission were observed for (15) emission 
band at 980 nm, although the effect was less pronounced. The decrease of the 
lanthanide emission observed with both (14) and (15) upon DNA addition was due to the 
disruption of the energy transfer process from the coumarin 2 to rhodamine. 
 
 
 
  
 
56 
 
1.3 Reactive Oxygen Species (ROS) 
In this section a description of ROS is provided since they represent the type of analytes 
for whose detection the lanthanide complexes developed in this project were designed. 
The ROS overview will be followed by a description of the biological processes involved 
in the ROS production and their biological roles. This would be help to understand the 
designing of the molecular systems studied in this project and the photophysical 
behaviour observed during both the cuvette- and cell- based tests performed to evaluate 
their ability to generate a ROS response, which are described in detail in the chapters 4 
and 5 respectively. The detailed description of the mitochondrial electron transport chain 
(ETC) provided below will be also useful to understand the effects of the lanthanide 
complexes developed in this project on the mitochondrial and/or cellular functions during 
the cell- and isolated mitochondrial-based tests performed on these compounds to 
assess their potential mitochondrial or cellular toxicity. These tests and their related 
results are described in details in the chapter 5.    
Reactive oxygen species (ROS) are chemically reactive molecules that are naturally 
produced within biological systems. There are diverse types of ROS including: 
superoxide anion, hydrogen peroxide, peroxide, hydroxyl radical and hydroxyl ion 
(Figure 24). 
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Figure 24. Electron structures of common reactive oxygen species . Each structure is provided with its 
name and chemical formula. The • designates an unpaired electron.  
 
When the molecular oxygen O2 is in its ground state (also called triplet state) it contains 
two unpaired electrons in the outer shell and so it is not highly reactive with the two 
electrons in a chemical bond. This is due to the fact that the two unpaired electrons in 
the molecular oxygen have the same spin and as consequence it can only react with one 
electron at a time. Molecular oxygen can be, however, converted to more reactive 
species containing oxygen. Energy transfer to O2 leads to the formation of the more 
reactive molecular oxygen form, singlet oxygen (1O2). Singlet oxygen has paired 
electrons with opposite spins and as consequence it can quickly react with other pairs of 
electrons, especially those involved in a double bond [39], [41], [42]. Singlet oxygen can 
form during lipid peroxidation and contribute to damage because of its ability to readily 
oxidize lipids, proteins and DNA [40], [41], [42]. The reduction of oxygen by one electron 
produces relatively stable intermediates. Superoxide anion (O2−•), the product of a one-
electron reduction of oxygen, is the precursor of most ROS and is involved in oxidative 
chain reactions. Dismutation of O2−• (either spontaneously or through a reaction 
catalyzed by superoxide dismutases) produces hydrogen peroxide (H2O2), which in turn 
may be fully reduced to water or partially reduced to hydroxyl radical (OH•), one of the 
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strongest oxidants in nature. The formation of OH• is catalyzed by reduced form of 
transition metals, which in turn may be re-reduced by O2−•, propagating this cyclic 
process [8], [43]. OH• can hydroxylate the position number 8 of the ring structure of 
guanine in DNA; the initial product is an 8-hydroxy-2’-deoxyguanosine radical, which can 
cause mutagenic lesion [44]. OH• can also attack other bases and the deoxyribose sugar 
in DNA, producing massive damage [45]. 
  
1.3.1 Electron transport chain (ETC) and Oxidative phosphorylation. 
Oxidative phosphorylation is the process in which ATP is formed through electron 
transfer from NADH or FADH2 to molecular oxygen via the electron transport chain (ETC) 
[46], [47]. Oxidative phosphorylation of eukaryotes takes place in the mitochondria. 
Mitochondria are ovoid shape cellular organelles, with a length of about 2 µm and a 
diameter of about 0.5 µm. The mitochondria have two systems of membranes: an outer 
membrane and a very extended and folded inner membrane. The inner membrane forms 
a series of folds called cristae. So there are two compartments in mitochondria: 
intermembrane space (the space between the inner membrane and the external 
membrane) and the matrix (the space delimited by the inner membrane) (Figure 25). 
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Figure 25. Mitochondrion 
 
The driving force of oxidative phosphorylation is the electron transfer potential of NADH 
or FADH2 relative to that of O2. The related half-reactions are: 
½ O2 + H+ + 2e- → H2O                              E’0 = +0.82 V                 (a) 
NAD+ + H+ + 2e- → NADH                         E’0 = -0.32 V                   (b) 
Subtracting reaction b from reaction a yields: 
½ O2 + NADH + H+→ H2O + NAD+                ΔE’0 = +1.14V                (c) 
 
The redox potential for the NAD+:NADH redox couple is E’0 = -0.32 V, while the redox 
potential for the O2:H2O redox couple is E’0 = +0.82 V, where E’0 represents the reduction 
potential (also called the redox potential or oxidation-reduction potential). This means 
that the difference between the redox potentials of NADH and O2 (ΔE’0) is +1.14V [44]. 
The electrons are transferred from NADH to oxygen through a chain of four protein 
complexes in the inner mitochondrial membrane. These complexes are numbered 
according to the order with which the electrons pass through them (Figure 26). The 
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electrons of NADH enter into the chain at the level of NADH-Q reductase (also called 
NADH dehydrogenase or Complex I). NADH binds to the complex I and the transfers its 
high-energy electrons to flavin mononucleotide (FMN) producing the reduced form 
FMNH2 [46], [47]. The electrons are then transferred from FMNH2 to a series of iron-
sulphur (Fe-S) centres. The iron atoms of these centres cyclically pass from the 
ionization state +2 (reduced) to the state +3 (oxidized). The electrons are then 
transferred from the iron-sulphur centres of the NADH-Q reductase to the coenzyme Q, 
also known as ubiquinone. The ubiquinone is reduced to semiquinone free radical when 
it receives a single electron, while the reduction of this intermediate with a second 
electron leads to the formation of ubiquinol (QH2) [46], [47]. The flow of two electrons 
from NADH to QH2 through the NADH-Q reductase causes the transport of four H+ ions 
from the matrix to the cytosolic side of the inner mitochondrial membrane. The electrons 
of FADH2 are transferred to the coenzyme Q by the complex of the succinate-Q 
reductase (Complex II), producing the reduced form QH2. The complex II is not a proton 
pump (it does not transfer H+ ions) consequently, less ATP is formed by the oxidation of 
FADH2 compared to the oxidation of NADH [46], [47]. The third complex of the respiratory 
chain is the cytochrome reductase (also called ubiquinol-cytochrome c reductase, 
cytochrome, cytochrome bc1 complex or Complex III). In general, a cytochrome is a 
protein containing a heme prosthetic group that transports electrons [46], [47].  
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Figure 26.  The picture shows a schematic representation of the mitochondrial electron transport chain. 
 
Also in this case the iron of the heme group passes from the oxidation state +2 (reduced) 
to the oxidation state +3 (oxidized) and vice versa. The function of the cytochrome 
reductase is to catalyse the transfer of electrons from QH2 to cytochrome 2, a water-
soluble protein, and at the same time to transfer protons H+ through the inner 
mitochondrial membrane. In particular the flow of two electrons through this complex 
causes the effective net transport of two H+ to the cytosolic side, half of the yield obtained 
with the NADH-Q reductase due to a lower thermodynamic driving force. The final 
complex chain of electron transport is the cytochrome oxidase, (also called Complex IV), 
an enzyme that catalyses the transfer of electrons from ferrocytochrome c (the reduced 
form) to molecular oxygen, the final acceptor [46], [47], [41]: 
4 cytochrome c (+2) + 4 H+ + O2 → 4 cytochrome c (+3) + 2 H2O 
62 
 
For a complete reduction of O2 to H2O, four electrons are transferred from the cytochrome 
c to O2 and concurrently protons (H+) are transferred from the matrix to the cytosolic side 
of the inner mitochondrial membrane. 
The electron transfer along the ETC causes the transport of protons (H+) from the matrix 
side to the cytosolic side of the inner mitochondrial membrane [47], [48]. This generates 
a pH gradient across the inner mitochondrial membrane, with the pH higher in the matrix 
than in the intermembrane space of about 1 unit [47], [48], and a voltage gradient 
(membrane potential, ΔV) across the inner mitochondrial membrane, with the inside 
negative and the outside positive (as a result of the net outflow of H+) [47], [48]. Together, 
the ΔpH and the ΔV thus generate an electrochemical proton gradient [47], [48]. The 
electrochemical proton gradient across the inner mitochondrial membrane is used to 
drive ATP synthesis in the process of oxidative phosphorylation. The synthesis of ATP 
is catalyzed by the enzyme ATP synthase or Complex V (Figure 26). This enzyme 
generates a hydrophilic pathway across the inner mitochondrial membrane that allows 
protons to flow from the inner membrane space to the matrix following their 
electrochemical gradient. As these ions flow down through the ATP synthase, they are 
used to promote the endergonic reaction of the ATP synthesis from ADP and Pi [46], 
[47]. 
  
1.3.2 ROS Production 
In eukaryotes, the main biological system where ROS are produced is represented by 
the electron transport chain (ETC), located in internal mitochondrial membrane [49], [50], 
[51]. As discussed in the above paragraph (1.4.1), the transfer of four electrons from the 
cytochrome c to O2 leads to the formation of a non-toxic product (two molecules of H2O), 
while the partial reduction of O2 generates potentially very dangerous compounds for the 
cells known as ROS [49], [50]. In mitochondria ROS are generated via escaping of 
electrons from ETC. The two principal sites of superoxide generation that have been 
identified in mitochondria are complex I and complex III. The amount of electrons 
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escaping ETC varies broadly and depends on physiological state of organisms [49], [51]. 
In living organisms under aerobic conditions more than 90% of oxygen consumed is 
reduced directly to water by cytochrome oxidase in ETC through  four-electron 
mechanisms and without ROS production (Figure 27) [49], [50], [51]. Much less than 
10% (1-5%) of oxygen consumed is reduced via one-electron pathways resulting in the 
partial reduction of molecular oxygen to superoxide anion radical (O2●-) (Figure 27) [49], 
[50], [51]. The production of  superoxide anion radical is followed by one-electron 
reduction with concomitant accepting of two protons to yield hydrogen peroxide (H2O2) 
(Figure 27) [49], [50], [51]. Then the hydrogen peroxide accepts one more electron and 
is converted into hydroxyl anion (HO-) and hydroxyl radical (OH●) (Figure 27). Finally, 
the hydroxyl radical reacts with one more electron and proton resulting in formation of 
water molecule. In biological systems, this reaction mainly occurs through the abstraction 
of a hydrogen atom from several compounds such as proteins and lipids and this results 
in the initiation of chain reaction processes [49], [50], [51]. 
 
Figure 27. Reduction of molecular oxygen via four- and one-electron schemes. 
 
The O2●- can be neutralized by the superoxide dismutase, an enzyme that catalyses the 
reaction between two O2●- to form H2O2 and H2O [46]. 
O2●- + O2●- + 2H3O+ → H2O2 + 2H2O + O2 
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The H2O2 formed by the reaction catalysed by the superoxide dismutase, is converted 
into H2O and O2 by the enzyme catalase [46].  
H2O2 + H2O2 → 2 H2O + O2 
The H2O2 can be also partially reduced to OH• by reduced transition metals. In the case 
of iron, this reaction is known as Fenton reaction [52]: 
Fe2+ + H2O2 → Fe3+ + OH• + OH-        (Fenton reaction) 
O2●- participates in the Haber-Weiss reaction which combines a Fenton reaction and the 
reduction of Fe3+ by O2●-, yielding Fe2+ and O2 [11].  
The Haber–Weiss reaction is: 
O2●- + H2O2 → O2 + OH• + OH-           (Haber-Weiss reaction) 
Indeed, the reduction of Fe3+ by O2●- is: 
Fe3+ + O2●- → Fe2+ + O2 
Apart from the mitochondria ETC, minor amounts of ROS are produced by ETC located 
in/at endoplasmic reticulum (ER), plasmatic, and nuclear membranes as well as some 
oxidases [53], [54]. ROS are also produced as consequence of the autoxidation of 
different small molecules of endo- and exogenous origin. Epinephrine (adrenalin) and 
norepinephrine provide a good example of endogenous molecules that undergo to 
autoxidation associated with ROS production [55]. ROS are also produced by ionizing 
and UV radiation and from the metabolism of a wide range of drugs and xenobiotics [40].  
 
1.3.3 Dual role of ROS 
The generation of ROS can be either beneficial or harmful. ROS at normal levels are 
involved in many cellular responses including cell growth and immune response [11], 
[56]. For example, during the oxidative burst occurring in an inflammatory process, 
activated neutrophils and macrophages produce large amount of O2●- and other ROS 
via the phagocytic isoform of NADPH oxidase. The concentration of H2O2 under such 
conditions may reach a level of 10-100 μM [11]. The rapid release of ROS during the 
oxidative burst represents a defence mechanism against pathogens [11]. ROS have also 
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a cell signalling role in many biological systems. ROS play important roles in cell 
proliferation, cell death, activation or suppression of many genes expression. ROS are 
also responsible for activating cell signalling cascades, such as those involving mitogen-
activated protein kinases [57]. Although ROS play a key role in many physiological 
processes, overproduction of ROS results in oxidative stress that can be responsible for 
damage to important cell structures, such as lipids and membranes, proteins, and DNA. 
Cells possess enzymatic and non-enzymatic antioxidants that work in synergy to 
regulate the ROS levels and prevent oxidative damages [12]. The main cellular 
antioxidant enzymes are superoxide dismutase (SOD), glutathione peroxidase (GPX), 
and catalase (CAT). Other antioxidant enzymes, such as thioredoxin (TRX), glutaredoxin 
(GRX), and peroxiredoxin (PRX), also play important roles to protect cells against 
oxidation [56]. In addition to antioxidant enzymes, cells also contain several non-
enzymatic antioxidants (e.g., glutathione (GSH), uric acid, and bilirubin). GSH is a 
tripeptide containing a thiol group that acts as reducing agent. GSH acts as electron and 
hydrogen atom (H+ + e-) donor to other molecules, including ROS, to neutralize them 
[58]. All these antioxidant systems developed by the cells contribute to the redox 
homeostasis, which is important to prevent the oxidative damage of important molecules, 
such as lipid, DNA and proteins. For example, unrepaired damage to mitochondrial DNA 
leads to defective complex I or III which in turn may cause an increased single-electron 
reduction of O2 to O2●. The consequent increased production of O2●- may lead to 
oxidative stress. One of the main consequence of damaged mitochondrial DNA is the 
decreasing of the expression of the genes codifying for proteins playing important roles 
during the electron transport chain. This may lead to mitochondrial dysfunction [10].  
Now that the beneficial and harmful roles of ROS have been elucidated, it is evident how 
important is to have means for detecting variation of ROS concentrations within the cells. 
This could be achieved by developing novel luminescent probes that could be used as 
ROS sensors allowing the measurement of the cellular oxidative stress.  
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1.4 ROS-responsive luminescent lanthanide complexes based on 
asymmetrically substituted cyclen-based ligands. 
The molecular systems developed by Bruce et al. [37], [38], examined in the previous 
section, provided clear evidence of how advantageous it is to design lanthanide 
complexes based on asymmetrically substituted cyclen ligands to signal the presence of 
an analyte of interest, even in the complex cellular environment. Using unsymmetrically 
substituted cyclen-based ligands allows the introduction of several different arms on the 
cyclen ring, each exerting a specific function. This is particularly useful when designing 
a molecular sensor based on luminescent lanthanide complexes that should be able to 
signal the presence of an analyte localised in a particular cellular compartment. In this 
case, the use of an asymmetrically substituted-cyclen based ligand allows incorporation 
on the same cyclen ring a suitable sensitizer antenna, essential for achieving the 
sensitization of the lanthanide ion, a receptor unit, able to bind the analyte of interest, 
and a targeting moiety that selectively deliver the complex into a specific cellular 
compartment. This allows the development of sophisticated molecular systems that 
combine the unique photophysical properties of the luminescent lanthanide ions with the 
properties of the ligand. Taking advantage of asymmetrically substituted cyclen ligands, 
a series of luminescent lanthanide complexes were developed in this project with the aim 
of producing effective probes able to signal variation of ROS concentration thus allowing 
the measurement of cellular oxidative stress. Their general chemical structure is shown 
in Figure 28. Therefore, the lanthanide complexes developed in this project may be 
applied for studying the effects of oxidative stress on mitochondrial function/dysfunction, 
but also for the screening of drug candidates during the drug development phase to 
assess their potentially toxic effects on mitochondria.  
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Figure 28. Representation of the general structure of the novel luminescent lanthanide complexes, based 
on asymmetrically substituted cyclen-based ligands, which contain two mitochondria targeting moieties.  
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2. Experimental Section 
2.1 Materials and Methods 
Cyclen, anhydrous europium(III) chloride, terbium(III) chloride, neodymium(III) chloride 
and ytterbium(III) chloride were obtained from Strem Chemicals. All other chemicals 
were purchased from Acros and Sigma Aldrich and used without further purification. All 
HPLC grade solvents were purchased from Sigma Aldrich and Fisher and were used as 
purchased. All anhydrous solvents were purchased from Sigma Aldrich and used as 
purchased. Thin Layer Chromatography was performed in Merck fluorescent silica or on 
Fluka fluorescent alumina plates with iodine, KMnO4 or UV visualisation. 1H NMR and 
13C NMR data were obtained using a 300 MHz and 400 MHz JEOL instruments 
manufactured by Oxford Instruments Limited.  ESI Mass spectrometry (via direct 
injection) was performed on a TSQ Quantum instrument manufactured by Thermo 
Scientific. ESI-MS and MALDI-MS for the lanthanide complexes were obtained through 
the EPSRC Swansea Mass Spectrometry Service (University of Swansea). UV spectra 
were measured on a Genesys 10S UV-Vis spectrophotometer manufactured by Thermo 
Scientific. All UV spectra were recorded in aqueous solutions (unless differently stated) 
at a compound concentration of 0.3 mM (unless differently stated). Excitation and 
emission spectra of the Eu(III) and Tb(III) complexes were measured on a Fluoromax-P 
(Jobin-Yvon Horiba) fluorimeter. Excitation and emission spectra were recorded in 
aqueous solution at a compound concentration of 3 mM. The fluorescence intensity 
during the cellular ROS assay were read using a microplate reader Fluorostar OPTIMA 
instrument manufactured by BMG LABTECH. DMEM+Glutamax was purchased from 
GIBCO-Thermo Fisher. FBS (10% in medium) and HBSS were purchased from Sigma 
Aldrich. H2O2 30% and TBHP 70% were purchased from Sigma Aldrich. The MST was 
performed on a Seahorse Xfe96 analyser. All chemicals used in the MST and calcium 
loading capacity assay were supplied by Sigma Aldrich. 
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2.1.1 Synthesis of N-Boc-2-bromoethylamine (18) 
 
 
 
Synthetic procedure: 
A suspension of 2-bromoethylamine hydrobromide (16) (10 g, 50 mmol) and di-tertbutyl 
dicarbonate (17) (10.8 g, 50 mmol) in DCM (24 mL) was cooled to 0ºC, and TEA (8 mL) 
was added dropwise. After stirring for 24 h at room temperature (leaving the ice-water 
bath throughout the process), DCM (300 mL) was added to the mixture. The solution 
was then extracted with: water (200 mL), 0.1M HCl solution (200 mL), saturated solution 
of sodium bicarbonate (200 mL) and a saturated solution of NaCl. The mixture was dried 
over MgSO4, filtered and concentrated in vacuum. Purification of the sample by column 
chromatography (silica column, elution with diethyl ether / hexane (2:8)) gave the product 
(18) as a colourless oil in 49% yield (8 g). 1H NMR (CDCl3, ): 1.38 (s, 9 H, CH3, H6), 
3.36-3.46 (m, 4 H, CH2, H1,2), 5.06 (br s, ~1 H, NH); 13C NMR: 28.2 (CH3, C6), 32.5 (CH2, 
C1), 42.23 (CH2, C2), 79.6 (Cq, C5), 155.51 (C=O, C4).  
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2.1.2 Synthesis of 1-N-Boc ethylamine-1,4,7,10-tetraazacyclododecane (20)  
 
 
 
Synthetic procedure: 
 
The N-Boc-2-bromoethylamine (18) (6.51 g; 0.029 mol; 1 eq) was added to a solution of 
cyclen (19) (25.00 g; 0.145 mol; 5 eq) and TEA (3.52 g; 0.035 mol; 1.2 eq) in one portion, 
in anhydrous CHCl3 (500 mL). The resulting solution was heated under reflux for 18 h, 
under an argon atmosphere. After cooling to room temperature, the CHCl3 was removed 
under vacuum and replaced with the same quantity of DCM (500 mL). The organic 
solution was washed with 1M sodium hydroxide solution (3 x 250 mL) to remove the 
excess of unreacted cyclen, and water (3 x 250 mL). The organic phase was dried over 
MgSO4 and evaporated to give a withe powder in 76% yield (4.76 g): mp 119-120°C; MS: 
316 [M+H]+; 1H NMR (CDCl3, ): 1.4 (s, 9 H, CH3, H17), 2.5 - 2.8 (m, 18 H, CH2, 
H2,3,5,6,8,9,11,12), 3.2 (m, 4 H, CH2, H13,14); 13C NMR (CDCl3, ): 28.4 (CH3, C17), 38.5 (CH2, 
C6,8), 46.0 (CH2, C5,9), 47.1 (CH2, C11,3), 47.7 (CH2, C2,12), 52.0 (CH2, C14), 54.1 (CH2, 
C13), 78.8 (Cq, C16), 156.0 (C=O, C15). 
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2.1.3 Synthesis of coumarin 2 bromoacetate (23)  
 
 
Synthetic procedure: 
Coumarin 2 (21) (0.50 g, 2.30 mmol, 1 eq) and bromoacetic acid (22) (1.90 g, 13.8 mmol, 
6 eq) were dissolved in DCM (30 mL), and EDCI*HCl (2.64 g, 13.8 mmol, 6 eq) was 
added in small portions to the vigorously stirred solution. The reaction was stirred at room 
temperature for 24 h. Water (50 mL) and DCM (30 mL) were added to the solution, the 
phases were separated and the product was extracted into DCM (2 x 30 mL). The 
combined organic phases were washed with water (40 mL) and 2 M NaOH (50 mL), dried 
over MgSO4, filtered, and the DCM was evaporated in vacuum. The product (23) was 
isolated as a white solid in 84% yield (5.28 g). Analytically pure samples were obtained 
by chromatography on silica with EtAc / DCM (1:9): mp 170-173°C; 1H NMR (CDCl3, ): 
1.12-1.16 (t, 3 H, CH3, H13, 3JHb,a 7.14 Hz), 2.31 (s, 3 H, CH3, H15), 2.43 (s, 3 H,  CH3, 
H14), 3.16-3.29 (m, 1 H, CH2, H12, 3JHa,b 7.14 Hz), 3.71 (s, 2 H, CH2, H11), 4.10-4.22 (m, 
1 H, CH2, H12,  3JHa,b 7.14 Hz), 6.32 (s, 1 H, CH, H2), 7.12 (s, 1 H, CH, H9), 7.52 (s, 1 H, 
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CH, H6); 13C NMR: 12.53 (CH3, C13), 17.54 (CH3, C15), 18.67 (CH3, C14), 41.55 (CH3, C12), 
44.02 (CH2, C11), 116.10 (CH, C9), 117.64 (CH, C6), 120.41 (CH, C3), 127.25 (Cq, C4), 
132.00 (Cq, C7), 142.21 (Cq, C8), 151.27 (C, C5), 152.06 (CH, C2), 159.98 (C=O, C10), 
165.49 (C=O, C1). 
 
2.1.4 Synthesis of 1-N-Boc-ethylamine-4-coumarin 2 acetamide-1,4,7,10-
tetraazacyclododecane (24) 
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Synthetic procedure: 
The 1-N-Boc ethylamine-1,4,7,10-tetraazacyclododecane (20) (1.54 g; 4.90 mmol; 1 eq) 
was dissolved in dry chloroform (100 mL), TEA (3.44 mL; 2.47 g; 24.5 mmol; 5 eq) was 
added to the solution, and the mixture was flushed with argon for 10 minutes. Coumarin 
2 bromoacetate (23) (1.66 g; 4.90 mmol; 1eq) in chloroform (23 mL) was added dropwise 
(in 1 h) to the reaction mixture and the stirring was continued for 36 h at room 
temperature. Water (40 mL) was added, the phases were separated, and the organic 
phase was washed with water again (40 mL). The organic phase was dried over MgSO4, 
filtered, and concentrated to ~5 mL. The desired product (24) was isolated by silica 
column chromatography by elution with DCM / iPrNH2 (2.5-10%) as a pale yellow solid 
in 13% yield (0.37 g): mp 54-56°C; 1H NMR (CDCl3, ): 1.05 (t, 3 H, CH3, H34, JHb,a = 7.14 
Hz), 1.28 (s, 9 H, CH3, H18), 2.26 (s, 3 H, CH3, H32), 2.43 (s, 3 H, CH3, H31), 2.50-3.35 
(m, 23 H, CH2, H2,3,5,6,8,9,11,12,13,14,19), 4.04 (m, 1 H, CH2, H33, 3JHa,b = 7.14 Hz), 6.30 (s, 1 
H, CH, H26), 7.06 (s, 1 H, CH, H23), 7.54 (s, 1 H, CH, H29); 13C NMR: 12.72 (CH3, C34), 
17.22 (CH3, C32), 18.55 (CH3, C31), 28.19 (CH3, C18), 38.79 (CH2, C33), 43.09 (CH2, C14), 
45.96 (CH2, C8,9), 47.41 (CH2, C11), 47.63 (CH2, C6), 51.49 (CH2, C12,5), 51.75 (CH2, C3), 
51.98 (CH2, C2), 53.16 (CH2, C13), 53.35 (CH2, C19), 77.98 (Cq, C17), 115.67 (CH, C26), 
117.07 (CH, C23), 120.02 (CH, C29), 127.25 (Cq, C22), 131.65 (Cq, C30), 142.70 (Cq, C28), 
151.44 (Cq, C24), 152.05 (Cq C27), 156.07 (C=O, C16), 169.56 (C=O, C25), 172.73 (C=O, 
C20). 
 
 
 
 
74 
 
2.1.5 Synthesis of N-methyl-L-glucamine pentaacetate-bromoacetate (25) 
 
 
Synthetic procedure: 
Bromoacetic acid (22) (1.38 g; 1 mmol; 1 eq) and N-methyl-L-glucamine (25) (1.95 g; 1 
mmol; 1 eq) were dissolved in 15 mL water, EDCI (3.84 g; 2 mmol; 2 eq) was added to 
the solution, and the reaction was allowed to proceed for 12 h at room temperature. The 
water was removed at reduced pressure, the residue (colourless oil) was dissolved in 
dry pyridine (12 mL), and the solution was cooled in an ice-water bath for ten minutes. 
The solution was stirred vigorously while acetic anhydride (15 mL) was added to the 
solution in small portions. The reaction mixture was allowed to reach room temperature 
and the stirring was continued for another 12 h. The excess acetic anhydride was 
consumed by the addition of water (10 mL). DCM (30 mL) and water (40 mL) were 
afterwards added to the mixture, the phases were separated and the aqueous phase 
was extracted with DCM (3 x 30 mL). The combined organic phases were washed with 
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water (2 x 30 mL) and dilute acid (1 M HCl, 1 x 40 mL), dried over MgSO4, filtered and 
the DCM was removed in vacuum. The product (26) was isolated as a colourless solid 
in 34% yield (1.80 g). 1H NMR (CDCl3, ): 1.99-2.04 (m, 15 H, CH3, H14,15,16,17,18), 2.11 (s, 
3 H, NCH3, H19), 2.96 (s, 2 H, BrCH2, H8), 3.50-3.60 (m, 2 H, CH2, H1), 4.04-4.09 (m, 1 
H, CH, H2), 4.22-4.23 (m, 1 H, CH, H3), 4.99-5.02 (m, 1 H, CH, H4), 5.25-5.29 (m, 1 H, 
CH, H5), 5.38-5.41 (m, 2 H, CH2, H6); 13C NMR: 20.37 (CH3,C14 ), 20.50 (CH3, C15), 20.66 
(CH3, C16), 20.71 (CH3, C17), 20.76 (CH3, C18), 37.23 (CH3, C19), 47.74 (CH2, C8), 61.49 
(CH2, C1), 68.60 (CH, C2), 68.68 (CH, C3), 68.78 (CH, C4), 69.26 (CH, C5), 69.60 (CH, 
C6), 169.80 (C=O, C9), 169.91 (C=O, C10), 170.16 (C=O, C11), 170.57 (C=O, C12), 170.61 
(C=O, C13), 171.19 (C=O, C7). 
 
2.1.6 Synthesis of allyl bromoacetate (18) 
 
 
 
Synthetic procedure: 
The allyl alcohol (32) (6.00 g; 0.103 mol; 1 eq) was dissolved in 200 mL of anhydrous 
dichloromethane. The solution was cooled down to 0°C and then TEA (11.48 g; 0.114 
mol; 1.1 eq) and DMAP (63.53 mg; 0.520 mmol; 0.005 eq) were added. The mixture was 
stirred at 0°C and the bromoacetyl bromide (22) (20.85 g; 0.103 mol; 1 eq) was then 
added dropwise. The reaction was stirred overnight at room temperature and under 
argon atmosphere. The reaction mixture was washed three times with water, dried over 
MgSO4 and filtered. The solvent (DCM) was removed under vacuum to give compound 
(33) as a very lachrymatory brown oil in 60% yield (11 g). 
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1H NMR (CDCl3, ): 3.82 (s, 2 H, CH2, H1), 4.61-4.63 (d, 2 H, CH2, H3, 3JHa,b = 6.8 Hz), 
5.22-5.26 (dd, 1 H, CH2, H5c, 3JHc,b = 10.3 Hz, 2JHc,d = 1.3 Hz), 5.29-5.36 (dd, 1 H, CH2,H5d 
3JHd,b = 17.2 Hz, 2JHd,c = 1.3 Hz)  5.82-5.95 (m, 1 H, CH, H4, 3JHb,d = 17.2, 3JHb,c = 10.3,  
3JHb,a = 6.8 Hz); 13C NMR (CDCl3, ): 25.7 (CH2, C3), 66.64 (CH2, C1), 119.01 (CH2, C5), 
130.58 (CH, C4), 166.80 (C=O, C2).  
 
 
2.1.7 Synthesis of 1-N-Boc ethylamine-4,7-diallyl acetate-1,4,7,10-
tetraazacyclododecane (DABC) (34) 
 
 
 
 
 
77 
 
Synthetic Procedure: 
The N-Boc ethylamine cyclen (20) (10.00 g; 0.032 mol; 1 eq) was dissolved in anhydrous 
chloroform (300 mL) with triethylamine (TEA) (1.60 g; 0.010 mol; 0.5 eq). The solution 
was heated under reflux and argon atmosphere. The allyl bromoacetate (33) (11.39 g; 
0.064 mol; 2 eq) was dissolved in 100 mL of anhydrous chloroform and slowly added 
dropwise to the stirring solution. The reaction mixture was kept under argon atmosphere 
and at reflux for 16 h. The reaction mixture was cooled down and extracted with water 
(2 x 400 mL). The organic phase was anhydrified over MgSO4 and filtered off. The solvent 
was evaporated under vacuum to give 16 g of crude mixture which was then purified 
through column chromatography using DCM/0.5-4% of TEA as eluent. The DABC (34) 
was isolated as an orange oil in 10% yield (1.478 g). MS: 512 [M+H]+; 1H NMR (CDCl3, 
:1.43 (s, 9 H, CH3, H27), 2.14-3.50 (m, 24 H, CH2, H2,3,5,6,8,9,11,12,13,18,23,24), 4.61-4.63 (d, 
4 H, CH2, H15,20, 3JHa,b 6.8 Hz), 5.22-5.36 (m, 4 H, CH2, H17,22, 3JHc,b 16.0 Hz, 3JHd,b 10.3 
Hz, 2JHc,d = 2JHdc 1.3 Hz), 5.82-5.95 (m, 2 H, CH, H16,21, 3JHb,c 16.0 Hz, 3JHb,d 10.3 Hz, 3JHb,a 
6.8 Hz ). 13C NMR (CDCl3, ):  28.52 (CH3, C27), 39.45 (CH2, C24), 47.14 (CH2, C9), 47.49 
(CH2, C11), 50.62 (CH2, C12), 50.79 (CH2, C5), 51.12 (CH2, C6), 51.17 (CH2, C8), 52.19 
(CH2, C3), 52.42 (CH2, C2), 53.40 (CH2, C23), 55.68 (CH2, C13), 56.04 (CH2, C18), 64.79 
(CH2, C15), 64.83 (CH2, C20), 78.61(Cq, C26),118.36 (CH2, C17,22), 132.02 (CH, C16,21), 
156.07 (C=O, C25), 171.36 (C=O, C14), 171.57 (C=O, C19). 
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2.1.8 Synthesis of the 1-N-Boc ethylamine-4,7-diallyl acetate-10-benzyl acetate-
1,4,7,10-tetraazacyclododecane (DABBC) (36) 
 
 
 
 
Synthetic procedure: 
DABC (34) (1.46 g; 2.865 mmol; 1 eq) and TEA (0.43 g; 4.300 mmol; 1.5 eq) were 
dissolved in 200 mL of anhydrous acetonitrile. The reaction mixture was heated under 
reflux under argon atmosphere. The benzyl bromoacetate (35) (0.85 g; 3.720 mmol; 1.3 
eq) was added to the solution dropwise and the reaction mixture was stirred at reflux 
under argon atmosphere overnight. After cooling to room temperature, the MeCN was 
removed under vacuum and replaced with the same quantity of DCM (200 mL). The 
organic solution was washed three times with water (3 x 120 mL). Afterwards the organic 
phase was dried over MgSO4, filtered and evaporated to yield the desired compound 
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(36) as a dark brown oil in 95% yield (1.79 g). MS: 660 [M+H]+; 682 [M+Na]+; 1H NMR 
(CDCl3, 1.38 (s, 9 H, CH3, H27), 2.74-3.75 (m, 26 H, CH2, H2,3,5,6,8,9,11,12,13,18,23,24,28), 
4.55-4.57 (d, 4 H, CH2, 3JHa,b 6 Hz, H15,20), 5.11-5.32 (m, 4 H, CH2, 3JHc,b 16 Hz, 3JHd,b 10 
Hz, 2JHc,d = 2JHd,c 1.3 Hz, H17,22), 5.79-5.94 (m, 2 H, CH, 3JHb,c 16 Hz, 3JHb,d 10 Hz, 3JHb,a 6 
Hz, H16, 21), 7.33 (s, 5 H, CH, H32,33,34,35,36). 13C NMR (CDCl3, ):  28.36 (CH3, C27), 39.05 
(CH2, C24), 48.16 (CH2, C5), 50.19 (CH2, C6), 51.46 (CH2, C3,8), 52.42 (CH2, C2,9), 53.56 
(CH2, C11,12), 54.69 (CH2, C23), 56.11 (CH2, C28), 65.58 (CH2, C13,18), 66.78 (CH2, C30), 
79.65 (Cq, C26), 119.12 (CH2, C17,22), 128.38 (CH, C32,36), 128.45 (CH, C34), 128.58 (CH, 
C33,35), 131.48 (CH, C16,21), 135.16 (Cq, C31), 156.57 (C=O, C25), 170.40 (C=O, C14), 
170.57 (C=O, C19), 170.80 (C=O, C29).  
  
2.1.9 Synthesis of 1-N-Boc ethylamine-4,7-diacetic acid-10-benzyl acetate-1,4,7,10-
tetraazacyclododecane (DAABBC) (37) / allyl ester group removal 
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Synthetic procedure: 
The doubly protected substrate (DABBC) (36) (0.90 g; 1.40 mmol; 1eq) was dissolved in 
MeCN:H2O (3.5:0.5 v/v) under argon atmosphere. Diethylamine (0.50 g; 6.86 mmol; 5 
eq) was added followed by rapid introduction of Pd(OAc)2 (0.006 g; 0.03 mmol; 0.02 eq) 
and TPPTS (0.03 g; 0.055 mmol 0.04 eq). The reaction mixture went to completion after 
2 h at room temperature. All solvents were removed under vacuum and the crude mixture 
was dissolved in chloroform (50 mL). The organic phase was then washed with 60 mL 
of water and the desired compound (37) was recovered from the aqueous phase. After 
removing all water under high vacuum, DAABBC (37) was obtained as a pale yellow oil 
in 97% yield (0.77 g). 
MS: 580 [M+H]+; 602 [M+Na]+ ; 1H NMR (CDCl3, 1.32 (s, 9 H, H21), 2.58-3.56 (m, 26 
H, CH2, H2,3,5.6,8,9,11,12,13,15,17,18,22), 5.04 (s, 2 H, CH2, H24), 7.27-7.32 (m, 5 H, 5CH, 
H26,27,28,29,30), 9.40 (broad signal, 2 H, COOH); 13C NMR (CDCl3, ): 28.12 (CH3, C21), 
41.63 (CH2 C18), 51.17 (CH2, C2,9,11,12), 52.97 (CH2, C3,5,6,8), 56.95 (CH2, C17,22), 66.24 
(CH2,C13,15), 66.70 (CH2, C24), 78.91 (Cq, C20), 128.18 (CH, C26,27,28,29,30), 134.89 (Cq, C25); 
155.93 (C=O, C19), 170.33 (C=O, C23), 174.14 (C=O, C14,16). 
 
2.1.10 Synthesis of (2-aminoethyl) triphenylphosphonium bromide (39) 
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Synthetic procedure: 
The (2-aminoethyl) triphenylphosphonium bromide (39) was prepared by dissolving the 
triphenyl phosphine (38) (10 g; 38.1 mmol; 1eq) and the bromoethylamine hydrobromide 
(16) (7.81 g; 38.1 mmol; 1eq) in anhydrous MeCN (50 mL) and heating the reaction 
mixture at reflux for 24 h. After 24 h, a white precipitate was formed. The reaction mixture 
was filtered when the acetonitrile was still hot and the white precipitate was washed for 
three times with 40 mL of hot acetonitrile in order to remove the impurities due to the 
unreacted starting materials (compound 38 and 16) and triphenylphosphine oxide 
formed as byproduct. After removing the solvent, the hydrobromide salt of the (2-
aminoethyl) triphenylphosphonium bromide was obtained without any further purification. 
To obtain the (2-aminoethyl) triphenylphosphonium bromide (39), the hydrobromide salt 
of 39 was dissolved in a sodium hydroxide aqueous solution (pH 9). The water was 
removed under high vacuum to give the desired product (39) in 80% yield (8.60 g): mp 
227-233°C; MS: 306 [M]+; 1H NMR (CDCl3, 3.10-3.19 (m, 2 H, CH2, H1), 3.72-3.81 (m, 
1 H, CH2, H2), 4.02-4.11 (m, 1 H, CH2, H2), 7.60-7.84 (m, 15 H, CH, 
H4,5,6,7,8,10,11,12,13,14,16,17,18,19,20); 13C NMR (CDCl3, ): 24.31 (CH2, C1), 41.90 (CH2, C2), 
118.17 (CH, C16,20),119.26 (CH, C4,8), 119.32 (CH, C14,10), 130.48 (CH, C17), 130.51 (CH, 
C19), 130.64 (CH, C5,7), 130.68 (CH, C11,13), 133.89 (CH, C18), 134.01 (CH, C6), 134.15 
(CH, C12), 134.80 (Cq, C15), 135.08 (Cq, C3), 135.12 (Cq, C9).  
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2.1.11 Synthesis of 1-N-Boc-ethylamine-4,7-di-(triphenylphosphonium bromide 
ethyl)acetamide-10-benzyl acetate-1,4,7,10-tetraazacyclododecane (DTPPBBC) 
(40) 
  
 
Synthetic procedure: 
To the DAABBC (37) (0.85 g; 1.471 mmol; 1 eq) dissolved in anhydrous DMF (50 mL), 
HOBt (0.40 g; 2.942 mmol; 2 eq) and EDCI*HCl (0.56 g; 2.942 mmol; 2 eq) were added 
and the reaction mixture was stirred at room temperature and under argon atmosphere 
for 1 h. Then the (2-aminoethyl) triphenylphosphonium bromide (39) (1.43 g; 2.942 mmol; 
2 eq) and DIPEA (0.76 g; 5.89 mmol; 4 eq) were added and the reaction mixture was 
stirred for 24 h at room temperature and under argon atmosphere. After stopping the 
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reaction the DMF was removed under vacuum and the crude mixture was dissolved in 
40 mL of DCM and extracted one time with 40 mL of water. After the extraction the 
organic phase was dried over MgSO4, filtered and dried to give the product (40) as a 
sticky light brown oil in 88% yield (1.5 g). 
MS: 577 [M]2+, 385 [M+H]3+; 1H NMR (CDCl3, 1.32 (s, 9 H, CH3, H61), 2.24-3.46 (m, 
34 H, CH2, H2,3,5,6,8,9,11,12,13,15,16,35,37,38,57,58,62), 5.27 (s, 2 H, CH2, H64), 7.12-7.15 (m, 2 H, 
CH, H66,70), 7.25-7.28 (m, 2 H, CH, H67,69), 7.38-7.41 (m, 1 H, CH, H68), 7.54-7.75 (m, 30 
H, CH, H18,19,20,21,22,24,25,26,27,28,30,31,32,33,34,40,41,42,43,44,46,47,48,49,50,52,53,54,55,56);13C NMR (CDCl3, 
): 28.33 (CH3, C61), 34.19 (CH2, C15), 35.85 (CH2, C37), 41.82 (CH2, C16,38,58), 49.41 (CH2, 
C3,5,6,8), 52.39 (CH2, C2,9,11,12), 57.22 (CH2, C57), 65.95 (CH2, C13,35), 66.34 (CH2, C62), 
66.73 (CH2, C64), 78.82 (Cq, C60), 117.01 (CH, C24,28), 117.47 (CH, C46,50), 118.15 (CH, 
C18,22,30,34), 118.31 (CH, C40,44,52,56), 123.89 (CH), 125.10 (CH, C66), 125.49 (CH, C70), 
128.16 (CH, C67), 128.36 (CH, C69), 128.56 (CH, C68), 130.21 (CH, C25,27), 130.39 (CH, 
C47,49), 130.43 (CH,C19,21,31,33), 130.60 (CH, C41,43,53,55), 133.48 (CH, C26,48), 133.62 
(CH, C20,32), 133.75 (CH, C42,54), 134.69 (Cq, C23,45), 135.18 (Cq, C17,29,39,51), 142.96 (Cq, 
C65), 157.5 (C=O, C59), 170.9 (C=O, C14,36), 171 (C=O, C63).  
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2.1.12 Synthesis of 1-ethylamine-4,7-di-(triphenylphosphonium bromide 
ethyl)acetamide-10-benzyl acetate-1,4,7,10-tetraazacyclododecane (DTPPBC) 
(41)-BOC group removal 
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Synthetic procedure: 
The DTPPBBC (40) (0.13 g; 0.115 mmol; 1eq) was dissolved in 6 mL of anhydrous DCM. 
Then 1.20 mL of TFA was added and the reaction mixture was stirred at room 
temperature for 2 h. After stopping the reaction 35 mL of DCM were added to the reaction 
mixture and extracted with 40 mL of 1M NaHCO3 aqueous solution. After the extraction 
the organic phase was dried over MgSO4, filtered and dried to give the product (41) as a 
sticky light brown oil in 84% yield (0.10 g).  
MS: 527 [M]2+, 352 [M+H]3+; 1H NMR (CDCl3, 2.10-3.63 (m, 34 H, CH2, 
H2,3,5,6,8,9,11,12,13,15,16,35,37,38,57,58,59), 5.02 (s, 2 H, CH2, H61), 7.19-7.24 (m, 5H, CH, 
H63,64,65,66,67), 7.55-7.71 (m, 30 H, CH, 
H18,19,20,21,22,24,25,26,27,28,30,31,32,33,34,40,41,42,43,44,46,47,48,49,50,52,53,54,55,56); 13C NMR (CDCl3, δ): 
30.24 (CH2, C58 ), 33.23 (CH2, C15), 34.13 (CH2, C37), 37.36 (CH2, C16,38), 41.88 (CH2, 
C57), 49.96 (CH2, C5,6), 50.27 (CH2, C3,8), 50.98 (CH2, C9,11), 53.39 (CH2, C2,12), 57.42 
(CH2, C59), 65.85 (CH2, C13,35), 66.48 (CH2, C61), 115.22, 117.06 (CH, C24,48), 117.12 (CH, 
C46,50) 117.81 (CH, C18,22), 118.20 (CH, C34,30), 118.26 (CH, C40,44), 118.95 (CH, C52), 
119.14 (CH, C56), 125.43 (CH, C63,67), 128.12 (CH, C64), 128.26 (CH, C66), 128.31, 
128.43, 128.50 (CH, C68), 130.17 (CH, C25,27), 130.34 (CH, C47,49), 130.41 (CH, C19,21), 
130.49 (CH, C31,33), 130.54 (CH, C41,43), 130.58 (CH, C53,55), 133.43 (CH, C26,48), 133.56 
(CH, C20,32,42,54), 134.71 (Cq, C23), 134.74 (Cq, C45), 135.03 (Cq, C17), 135.12 (Cq, C29), 
135.41 (Cq, C39,51), 135.68, 135.74, 142.06 (Cq, C65), 171.07 (C=O, C14), 171.31 (C=O, 
C36), 171.63 (C=O, C60).  
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2.1.13 Synthesis of 1-N-(dihydrofluorescein diacetate)ethylamide-4,7-di-
(triphenylphosphonium bromide ethyl)acetamide-10-benzyl acetate-1,4,7,10-
tetraazacyclododecane (L1) 
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Synthetic procedure: 
To a solution of dihydrofluorescein diacetate (42) (0.05 g; 0.129 mmol; 1eq) dissolved in 
20 mL of anhydrous DMF, EDCI*HCl (0.05g; 0.257 mmol; 2 eq) and HOBt (0.04 g; 0.257 
mmol; 2 eq) were added and the reaction mixture was stirred for 1 h at room temperature 
and under argon atmosphere. After 1 h, the DTPPBC (41) (0.16 g; 0.129 mmol; 1 eq) 
and DIPEA (0.07 g; 0.566 mmol; 4.4 eq) were added to the reaction mixture that was 
kept under stirring for 24 h, at room temperature and under argon atmosphere. After 24 
h the reaction was stopped and the DMF was removed under high vacuum and replaced 
with 40 mL of chloroform. The organic phase was then extracted with water (35 mL), 
dried over MgSO4 and filtered. After removing the solvent, L1 was obtained as a brown 
sticky oil in 60% yield (0.13 g). MS: 728 [M]2+, 485 [M+H]3+; 1H NMR (CDCl3,  2.23 (s, 
6 H, CH3, H89,91),2.66-3.92 (m, 34 H, CH2, H2,3,5,6,8,9,11,12,13,15,16,35,37,38,57,66,67), 4.46 (s, 2 H, 
CH2, H59), 6.40-6.87 (m, 11 H, CH, H61,62,63,64,65,77,78,80,83,85,86), 7.02-7.46 (m, 34 H, CH, 
H18,19,20,21,22,24,25,26,27,28,30,31,32,33,34,40,41,42,43,44,46,47,48,49,50,52,53,54,55,56,71,72,73,74), 7.99 (s, 1H, CH, 
H75); 13C NMR (CDCl3, δ): 21.21 (CH3, C89,91), 31.52 (CH2, C15,37), 36.58 (CH2, C16,38,67), 
50.37 (CH2, C5,6), 51.65 (CH2, C8,9), 52.44 (CH2, C3,2), 53.84 (CH2, C11,12,57), 55.83 (CH2, 
C66), 65.56 (CH2, C13,35), 66.71 (CH2, C59), 109.66 (CH, C75), 111.33 (CH), 118.12 (CH), 
118.24 (CH), 119.70 (CH), 123.91 (CH), 124.56 (CH), 128.40 (CH), 128.45 (CH), 128.51 
(CH), 128.66 (CH), 130.54 (CH), 130.98 (CH), 131.68 (CH), 136.20 (Cq), 143.26 (Cq), 
149.89 (Cq), 150.85 (Cq), 162.65 (C=O, C68), 169.26 (C=O, C88,90), 170.53 (C=O, C14,36), 
170.57 (C=O, C58).  
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2.1.14 Synthesis of 1-N-(coumarin 343)ethylamide-4,7-di-(triphenylphosphonium 
bromide ethyl)acetamide-10-benzyl acetate-1,4,7,10-tetraazacyclododecane (L2) 
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Synthetic procedure: 
To the coumarin 343 (43) (0.04 g; 0.129 mmol; 1 eq), dissolved in 15 mL of dry DMF, 
HOBt (0.04 g; 0.257 mmol; 2.2 eq) and EDCI*HCl (0.05 g; 0.257 mmol; 2.2 eq) were 
added and the reaction mixture was stirred at room temperature under argon atmosphere 
for 1 h. Then DTPPBC (41) (0.16 g; 0.129 mmol; 1 eq) was added followed by DIPEA 
(0.07 g; 0.566 mmol; 4.4 eq). The reaction mixture was stirred under argon atmosphere 
and at room temperature for 24 h.  After 24 h the reaction was stopped and the DMF was 
removed under high vacuum and replaced with 25 mL of chloroform. The organic phase 
was then extracted with water (20 mL), dried over MgSO4 and filtered. After removing 
the solvent, L2 was obtained as an orange oil in 30% yield (0.06 g).  
MS: 661 [M]2+, 441 [M+H]3+. 1H NMR (CDCl3, : 1.93 (m, 8 H, CH2, H69,70,73,74), 2.47-4.05 
(m, 38 H, CH2, H2,3,5,6,8,9,11,12,13,15,16,35,37,38,57,58,71,72,75), 6.96 (s, 2 H, CH2, H77), 7.10-7.17 (m, 
5 H, CH, H79,80,81,82,83), 7.43-7.97 (m, 28 H, CH, 
H18,19,20,21,22,24,25,26,27,28,30,31,32,33,34,40,41,42,43,44,46,47,48,49,50,52,53,54,55,56), 8.44 (s, 1 H, CH, H65), 
8.51 (s, 1 H, CH, H64); 13C NMR (CDCl3, δ): 20.05 (CH2, C70,73), 21.05 (CH2, C69,74), 29.91 
(CH2, C71,72), 30.24 (CH2, C15,37), 33.23 , 34.13 (CH2, C16), 34.31 (CH2, C38), 41.88 (CH2, 
C58), 49.96 (CH2, C5,6), 50.27 (CH2, C2,3), 50.98 (CH2, C8,9), 53.39 (CH2, C11,12), 57.42 
(CH2, C57), 58.51 (CH2, C75), 65.85 (CH2, C13,35), 66.48 (CH2, C77), 115.22 (CH), 117.06 
(CH), 117.81 (CH), 118.20 (CH), 118.26 (CH), 118.95 (CH), 119.14 (CH), 125.43 (CH), 
128.06 (CH), 128.31 (CH), 128.43 (CH), 128.50 (CH), 130.17 (CH), 130.34 (CH), 130.41 
(CH), 130.49 (CH), 130.54 (CH), 130.58 (CH), 133.43 (CH), 133.56 (CH), 134.71 (Cq), 
134.74 (Cq), 135.03 (Cq), 135.12 (Cq), 135.41 (Cq), 135.68 (Cq), 135.74 (Cq), 137.41 (Cq), 
140.90 (Cq), 142.06 (Cq), 143.73 (CH, C65), 148.81 (CH, C64), 162.01 (C=O, C61), 167.56 
(C=O, C59), 171.07 (C=O, C36), 171.31 (C=O, C14), 171.63 (C=O, C76).  
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2.1.15 Synthesis of 1-N-(rhodamine B)ethylamide-4,7-di-(triphenyl phosphonium 
bromide ethyl)acetamide-10-benzyl acetate-1,4,7,10-tetraazacyclododecane  (L3) 
 
                                                                               
 
Synthetic procedure: 
To the rhodamine B (44) (0.04 g; 0.076 mmol; 1 eq), dissolved in 20 mL of dry DMF, 
HOBt (0.02 g; 0.167 mmol; 2.2 eq) and EDCI*HCl (0.03 g; 0.167 mmol; 2.2 eq) were 
added and the reaction mixture was stirred at room temperature under argon atmosphere 
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for 1 h. Then DTPPBC (41) (0.09 g; 0.076 mmol; 1 eq) was added followed by DIPEA 
(0.04 g; 0.334 mmol; 4.4 eq). The reaction mixture was stirred under argon atmosphere 
and at room temperature for 24 h. After 24 h the reaction was stopped and the DMF was 
removed under high vacuum and replaced with 30 mL of chloroform. The organic phase 
was then extracted with water (25 mL), dried over MgSO4 and filtered. After removing 
the solvent, (L3) was obtained as a dark pink oil in 93% yield (0.12 g). MS: 740 [M]2+, 
493 [M]3+. 1H NMR (CDCl3, : 09-1.12 (m, 20H, CH3 (H89,91,93,95)), CH2 (H88,90,92,94), 2.12-
3.51 (m, 34 H, CH2, H2,3,5,6,8,9,11,12,13,15,16,35,37,38,57,66,67), 4.99 (s, 2H, CH2, H59), 6.30-6.51 
(m, 9 H, CH, H61,62,63,64,65,79,81,82,85), 7.03-7.57 (m, 35 H, CH, 
H18,19,20,21,22,24,25,26,27,2830,31,32,33,34,40,41,42,43,44,46,47,48,49,50,52,53,54,55,56), 7.95 (s, 2H, CH, 
H84,87);13C NMR (CDCl3, ): 27.45 (CH3, C89,91,93,95), 30.28 (CH2, C15,37), 34.19 (CH2, 
C16,38), 35.85 (CH2), 41.82 (CH2), 42.94 (CH2, C67), 48.83 (CH2, C88,89,92,94), 49.41 (CH2, 
C5,6), 52.39 (CH2, C2,3,8,9,11,12), 57.22 (CH2, C66,57), 65.95 (CH2, C13,35,59), 78.82 (C), 110.77 
(CH), 117.01 (CH), 117.47 (CH), 118.15 (CH), 118.31 (CH), 123.89 (CH), 125.10 (CH), 
125.49 (CH), 128.16 (CH), 128.36 (CH), 128.56 (CH), 130.21 (CH), 130.39 (CH), 130.43 
(CH), 130.60 (CH), 133.48 (CH), 133.62 (CH), 133.75 (Cq), 134.69 (Cq), 135.18 (Cq), 
144.52 (Cq) 147.76 (Cq), 155.32 (Cq), 163.21 (C=N+, C86), 167.91 (C=O, C68), 170.34 
(C=O, C14,36), 171.36 (C=O, C58).  
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2.1.16 Synthesis of 1-N-(coumarin 3 carboxylic acid)ethylamide-4,7-di-(triphenyl 
phosphonium bromide ethyl)acetamide-10-benzyl acetate-1,4,7,10-
tetraazacyclododecane  (L4) 
 
 
 
 
Synthetic procedure: 
To the coumarin-3-carboxylic acid (45) (0.01 g; 0.046 mmol; 1 eq), dissolved in 20 mL of 
dry DMF, HOBt (0.01 g; 0.101 mmol; 2.2 eq) and EDCI*HCl (0.02 g; 0.102 mmol; 2.2 eq) 
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were added and the reaction mixture was stirred at room temperature under argon 
atmosphere for 1 h. Then DTPPBC (41) (06 g; 0.046 mmol; 1 eq) was added followed 
by DIPEA (0.03 g; 0.203 mmol; 4.4 eq). The reaction mixture was stirred under argon 
atmosphere and at room temperature for 24 h. After 24 h the reaction was stopped and 
the DMF was removed under high vacuum and replaced with 30 mL of chloroform. The 
organic phase was then extracted with water (25 mL), dried over MgSO4 and filtered. 
After removing the solvent, (L4) was obtained as a pale yellow oil in 94% yield (60 mg). 
MS: 614 [M]2+, 409 [M+H]3+; 1H NMR (CDCl3, : 2.28-4.31 (m, 34 H, CH2, 
H2,3,5,6,8,9,11,12,13,15,16,35,37,38,57,58,69), 4.52 (s, 2 H, 1 CH2, H71), 7.11-7.30 (m, 5 H, CH, 
H65,66,67,68), 7.61-7.66 (m, 35 H, CH, 
H18,19,20,21,22,24,25,26,27,28,30,31,32,33,34,40,41,42,43,44,46,47,48,49,50,52,53,54,55,56,73,74,75,76,77), 8.72 (s, 1 H, 
CH, H64); 13C NMR (CDCl3, δ): 30.13 (CH2, C15,37), 32.26 (CH2, C16,38), 34.20 (CH2), 37.43 
(CH2), 40.80 (CH2, C58), 48.96 (CH2, C5,6), 50.67 (CH2, C2,3), 51.98 (CH2, C8,9), 53.79 
(CH2, C11,12), 56.72 (CH2, C57,69), 65.75 (CH2, C13,35), 66.48 (CH2, C71), 115.22 (CH), 
117.06 (CH), 117.12, 117.81 (CH), 118.20 (CH), 118.26 (CH), 118.75 (CH), 119.34 (CH), 
125.33 (CH), 128.06 (CH), 128.31 (CH), 128.43 (CH), 128.50 (CH), 130.17 (CH), 130.34 
(CH), 130.41 (CH), 130.49(CH), 130.54(CH), 130.58 (CH), 133.43 (CH), 133.56 (CH), 
134.71 (Cq), 134.74 (Cq), 135.03 (Cq), 135.12 (Cq), 135.41 (Cq), 135.68 (Cq), 135.74 (Cq), 
142.06 (Cq), 153.7 (Cq), 162.01 (C=O, C61), 166.53 (C=O, C59), 171.07 (C=O, C14), 
171.31 (C=O, C36), 171.63 (C=O, C70).  
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2.1.17 Synthesis of 1-N-Boc-ethylamine-4,7-di-(coumarin 151)-N-acetamide-10-
benzyl acetate-1,4,7,10-tetraazacyclododecane  (L5) 
 
 
 
Synthetic procedure: 
The acid (DAABBC) (37) (0.15 g; 0.259 mmol; 1eq) was dissolved in 30 mL of anhydrous 
DMF. Then HOBt (0.11 g; 0.777 mmol; 3eq) and EDCI*HCl (0.15 g; 0.777 mmol; 3eq) 
were added and the reaction was kept under stirring, under argon atmosphere and at 
room temperature for about 1h. The amine, the coumarin 151 (46) (0.12 g; 0.518 mmol; 
2 eq) was added to the reaction mixture, followed by DIPEA (0.15 g; 1.140 mmol; 4.4 eq) 
and the reaction mixture was kept under stirring, under argon atmosphere and at room 
temperature for 24 h. After 24 h the reaction mixture was stopped and the DMF was 
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removed under high vacuum. The crude mixture was then dissolved into 40 mL of CHCl3 
and extracted with H2O (3 x 40 mL). After removing the solvent, the product (L5) was 
obtained as a pale yellow oil in 46% yield (0.12 g). MS: 690 [M1+H]+; 712 [M1+Na]+; 677 
[M2+H]+; 1H NMR (CDCl3, : 1.39 (s, 9 H, CH3, H50), 2.79-3.64 (m, 26 H, CH2, 
H2,3,5,6,8,9,11,12,13,25,37,46,47), 4.47 (s, 2 H, CH2, C39), 5.08 (s, 2 H, CH, H23,35), 6.43 (s, 2 H, 
CH, H16,28), 6.57 (s, 2 H, CH, H22,34), 7.16-7.31 (m, 7 H, CH, H41,42,43,44,45,19,31); 13C NMR 
(CDCl3, δ): 13.15 (CH2), 14.38 (CH2), 28.61 (CH3, C50), 40.32 (CF3, C24,36), 41.45 (CH2, 
C47), 51.31 (CH2, C5,6,3,8), 52.24 (CH2, C2,9,11,12), 66.55 (CH2, C13,25,39), 78.80 (Cq, C49), 
101.148 (CH), 104.69 (CH), 109.73 (CH), 112.56 (CH), 118.25 (CH), 120.09 (CH), 
123.53 (CH), 126.63 (CH), 128.45 (CH), 128.71 (CH), 142.34 (Cq), 143.73 (Cq), 151.55 
(C=O, C48), 156.85 (C=O, C14,26), 160.29 (C=O, C38). 
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2.1.18 Deprotection of the Boc group from the 1-N-Boc-ethylamine-4,7,10- triallyl 
acetate-1,4,7,10-tetraazacyclododecane (TABC) (47) 
 
 
Synthetic procedure: 
The TABC (47) was recovered as by product during the column chromatography 
performed for the purification of the reaction mixture obtained during the synthesis of 
DABC (36). The TABC (47) (0.16 g; 0.263 mmol) was dissolved in 10 mL of anhydrous 
DCM. Then 1 mL of TFA was added and the reaction mixture was stirred at room 
temperature for 2 hours. After stopping the reaction, 20 mL of DCM were added to the 
reaction mixture and extracted with 30 mL of 1M NaHCO3 aqueous solution. After the 
extraction the organic phase was dried over MgSO4 and filtered. After removing the 
solvent, the product (48) was obtained as a light brown oil in 45% yield (0.06 g). MS: 510 
[M+H]+. 1H NMR (CDCl3, : 2.52-3.43 (m, 36 H, CH2, H2,3,5,6,8,9,11,12,13,18,23,24), 4.53-4.55 
(d, 6 H, CH2, 3JHa,b 6 Hz, H15,20), 5.16-5.29 (m, 6 H, CH2, 3JHd,b 16 Hz, 3JHc,b 10 Hz, 2JHc,d 
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= 2JHd,c 1.4 Hz, H17,22), 5.79-5.92 (m, 3H, CH, 3JHb,d 16 Hz, 3JHb,c 10 Hz, 3JHb,a 6 Hz, H16,21).  
13C NMR (CDCl3, ):  39.45 (CH2 C24), 47.14 (CH2, C6), 47.49 (CH2, C8), 50.62 (CH2, C5), 
50.79 (CH2, C9), 51.12 (CH2, C3), 51.17 (CH2, C11), 52.19 (CH2, C2), 52.42 (CH2, C12), 
53.40 (CH2), 55.68 (CH2, C23), 56.04 (CH2, C13,18), 64.79 (CH2, C15), 64.83 (CH2, C20), 
118.36 (CH2, C17,22), 132.02 (CH, C16,21), 171.36 (C=O, C14), 171.57 (C=O, C19).  
 
 
2.1.19 Synthesis of 1-N-(coumarin 343)ethylamide-4,7,10-triallyl acetate-1,4,7,10-
tetraazacyclododecane  (L6) 
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Synthetic procedure: 
The acid (coumarin 343) (43) (0.03 g; 0.118 mmol; 1 eq) was dissolved in 30 mL of 
anhydrous DMF. Then HOBt (0.02 g; 0.177 mmol; 1.5 eq) and EDCI*HCl (0.03 g; 0.177 
mmol; 1.5 eq) were added and the reaction mixture was kept under stirring for 1h at room 
temperature. After 1h, the amine, TAC (48), (0.06 g; 0.118 mmol; 1 eq) was added, 
followed by DIPEA (0.03 mg, 0.259 mmol; 2.2 eq). The reaction mixture was stirred under 
argon atmosphere and at room temperature for 24 h. After 24 h the reaction was stopped 
and the DMF was removed under high vacuum and replaced with 30 mL of chloroform. 
The organic phase was then extracted with water (2 x 25 mL), dried over MgSO4 and 
filtered. After removing the solvent L6 was obtained as a yellow oil in 77% yield (0.07 g). 
MS: 777 [M+H]+, 799 [M+Na]+. 1H NMR (CDCl3, : 1.93 (m, 4 H, CH2, H36,39), 2.71-3.61 
(m, 34 H, CH2, H2,3,5,6,8,9,11,12,13,18,23,24,35,3738,40), 4.53-4.55 (d, 6 H, CH2, 3JHa,b 6 Hz, H15,20), 
5.16-5.29 (m, 6 H, CH2, 3JHd,b 16 Hz, 3JHc,b 10 Hz, 2JHc,d = 2JHd,c 1.4 Hz, H17,22 ), 5.79-5.92 
(m, 3 H, CH, 3JHb,d 16 Hz, 3JHb,c 10 Hz, 3JHb,a 6 Hz H, H16,21), 6.84 (s, 1 H, CH, H31), 8.49 
(s, 1 H, CH, H30). 13C NMR (CDCl3, δ): 20.05 (CH2, C36,39), 21.05 (CH2, C37,40), 27.40 
(CH2, C35), 29.63 (CH2 C38), 36.43 (CH2, C15,20), 49.63 (CH2, C6), 49.77 (CH2, C8 ), 50.01 
(CH2, C5), 50.19 (CH2, C9), 52.23 (CH2, C11,3 ), 52.60 (CH2, C2,12), 54.36 (CH2, C23), 55.83 
(CH2, C13,18), 64.99 (CH2, C15), 105.61(CH2), 106.05 (CH2), 110.97 (CH2), 118.45 (CH2, 
C17), 119.58 (CH2, C22), 128.150 (CH, C16), 131.86 (CH, C21), 143.54 (Cq), 144.84 (Cq), 
147.91(CH, C31),  148.21 (CH, C30), 152.69 (Cq), 162.67 (C=O, C25), 164.04 (C=O, C27), 
170.86 (C=O, C14,19). 
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2.1.20 Deprotection of the Boc group from DABBC (36) 
 
Synthetic procedure: 
The DABBC (36) (0.31 g; 0.470 mmol; 1 eq) was dissolved in 20 mL of DCM and 1 mL 
of TFA was added. The reaction was kept under stirring for 2 h. After 2 h the reaction 
was stopped and 20 mL of DCM were added to the reaction mixture and extracted with 
30 mL of 1M NaHCO3 aqueous solution. After the extraction, the organic phase was 
dried over MgSO4, filtered and the solvent was removed to give the DABnC (49) in 53% 
yield (0.14 g). MS: 560 [M+H]2; 582 [M+Na]+. 1H NMR (CDCl3, : 2.70-3.70 (m, 26 H, 
CH2, H2,3,5,6,8,9,11,12,13,18,23), 4.51-4.52 (d, 4 H, CH2, 3JHa,b 6Hz, H15,20), 5.08 (s, 2 H, CH2. 
H25), 5.15-5.27 (m, 4 H, CH2, 3JHd,b 16.2 Hz, 3JHc,b 10.3 Hz, 2JHd,c = 2JHc,d  1.3 Hz, H17,22), 
5.75-5.87 (m, 2 H, CH, 3JHb,d 16.2 Hz, 3JHb,c 10.3 Hz,  3JHb,a 6 Hz, H16,21), 7.21-7.30 (m, 5 
H, CH, C27,28,29,30,31).  
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2.1.21 1-N-(dihydrofluorescein diacetate)ethylamide-4,7-diallyl acetate-10-benzyl 
acetate-1,4,7,10-tetraazacyclododecane  (L7) 
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Synthetic procedure: 
The acid (dihydrofluorescein diacetate) (42) (0.11 g; 0.251 mmol; 1 eq) was dissolved in 
40 mL of anhydrous DMF. Then HOBt (0.07 g; 0.5014 mmol; 2 eq) and EDCI*HCl (0.09 
g; 0.501 mmol; 2 eq) were added and the reaction mixture was kept under stirring for 1 
h at room temperature. After 1 h, the amine, the DABnC (49), (0.14 g; 0.251 mmol; 1eq) 
was added, followed by DIPEA (0.10 g; 0.752 mmol; 3 eq). The reaction mixture was 
stirred under argon atmosphere and at room temperature for 24 h. After 24 h the reaction 
was stopped and the DMF was removed under high vacuum and replaced with 40 mL of 
chloroform. The organic phase was then extracted with water (2 x 30 mL), dried over 
MgSO4 and filtered. After removing the solvent, L7 was obtained as yellow oil in 68% 
yield (0.14 g). MS: 960 [M+H]+; 982 [M+Na]+. 1H NMR (CDCl3, : 1.95 (s, 6 H, CH3, 
H55,57), 2.70-3.70 (m, 26 H, CH2, H2,3,5,6,8,9,11,12,13,18,23,32,33), 4.51-4.52 (d, 4 H, CH2, 3JHa,b 6 
Hz, H15,20), 5.08 (s, 2 H, CH2, H25), 5.15-5.27 (m, 4 H, CH2, 3JHd,b 16 Hz, 3JHc,b 10 Hz, 2JHd,c 
= 2JHc,d  1.3 Hz, H17,22), 5.75-5.87 (m, 2 H, CH, 3JHb,d 16 Hz, 3JHb,c 10 Hz,  3JHb,a 6 Hz, 
H16,21), 6.43-6.84 (m, 10 H, CH, H37,38,39,40,44,46,47,50,52,53), 7.21-7.30 (m, 5 H, CH, 
H27,28,29,30,31), 8.49 (s, 1 H, CH, H41).  
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2.1.22 Complexation of L1 with Eu(III): synthesis of EuL1                                                                                                         
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Synthetic procedure: 
L1 (0.03 g; 0.017 mmol; 1 eq) and anhydrous europium chloride (EuCl3) (0.004 g; 0.017 
mmol; 1eq) were dissolved in 20 mL of anhydrous methanol. The reaction mixture was 
heated under reflux and argon atmosphere for 15 h. The reaction was monitored through 
ESI mass spectrometry via direct injection and TLC (DCM/isopropylamine 95:0.5). The 
reaction was stopped when no peak related to the free ligand (L1) was observed in the 
mass spectrum and no spot related to the free ligand (L1) was observed on TLC plate.  
The reaction mixture was allowed to cool back to room temperature and was poured into 
cold diethyl ether (15 mL). The mixture was centrifuged and the ether was poured off the 
pale yellow precipitate. The precipitated was dissolved in distilled water (5 mL) and the 
sample was freeze-dried. The observed product (EuL1) was obtained as pale yellow 
solid in 96% yield (based on L1 containing the acetate groups) (0.03 g). EuL1 was 
characterized via mass spectrometry and absorption and emission spectroscopy. λmax =  
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489 nm; MS (ESI) m/z: [L1+Eu+Br+2H2O-2COCH3]4+ Calcd for [C83H89Br153EuN7O10P2]4+ 
409.3630; Found 409.1623; MS (MALDI) m/z: [L1+Eu+Br+2H2O-2COCH3]4+ Calcd for 
[C83H89Br153EuN7O10P2]4+ 409.3630; Found 409.2. 
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2.1.23 Complexation of L1 with Tb(III): synthesis of TbL1 
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Synthetic procedure: 
L1 (0.03 g; 0.021 mmol; 1 eq) and anhydrous terbium chloride (TbCl3) (0.005 g; 0.021 
mmol; 1 eq) were dissolved in 20 mL of anhydrous methanol. The reaction mixture was 
heated under reflux and argon atmosphere for 15 h. The reaction was monitored through 
ESI mass spectrometry via direct injection and TLC (DCM/isopropylamine 95:0.5). The 
reaction was stopped when no peak related to the free ligand (L1) was observed in the 
mass spectrum and no spot related to the free ligand (L1) was observed on TLC plate. 
The reaction mixture was allowed to cool back to room temperature and was poured into 
cold diethyl ether (15 mL). The mixture was centrifuged and the ether was poured off the 
pale yellow precipitate. The precipitated was dissolved in distilled water (5 mL) and the 
sample was freeze-dried. The observed product (TbL1) was obtained as pale yellow 
solid in 98.9 % yield (based on L1 containing the acetate groups) (0.04 g). TbL1 was 
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characterized via mass spectrometry and absorption and emission spectroscopy. λmax =  
489 nm; MS (ESI) m/z: [L1+Tb+Br-2COCH3]4+ Calcd for [C83H85BrN7O8P2Tb]4+ 401.8588; 
Found 402.1225. 
108 
 
2.1.24 Complexation of L2 with Eu(III): synthesis of EuL2 
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Synthetic procedure: 
L2 (0.04 g; 0.029 mmol; 1 eq) and anhydrous europium chloride (EuCl3) (0.008 g; 0.029 
mmol; 1 eq) were dissolved in 20 mL of anhydrous methanol. The reaction mixture was 
heated under reflux and argon atmosphere for 15 h. The reaction was monitored through 
ESI mass spectrometry via direct injection and TLC (DCM/isopropylamine 95:0.5). The 
reaction was stopped when no peak related to the free ligand (L2) was observed in the 
mass spectrum and no spot related to the free ligand (L2) was observed on TLC plate. 
The reaction mixture was allowed to cool back to room temperature and was poured into 
cold diethyl ether (15 mL). The mixture was centrifuged and the ether was poured off the 
orange precipitate. The precipitated was dissolved in distilled water (5 mL) and the 
sample was freeze-dried. The complex (EuL2) was obtained as orange solid in 99 % 
yield (0.05 g). EuL2 was characterized via mass spectrometry and absorption and 
emission spectroscopy. λmax =  447 nm; MS (MALDI) m/z: [L2+Eu+Br+4H2O]4+ Calcd for 
[C79H96Br153EuN8O11P2]4+ 406.6262; Found 407.2.  
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2.1.25 Complexation of L2 with Tb(III): synthesis of TbL2 
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Synthetic procedure: 
L2 (0.04 g; 0.027 mmol; 1 eq) and anhydrous terbium chloride (TbCl3) (0.01 g; 0.027 
mmol; 1 eq) were dissolved in 20 mL of anhydrous methanol. The reaction mixture was 
heated under reflux and under argon atmosphere for 15 h. The reaction was monitored 
through ESI mass spectrometry via direct injection and TLC (DCM/isopropylamine 
95:0.5). The reaction was stopped when no peak related to the free ligand (L2) was 
observed in the mass spectrum and no spot related to the free ligand (L2) was observed 
on TLC plate. The reaction mixture was allowed to cool back to room temperature and 
was poured into cold diethyl ether (15 mL). The mixture was centrifuged and the ether 
was poured off the orange precipitate. The precipitated was dissolved in distilled water 
(5 mL) and the sample was freeze-dried. The complex (TbL2) was obtained as orange 
solid in 81 % yield (0.04 g). TbL2 was characterized via mass spectrometry and 
absorption and emission spectroscopy. λmax =  447 nm; MS (MALDI) m/z: 
[L2+Tb+4H2O+Br]4+ Calcd for [C79H96BrN8O11P2Tb]4+ 408.1272; Found 408.2; MS (ESI) 
m/z: [L2+Tb+4H2O+Br]4+ Calcd for [C79H96BrN8O11P2Tb]4+ 408.1272; Found 408.1692. 
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2.1.26 Complexation of L4 with Eu(III): synthesis of EuL4 
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Synthetic procedure: 
The ligand (L4) (0.03 g; 0.022 mmol; 1 eq) and anhydrous europium chloride (EuCl3) 
(0.01 g; 0.022 mmol; 1 eq) were dissolved in 20 mL of anhydrous methanol. The reaction 
mixture was heated under reflux and argon atmosphere for 15 h. The reaction was 
monitored through ESI mass spectrometry via direct injection and TLC 
(DCM/isopropylamine 95:0.5). The reaction was stopped when no peak related to the 
free ligand (L4) was observed in the mass spectrum and no spot related to the free ligand 
(L4) was observed on TLC plate. The reaction mixture was allowed to cool back to room 
temperature and was poured into cold diethyl ether (20 mL). The mixture was centrifuged 
and the ether was poured off the pale yellow precipitate. The precipitated was dissolved 
in distilled water (5 mL) and the sample was freeze-dried. The complex (EuL4) was 
obtained as pale yellow solid in 97% yield (0.03 g).  EuL4 was characterized via mass 
and absorption and emission spectroscopy. λmax =  298 nm; MS (ESI) m/z: 
[L4+Eu+H2O]5+ Calcd for [C73H81153EuN7O8P2]5+ 279.6961; Found 279.0936. 
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2.1.27 Complexation of L5 with Eu(III): synthesis of EuL5 
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Synthetic procedure: 
The ligand (L5) (0.03 g; 0.033 mmol; 1 eq) and anhydrous europium chloride (EuCl3) 
(0.01 g; 0.033 mmol; 1 eq) were dissolved in 20 mL of anhydrous methanol. The reaction 
mixture was heated under reflux and argon atmosphere for 15 h. The reaction was 
monitored through ESI mass spectrometry via direct injection and TLC 
(DCM/isopropylamine 95:0.5). The reaction was stopped when no peak related to the 
free ligand (L5) was observed in the mass spectrum and no spot related to the free ligand 
(L5) was observed on TLC plate.  The reaction mixture was allowed to cool back to room 
temperature and was poured into cold diethyl ether (20 mL). The mixture was centrifuged 
and the ether was poured off the pale yellow precipitate. The precipitated was dissolved 
in distilled water (5 mL) and the sample was freeze-dried. The complex (EuL5) was 
obtained as pale yellow solid in 94% yield (0.04 g).  EuL5 was characterized via mass 
spectrometry and absorption and emission spectroscopy. λmax =  339 nm; MS (ESI) m/z: 
[L5+Eu+Cl]2+ Calcd for [C48H53Cl153EuF6N7O10]2+ 594.6324; Found 595.2107. 
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2.1.28 Complexation of L6 with Eu(III): synthesis of EuL6 
 
 
  
Synthetic procedure: 
The ligand (L6) (0.04 g; 0.045 mmol; 1 eq) and anhydrous europium chloride (EuCl3) 
(0.01 g; 0.045 mmol; 1 eq) were dissolved in 20 mL of anhydrous methanol. The reaction 
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mixture was heated under reflux and argon atmosphere for 15 h. The reaction was 
stopped when no peak related to the free ligand (L6) was observed in the mass spectrum 
and no spot related to the free ligand (L6) was observed on TLC plate. The reaction 
mixture was allowed to cool back to room temperature and was poured into cold diethyl 
ether (20 mL). The precipitated was dissolved in distilled water (5 mL) and the sample 
was freeze-dried. The mixture was centrifuged and the ether was poured off the yellow 
precipitate. The complex (EuL6) was obtained as yellow solid in 87% yield (34 mg).  
EuL6 was characterized via mass spectrometry and absorption and emission 
spectroscopy. λmax =  275 nm, λmax =  452 nm; MS (MALDI) m/z: [L6+Eu+5H2O+Cl]2+ 
Calcd for [C41H66Cl153EuN6O14]2+ 527.1764; Found 526.5. 
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2.1.29 Complexation of L7 with Eu(III): synthesis of EuL7 
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Synthetic procedure: 
The ligand (L7) (0.04 g; 0.036 mmol; 1 eq) and anhydrous europium chloride (EuCl3) 
(0.01 g; 0.036 mmol; 1 eq) were dissolved in 20 mL of anhydrous methanol. The reaction 
mixture was heated under reflux and argon atmosphere for 15 h. The reaction was 
monitored through ESI mass spectrometry via direct injection and TLC 
(DCM/isopropylamine 95:0.5). The reaction was stopped when no peak related to the 
free ligand (L7) was observed in the mass spectrum and no spot related to the free ligand 
(L7) was observed on TLC plate. The reaction mixture was allowed to cool back to room 
temperature and was poured into cold diethyl ether (20 mL). The mixture was centrifuged 
and the ether was poured off the pale yellow precipitate. The precipitated was dissolved 
in distilled water (5 mL) and the sample was freeze-dried. The complex (EuL7) was 
obtained as pale yellow solid in 90% yield (0.04 g). EuL7 was characterized via mass 
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spectrometry and absorption and emission spectroscopy. λmax =  280 nm, λmax =  309 nm, 
λmax = 483 nm; MS (MALDI) m/z: [L7+Eu+Cl-2COCH3]+ Calcd for [C49H54Cl153EuN5O10]+  
1060.2766; Found 1060.5. 
  
 
 
2.2 Assay Protocols 
 
2.2.1 Mitochondrial Isolation 
Mitochondria were prepared from the livers of control using the Qproteome™ 
Mitochondria Isolation kit (Qiagen, Limburg, Netherlands) according to the 
manufacturer’s instructions with minor modifications. Briefly, 1.3 g of liver was minced 
using a scalpel prior to homogenisation in ice cold lysis buffer using a Qiagen Tissue 
Ruptor. The homogenate was incubated on an end-over-end shaker for 10 minutes at 
4°C prior to centrifugation at 1300 g for 13 minutes. The resulting pellet was resuspended 
in disruption buffer firstly by gentle pipetting and secondly using a Dounce homogenizer 
(4 strokes at 200 rpm). The resulting lysate was centrifuged at 1000g for 13 minutes with 
the resulting supernatant washed and pelleted twice at 6000g for 13 minutes. The crude 
mitochondrial pellet was finally resuspended in Incubation Buffer B (130 mM sucrose, 50  
mM KCl, 2.5 mM KH2PO4 and 5 mM N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic 
acid [HEPES], pH7.4 with KOH) and protein content was measured using a bicinchoninic 
acid (BCA) protein assay kit (Pierce, Rockford, IL, USA).  
 
 
2.2.2 Calcium Retention Capacity 
Mitochondria were suspended at 0.2mg/ml in Incubation Buffer B, supplemented with 
100 µM arsenazo III, 2.5 µM rotenone and 1 µg/mL oligomycin in each well of a 96 well 
microplate and absorbance measured every 2 seconds at 650 nm in a FlexStation3 
microplate reader (Molecular Devices, Sunnyvale, CA, USA). After approximately 1 
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minute of reading, Ca2+ was added (1µmol/mg mitochondrial protein) shortly followed by 
the addition of 10 mM succinate as the mitochondrial substrate. The CRC was calculated 
as the difference in optical density (∆OD) between the point at which mitochondria were 
energised and were undergoing mitochondrial permeability transition (i.e. the lowest OD 
reading following calcium release via MPT).  
The direct effect of complexes (EuL1, TbL1, EuL2, TbL2, NdL3, YbL3, EuL4 and TbL4) 
on CRC was examined as above by treating freshly isolated mitochondria with prior 
exposure to compounds EuL1-TbL4. All complexes were added in a six point 
concentration range (250 μM, 125 μM, 62.5 μM, 15.6 μM, 3.9 μM and 0.97 μM) alongside 
0.5% DMSO (vehicle control) and 1 µM cyclosporine A (mPTP inhibitor positive control) 
to the mitochondrial suspension prior to reading. And the effect of the compounds on 
CLC assessed as above. 
 
2.2.3 Measurement of Oxygen Consumption Rate in HepG2 Cells 
Human hepatocellular liver carcinoma (HepG2) cells were obtained from the European 
collection of cell cultures (ECCAC, Sailsbury UK). Cells were grown in DMEM medium 
(Invitrogen #11966) supplemented with 10 mM galactose, 100 µM sodium pyruvate, 5 
mM HEPES, 2 mM GlutaMAX, 10% fetal bovine serum and 5 µg/ml gentamycin. Cells 
were maintained in a 37°C, 5% CO2 humidified atmosphere. HepG2 cells were seeded 
in an XF96-well plate at 20,000 cells / 80 µL cell culture medium / well and incubated in 
a 37°C, 5% CO2 humidified atmosphere for 24 hours. Following incubation the culture 
medium was replaced with 175 µL pre-warmed, serum-free XF Base Assay Media 
(Seahorse Bioscience, Billerica, MA), supplemented with 2 mM L-glutamine, 1 mM 
sodium pyruvate and 10 mM glucose (pH 7.4) and incubated at 37°C for one hour. 
Compounds EuL1-TbL4 were maintained in DMSO and a five point dose response (200 
µM – 0.8 µM), plus 0.1% DMSO control,  was diluted to 8X concentration in XF Assay 
media and 25 µL was loaded into Port A of the XF Assay Cartridge (2 technical replicates 
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per concentration of Compound / DMSO control). Oligomycin (2 µM final), FCCP (0.25 
µM final) and antimycin A / rotenone (1 µM final) were loaded into ports B, C and D at 
9X, 10X and 11X concentrations respectively (all 25 µL volume). Following calibration of 
the XF Assay Cartridge, the cell plate was inserted into the analyser and 2 basal 
measurements were made using a 3 minute mix, 3 minute measure protocol. The 
compounds were then injected pneumatically into each well from ports A-D (compounds 
EuL1 to TbL4 first followed by mito-stress test compounds) with ten, 1 minute mix, 2 
minute measure cycles performed over a 1 hour incubation with compounds  EuL1-
TbL4.  This was followed by three 2 minute mix 2, minute measure cycles following each 
injection with the exception of AA/Rot which had two 2 minute mix and 2 minute measure 
cycles. Data is expressed in pmol/min OCR and represent the mid-point of each 
measurement period. 
 
 
2.2.4 Cellular ROS assay protocol 
100000 cells per well were seeded and left to incubate at 37◦C with 5% CO2 overnight in 
DMEM+Glutamax medium supplemented with 10% FBS (serum) and 1% P/S 
(penicillin/streptomycin) in a 96 wells per plate. The following day the cells were exposed 
to H2O2 50 μM and TBHP 150 uM and incubated for 30 minutes at 37◦C. After 30 minutes 
of incubation, the H2O2 and TBHP solutions were removed and replaced with the EuL4 
and EuL5 at concentrations of 1 μM, 10 μM and 100 μM, and with the Mitosox at 2.5 μM 
and 5 μM concentrations. The medium was removed from other cells that were not 
previously exposed to H2O2 and TBHP and replaced with EuL4 and EuL5 at 
concentrations of 1 μM, 10 μM and 100 μM and Mitosox at 2.5 μM and 5 μM 
concentrations. Mitosox was used as positive control. After 30 minutes the plates were 
read with a microplate reader. Second time reading was made by washing all wells twice 
with HBSS, a transparent medium. 
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3. Results and Discussion: design and synthesis of lanthanide 
complexes based on asymmetrically substituted cyclen ligands 
 
This chapter describes how lanthanide complexes based on asymmetrically substituted 
cyclen ligands were designed in order to produce molecular sensors able to signal the 
presence of ROS species. A detailed description of the synthetic routes that were applied 
to the synthesis of these molecular sensors is provided. Two different synthetic routes 
were used to synthesize the final asymmetrically substituted cyclen-based ligands before 
the complexation with the lanthanide ions.  The first synthetic route was based on the 
direct and selective N-alkylation of four pendant arms on the cyclen ring. This synthetic 
approach required that the pendant arms had to be synthesised separately and then 
could be used for the direct N-alkylation. This route presented many issues such as very 
low yields, due to the low stability of the products during the purification by column 
chromatography. In order to overcome the issues encountered with the first synthetic 
route, a new synthetic scheme based on a different synthetic approach was developed. 
It involved the synthesis of an intermediate ligand that was called “the generic ligand” 
since it possesses a chemical structure that could be modified in many ways in order to 
produce different types of ligands. The generic ligand was designed and synthesised by 
exploiting an orthogonal protection strategy (Scheme 3.1). Starting from the generic 
ligand and selectively removing the protecting groups attached to it, it was possible to 
synthesise different types of asymmetrically substituted cyclen based ligands.  
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Scheme 3.1 A strategy for the synthesis of asymmetrically substituted cyclen based on orthogonal protecting 
groups (PG). 
 
3.1 Designing ROS-responsive luminescent lanthanide complexes based 
on asymmetrically substituted cyclen-based ligands. 
Taking advantage from the lanthanide complexes based on asymmetrically substituted 
cyclen ligands developed by Bruce and co-workers. [37], [38], which were examined in 
the chapter 1, a series of lanthanide complexes based on asymmetrically substituted 
cyclen ligands were designed in this project in order to develop ROS-responsive 
luminescent probes. The general structure of the lanthanide complexes designed in this 
project is shown in Figure 29.  
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Figure 29. A cartoon representation of the general structure of a lanthanide complex based on 
asymmetrically substituted cyclen ligand that was designed to be responsive to ROS species. 
  
The ligand structure of the molecular system shown in Figure 29 is formed by an 
asymmetrically substituted cyclen bearing four pendant arms. Two arms containing 
targeting molecules were introduced on the cyclen ring in order to increase the 
permeability of the complex through the cellular and mitochondrial membranes. This was 
to allow not only to achieve a high concentration of the complex within the cells, but also 
to target it to the mitochondria that represent the targeted organelles since, as discussed 
in the chapter 1, they are the main source of ROS. The other two moieties attached to 
the cyclen ring were two chromophore antennae that were chosen to act as sensitizers 
towards the trivalent lanthanide ion and in meantime to be able to sense the presence of 
ROS species. In this system one of the two antennae, for example antenna 2, could be 
an organic chromophore, such as a fluorescein or coumarin derivative, which acts as 
sensitizer of the trivalent lanthanide ion and in the meantime should be oxidized by a 
ROS species, such as H2O2 or OH●. The oxidation of antenna 2 by a ROS species should 
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cause changes in its photophysical properties that in turn should cause changes in the 
lanthanide emission. In fact, a quenching or an enhancement and/or spectral form 
changes of lanthanide emission could take place as results of changes of photophysical 
properties of the sensitizer antenna. This means that changes in the lanthanide emission 
are indicative of the presence of ROS species. The other antenna introduced on the 
cyclen ring, namely antenna 1, should be able to reduce back the antenna 2 thus 
restoring its reduced form that can react again with other ROS species. Moreover, the 
sensitisation of the lanthanide ion achievable by using two sensitizer antennae could be 
more effective than the sensitisation achievable by using one antenna, and using two 
antennae allows a wider wavelength range. Finally, the three carbonyl functions present 
on three pendant arms of the cyclen ring participate together with the four nitrogen atoms 
of the cyclen ring to the coordination of the trivalent lanthanide ion.  
 
3.2 Design and synthesis of the first asymmetrically substituted cyclen-
based ligand 
An asymmetrically substituted cyclen-based ligand was designed at the beginning of this 
project in order to have all the properties mentioned in the section 3.1 that would have 
allowed the development of a ROS responsive molecular sensor. The chemical structure 
of this ligand is shown in Figure 30.  
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Figure 30. The first asymmetrically substituted cyclen-based ligand designed in this project. 
 
The ligand shown in Figure 30 is formed by an asymmetrically substituted cyclen to which 
four pendant arms are attached. The two arms containing the N-methyl-L-glucamine 
derivative were chosen in order to increase the hydrophilicity of the ligand thanks to the 
presence of ten hydroxyl functions thus making the ligand an amphiphilic molecule. It 
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was thought that adding two high hydrophilic moieties like N-methyl-L-glucamine 
derivative would have provided the ligand with similar properties of plasma and 
mitochondria membranes, facilitating its diffusion through these systems of membranes. 
It is well known that the plasma membrane as well as the mitochondrial membranes are 
formed by a phospholipid bilayer, which are amphiphilic molecules since they possess a 
hydrophilic phosphate head and a hydrophobic tail consisting of two fatty acid chains 
(C1-8). The synthetic route that was applied to the synthesis of the asymmetrically 
substituted cyclen-based ligand shown in Figure 30, is illustrated Figure 31. The 
synthetic approach used in this synthetic route required that the pendant arms of the 
cyclen had to be synthesised separately and then could be used for the N-alkylation 
reaction thus allowing the functionalization of the cyclen ring. 
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Figure 31. Schematic representation of the synthetic route applied to the synthesis of the 1-ethylamide-
dihydrofluorescein-4-coumarin 2-acetamide-7,10-di-N-methyl-L-glucamine-N-acetamide-1,4,7,10- 
tetraazecyclododecane (31). 
 
The synthetic route started with the synthesis of the N-Boc-2-bromoethylamine (18), 
which was synthesised starting from the bromoethylamine hydrobromide (16) and di-
tertbutyl dicarbonate (17). This reaction allowed the introduction of the Boc group on the 
amino function to protect it and prevent it from reacting during the following steps. The 
protection of the primary amino function with the Boc group was essential in order to 
prevent its participation during the following N-alkylation reactions of the cyclen ring. In 
fact, if the reactivity of the amino function had not been properly masked by a protecting 
group (such as the Boc group), then the amino function would have competed with the 
secondary amino functions of the cyclen ring during the nucleophile substitution 
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reactions employed for the cyclen ring functionalization. The Boc group is widely used to 
protect amino functions and is stable towards most nucleophiles and bases. It is usually 
removed using moderate acidic conditions such as trifluoroacetic acid in DCM [58], [59].  
 
3.2.1 Synthesis of the N-Boc-ethylamine-1,4,7,10-tetraazacyclododecane (20) 
The N-Boc-2-bromoethylamine (18) was then introduced on the cyclen (19) ring to obtain 
the N-Boc-ethylamine-1,4,7,10-tetraazacyclododecane (20) through a mono alkylation 
reaction. The first attempt to obtain the monosubstituted cyclen (20) was made using 
both the cyclen and the N-Boc bromoethylamine in 1:1 ratio, anhydrous chloroform as 
solvent and triethylamine as base. This reaction turned out to be not selective since a 
complex mixture of mono-, di-, and tri- substituted cyclen was observed during the 
monitoring of the crude mixture with TLC (DCM/isopropylamine 9.5:0.5) and NMR 
spectroscopy. The formation of mono-, di-, and tri- substituted cyclen suggested that the 
reactivity of the cyclen and the mono- and di- substituted cyclen was approximately the 
same. Unfortunately many attempts to purify the monosubstituted cyclen and recover it 
through column chromatography were made, using different combinations of eluents and 
stationary phase, but all failed (Table 1). 
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Mobile phase Stationary phase 
hexane/ethyl acetate (80:20) Silica gel 
DCM/isopropylamine (from 0.5 to 10%) Silica gel 
DCM/methanol (90:10) Silica gel 
hexane/ethyl acetate (80:20) Alumina gel 
DCM/isopropylamine (from 0.5 to 10%) Alumina gel 
DCM/methanol (90:10) Alumina gel 
 
Table 1. Combination of solvents and stationary phases used to purify the reaction mixture obtained with 
the first procedure applied to the synthesis of the monosubstituted cyclen.  
 
 
The combinations of solvents used as mobile phase were: hexane/ethyl acetate (80:20), 
DCM/isopropylamine (from 0.5 to 10%) and DCM/methanol (90:10). Silica and alumina 
gel were used as stationary phase with the combinations of solvents mentioned above 
but no product was recovered from the column. In order to overcome the issue related 
to the impossibility of recovering the monosubstituted cyclen from the column 
chromatography, a different synthetic procedure, which did not require the purification 
by column chromatography, was used [60]. According to the new procedure applied to 
the synthesis of the monosubstituted cyclen, 5 equivalents of cyclen per equivalent of N-
Boc-2-bromoethylamine were used as starting material [60]. The reaction was carried 
out in anhydrous CHCl3, under argon atmosphere and kept under reflux conditions for 
16 hours. The reaction mixture was monitored by TLC (DCM/isopropylamine 95:0.5) and 
mass spectrometry via direct injection. In particular, the TLC performed on the reaction 
mixture after 15 hours at reflux showed the presence of two spots: one spot was related 
to the excess of unreacted cyclen and the other spot was obtained to the alkylated cyclen 
formed during the reaction. No spot related to the N-Boc bromoethylamine was observed 
on the TLC confirming that the reaction went to completion. The results obtained with 
the mass spectrometry performed on the reaction mixture after 15 hours at reflux 
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confirmed the presence of two main peaks: one peak related to the excess of unreacted 
cyclen at m/z 173 and another peak at m/z [M+1]+ 316, which corresponded to the 
monosubstituted cyclen. No peaks related to the di-, tri-, and tetrasubstituted cyclen were 
observed in the mass spectrum.  The results obtained with the mass spectrometry were 
aligned with the results obtained with the TLC and confirmed that one of the two spots 
seen on the TLC plate was related to the monosubstituted cyclen. The results obtained 
with the TLC and mass spectrometry proved that the excess of cyclen used in the new 
procedure applied to the synthesis of the monosubstituted cyclen had proved to be 
effective in preventing the polyalkylation of the cyclen ring. The excess of unreacted 
cyclen was easily recovered from the aqueous phase after extracting the reaction mixture 
three times with a 2M NaOH aqueous solution [60]. The monosubstituted cyclen was 
recovered from the organic phase with a high degree of purity and without the necessity 
to perform column chromatography.  
 
3.2.2 Synthesis of the coumarin 2 bromoacetate (23) 
The following pendant arm that was introduced on the cyclen was the coumarin 2 
bromoacetate (23), which was synthesized from coumarin 2 and bromoacetic acid and 
using EDCI * HCl as coupling agent and DCM as solvent at room temperature [61]. The 
reaction was performed six times using each time different equivalents of EDCI*HCl and 
bromoacetic acid per equivalent of coumarin 2 as shown in the Table 2.  
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Coumarin 2 (eq) Bromoacetic acid 
(eq) 
EDCI*HCl (eq) Reaction time 
(hour) 
Yield % 
1 1 1 24 reaction not 
complete 
1 2 2 24 reaction not 
complete 
1 3 3 24 reaction not 
complete 
1 4 4 24 reaction not 
complete 
1 5 5 24 reaction not 
complete 
1 6 6 24 84 
 
Table 2. Reaction conditions used during the peptide coupling reaction that lead to the synthesis of the 
coumarin 2 bromoacetate (23). 
 
When 1-5 equivalents of bromoacetic acid and EDCI*HCl were used the reaction did not 
go to completion when observed using TLC. After 24 hours there was still decreasing 
amounts of unreacted coumarin 2 present. It was found that the reaction went to 
completion when 6 equivalents of bromoacetic acid and 6 equivalents of EDCI*HCl per 
equivalent of coumarin 2 were used. This was shown by the TLC results related to the 
reaction monitoring, where no spot related to the unreacted coumarin 2 was observed 
after 24 hours.  
 
3.2.3 Synthesis of the 1-N-Boc-ethylmine-4-coumarin 2 acetamide-1,4,7,10-
tetraazacyclododecane (24) 
The coumarin 2 bromoacetate was introduced in the position 4 of the cyclen ring through 
a selective 1-4 N-alkylation [62] to obtain the 1-N-Boc-ethylmine-4-coumarin 2 
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acetamide-1,4,7,10-tetraazacyclododecane (24). In order to obtain the 1-4 substituted 
cyclen, the coumarin 2 bromoacetate and (20) were reacted in a 1:1 ratio. The reaction 
was performed using 1.1 equivalents of TEA as base and anhydrous CHCl3 as solvent 
and keeping the reaction mixture under argon atmosphere at room temperature. The 1-
4 regioselectivity is observed in less polar and aprotic solvent such as chloroform at room 
temperature [62], [38]. This can be explained by the fact that after the first N-alkylation 
of the cyclen, the two N-H groups of the position number 4 of the cyclen ring will be 
intraannular and bonded through hydrogen bonds to the two lone pairs of the nitrogen 
atoms in position number 1 and 7. This means that the lone pair of the nitrogen atoms in 
position number 7 will be intraannular and so not available to act as nucleophile during 
the alkylation reaction. The only lone pairs that can act as nucleophile and be further 
alkylated are the ones in position number 4, since they are extraannular [62]. The 1-4 
disubstituted cyclen (24) was purified through column chromatography using a 
combination of DCM and isopropylamine from 0.5 to 5% as eluent.  
 
3.2.4 Synthesis of the 1-N-Boc-ethylamine-4-coumarin 2 acetamide-7,10-di-N-
methyl-L-glucamine pentaacetate-N-acetamide-1,4,7,10-tetraazacyclododecane 
(27) 
The two pendant arms of N-methyl-L-glucamine pentaactetate bromoacetate (26) that 
had to be introduced on the 1-4 disubstituted cyclen (24) were synthesized separately in 
a two-step reaction. The first step was the synthesis of the N-methyl-L-glucamine 
pentaactetate-bromoacetate (26), which was a peptide coupling reaction, performed 
using bromoacetic acid and N-methyl-L-glucamine as starting materials and EDCI as 
coupling reagent [61]. The second step was the protection of the five hydroxyl functions 
with acetate protecting group. This reaction was performed by dissolving the crude 
mixture obtained with the first step in dry pyridine and adding an excess of acetic 
anhydride in small portions [63]. The excess of acetic anhydride was consumed by the 
addition of water and the compound was recovered into the organic layer after first 
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extracting the reaction mixture with DCM and water and then with DCM and diluted acidic 
aqueous solution. Three attempts (Table 3) to introduce the two arms of the N-methyl-L-
glucamine pentaactetate-bromoacetate (26) in position 7 and 10 of (24) through a direct 
N-alkylation reaction were made but all were unsuccessful since no signal of the two N-
methyl-L glucamine pentaacetate moieties were found in the proton NMR spectra 
performed on the crude mixtures obtained from each attempt. The reaction was generally 
performed using one equivalent of (24), two equivalents of N-methyl-L-glucamine 
pentaactetate-bromoacetate (26), TEA as base and anhydrous acetonitrile as solvent 
and the reaction mixture was kept under argon atmosphere under reflux conditions [37]. 
 
1-4 disubstituted cyclen 
(1 eq) 
N-methyl-L-glucamine 
pentaactetate 
bromoacetate 
(2 eq) 
 
TEA 
(eq) 
Reaction 
Time  
(hour) 
Product: 
(27) 
 
 
 
2 12 - 
 
 
5 24 - 
 
 
10 36 - 
 
 
Table 3. The three attempts were made to synthesize the 1-N-Boc-ethylamine-4-coumarin 2 acetamide-
7,10-di-N-methyl-L-glucamine pentaacetate-N-acetamide-1,4,7,10-tetraazacyclododecane (27). 
 
As it shown in Table 3, the first attempt of introducing two moieties of N-methyl-L 
glucamine pentaacetate-bromoacetate (26) on the 1-4 disubstituted cyclen (24) was 
made using 2 equivalents of TEA per equivalent of 1-4 disubstituted cyclen (24) and 
138 
 
keeping the reaction under argon atmosphere under reflux conditions for 12 hours. The 
proton NMR spectroscopy performed on the crude mixture obtained from this reaction 
did not show the peaks related to hydrogen atoms of the N-methyl-L-glucamine 
pentaacetate-bromoacetate (26) moieties, indicating that no product was formed. This 
could be due to the fact that the reaction conditions used to perform the reaction were 
not suitable to introduce the two moieties of N-methyl-L glucamine pentaacetate- 
bromoacetate (26) in position 7 and 10 of the 1-4 disubstituted cyclen (24). The reaction 
was repeated again increasing both the amount of TEA and the reaction time. In 
particular, 5 equivalents of TEA per equivalent of 1-4 disubstituted cyclen (24) were used 
and the reaction mixture was kept 24 h at reflux. Unfortunately the proton NMR spectrum 
of the reaction mixture after 24 hours at reflux, did not show the peaks related to the 
hydrogens of the N-methyl-L-glucamine pentaacetate-bromoacetate (26) moieties, 
indicating that also in this case no product was formed. The reaction was repeated again 
increasing the amount of TEA up to 10 equivalents per equivalent of 1-4 disubstituted 
cyclen (24) and the reaction time up to 36 hours (Table 1). Even in this case the proton 
NMR performed on the reaction mixture did not revealed the presence of hydrogen 
atoms related to the N-methyl-L-glucamine pentaacetate-bromoacetate (26) moieties, 
indicating that no product was formed. This suggested that probably the N-methyl-L 
glucamine pentaacetate-bromoacetate (26) was not stable to the reaction conditions 
used for running the reaction. It could be possible that the conditions caused a 
decomposition of the N-methyl-L glucamine pentaacetate-bromoacetate (26), explaining 
why the proton NMR spectra related to the reaction mixtures obtained from the three 
attempts made to synthesize the 1-N-Boc-ethylamine-4-coumarin 2-acetamide-7,10-di-
N-methyl-L-glucamine pentaacetate-N-acetamide-1,4,7,10-tetraazacyclododecane (27) 
did not show the peaks related to the hydrogen atoms of the N-methyl-L glucamine 
pentaacetate-bromoacetate (26). It was also thought the steric hindrance of the two N-
methyl-L glucamine pentaacetate-bromoacetate (26) moieties could in some way 
prevent the N-alkylation reaction of the 1-4 disubstituted cyclen (24) from taking place.  
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3.3 The second synthetic route applied to the synthesis of asymmetrically 
substituted cyclen-based ligands 
Based on the hypothesis that the N-methyl-L-glucamine pentaacetate-bromoacetate (26) 
was not stable under reflux conditions used for the direct N-alkylation, it was replaced by 
another moiety, which was thought to be stable under reflux conditions. In particular, two 
moieties of a lipophilic triphenylphosphonium cation were used. Moreover, based on the 
hypothesis that the steric hindrance of the two N-methyl-L-glucamine pentaacetate-
bromoacetate (26) moieties could be responsible for the failure of the direct N-alkylation 
reaction, a different synthetic approach for the synthesis of the asymmetrically 
substituted cyclen-based ligands was used. It involved the synthesis of an intermediate 
ligand, the 1-N-Boc ethylamine-4,7-diallyl acetate-10-benzyl acetate-1,4,7,10-
tetraazacyclododecane (DABBC) (36), which was called “the generic ligand” since it 
possesses a generic chemical structure that could be modified in many ways in order to 
produce different types of ligands. The chemical structure of DABBC (36) (generic ligand) 
is shown in Figure 32.  
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Figure 32.  1-N-Boc ethylamine-4,7-diallyl acetate-10-benzyl acetate-1,4,7,10-tetraazacyclododecane 
(DABBC) (Generic Ligand) (36) 
 
The generic ligand (36) was designed and synthesized by exploiting an orthogonal 
protection strategy. Orthogonal protection is a synthetic strategy allowing the sequential 
deprotection of protective groups one at a time each with a dedicated set of reaction 
conditions without affecting the other [64]. The generic ligand was designed in a way that 
it contained three different protecting groups, used for masking the reactivity of carboxyl 
and amino functions. These protecting groups could be selectively and sequentially 
removed allowing to insert different pendant arms on the cyclen ring. The sequential 
attachment of different pendant arms to the cyclen ring, after that each protecting group 
has been removed, would allow to obtain an asymmetrically substituted cyclen-based 
ligand and could be achieved using a peptide coupling reaction. The peptide coupling 
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reaction could be performed using EDCI*HCl and HOBt as coupling agent and 
anhydrous DMF as the solvent. The three protecting groups that were chosen for the 
synthesis of the general ligand are: one Boc group, two allyl ester groups and one benzyl 
ester group. The two allyl ester groups were chosen to protect two of the three carboxylic 
functions shown in Figure 32. The two carboxylic functions protected via allyl ester were 
the ones on the pendant arms in position 4 and 7 of the cyclen ring. The esterification 
represents a useful and well established way to protect a carboxylic function and prevent 
its reactivity during the following steps of a multistep synthesis, such as the one involving 
the synthesis of peptides. There are many alcohols that can be used for esterifying 
carboxylic functions and the benzyl alcohol and the allyl alcohol are an example of 
alcohols widely employed for carboxylic functions esterification [65]. The Boc group was 
used to protect the primary amino function on the pendant arm in position 1 of the cyclen 
ring (Figure 32). The use of protecting groups able to mask the reactivity of the three 
carboxylic functions and the amino function was essential for the selective and sequential 
introduction of different pendant arms on the cyclen ring in order to achieve an 
asymmetrically substituted cyclen-based ligand. In fact, if the carboxylic and amino 
functions were not protected, they would have reacted during the subsequent peptide 
coupling reactions randomly, giving rise to many side products, which could be difficult 
to purify. The second synthetic route, which involved the synthesis of the intermediate 
generic ligand, presented two important advantages over the previous route: 
1. Although the attachment of the pendant arms containing the protecting groups to 
the cyclen ring to obtain the generic ligand would involve reactions under reflux 
conditions, once the protecting groups are removed, the incorporation of the 
pendant arms can be achieved using a peptide coupling reaction. Since the 
coupling reaction is performed at room temperature, it can be applied when the 
starting materials are thought to be unstable to the high temperature required for 
the refluxing conditions, as hypothesized for the N-methyl-L-glucamine 
pentaacetate-bromoacetate (26). 
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2. The peptide coupling reactions are less susceptible to the steric hindrance 
compared to the nucleophilic substitution reactions and in some cases the 
peptide coupling is achievable using sterically hindered substrates [66]. The N-
alkylation of the cyclen is a nucleophilic substitution reaction and as such it is 
widely affected by the steric hindrance of both substrates taking part in the 
reaction. In the case of the N-alkylation reactions applied to the functionalization 
of the cyclen, the latter acts as nucleophile and the pendant arm to be introduced, 
containing a bromine (or a chlorine) as leaving group, acts as electrophile. 
Although the peptide coupling reactions may be affected by steric hindrance of 
the substrates involved in the reaction, they are more influenced by the ability of 
the coupling agent to activate the carboxyl function. In the peptide coupling 
reactions, two substrates containing respectively a carboxyl function and an 
amino function are bound together via an amide (or peptide) bond. In order to 
make the reaction possible, it is necessary to increase the electrophilicity of the 
carboxyl function by converting it into a more reactive form [61]. This can be 
achieved by converting the carboxyl function into an acyl chloride (or bromide) or 
an activated ester. In the latter case a wide range of coupling agents are 
employed to convert the carboxyl function into an activated ester and among 
these the combination of HOBt, EDCI is one of the most effective [61]. The 
chance that the peptide coupling reactions could be applied sometimes to 
sterically hindered substrates represents an important advantage over the N-
alkylation reaction since it would allow the functionalization of the cyclen ring 
using sterically hindered substrates, such as the ones containing bulky groups 
like triphenylphophonium cations. 
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3.3.1 Orthogonal protection strategy  
This section describes the orthogonal protection strategy that was exploited to synthetize 
asymmetrically substituted cyclen based ligands and overcome the issues encountered 
with the first synthetic route discussed in the previous sections. An important advantage 
of the orthogonal protection strategy applied to the synthesis of the intermediate ligand, 
namely the DABBC or generic ligand (36) (Figure 32) is that it could be achieved in two 
different ways. One way is to start with the two allyl ester groups removal, using Pd(0)-
catalyzed allyl transfer to diethylamine as the accepting nucleophile, also called a 
scavenger (Figure 33). The Pd(0)-catalyst can be generated in situ from Pd(OAC)2 
(palladium acetate) and TPPTS (triphenylphosphinotrisulfonate sodium salt) [71]. In 
chemistry, a scavenger is defined as a chemical substance that is added to a reaction 
mixture in order to remove or deactivate reactive intermediate formed during a reaction. 
In the specific case of the allyl ester deprotection, an excess of diethylamine is added in 
order to react with the allyl cations formed as result of the allyl ester bond breaking 
catalysed by the Pd(0). The deactivation of the allylic cations by using an excess 
diethylamine is important to prevent their reactivity during the reaction that may lead to 
the formation of unwanted side products. Under the reaction conditions used for the allyl 
ester removal, both the benzyl ester and the Boc groups should be unaffected. Once the 
allyl ester groups have been removed, it is possible to couple two moieties, bearing a 
primary or secondary amino function, to the free carboxylic acid functions using a peptide 
coupling reaction, such as the one involving EDCI*HCl and HOBt as coupling agents 
(Figure 33).  Then the benzyl ester group can be cleaved in a selective manner using a 
catalytic hydrogenation reaction, which can be performed using 10% palladium on 
charcoal as catalyst and gaseous molecular hydrogen (H2) as hydrogen donor (Figure 
33). These reaction conditions should leave intact the Boc group. After the benzyl ester 
group deprotection, it is possible to couple another moiety containing a primary or 
secondary amino function that can take part in a peptide coupling with the free carboxylic 
function. Also in this case a peptide coupling reaction, involving the use of EDCI*HCl and 
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HOBt as coupling agents, could be applied. Finally, the Boc group can be removed in a 
mild acidic environment, using TFA and DCM. This reaction frees the amino function, 
whose reactivity had been masked by Boc group, and allows introducing another moiety, 
bearing a free carboxylic function, via peptide coupling reaction (Figure 33).  
 
 
Figure 33.  Schematic representation of an orthogonal deprotection strategy involving the generic ligand  
(36). 
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The deprotection strategy descried so far can be applied only if the pendant arms that 
are sequentially added to the cyclen via peptide coupling reactions are stable to the mild 
acidic conditions used for the final Boc group removal. If one or more than one pendant 
arms used to functionalize the cyclen are unstable under the mild acidic condition used 
for the Boc deprotection, then an alternative orthogonal deprotection strategy is required. 
This can be achieved by changing the order by which the protecting groups are 
selectively removed from the generic ligand. An alternative orthogonal deprotection 
strategy, applied to the generic ligand to obtain asymmetrically substituted cyclen-based 
ligands, is shown in Figure 34. It starts with the selective removal of the Boc group using 
TFA and DCM, followed by the introduction of the acid labile moiety via a peptide 
coupling reaction. This should guarantee that one or more acid labile pendant arms can 
be introduced on the cyclen ring without being affected from the reaction conditions used 
in following steps. This is possible since the Boc group is the only protecting group 
among those that were used for the synthesis of the generic ligand that can be only 
removed in mild acidic conditions. Although the benzyl ester can be removed using a 
catalytic hydrogenation reaction, it can be also removed in acidic conditions. However in 
this case stronger acidic conditions are required for the deprotection compared to the 
mild acidic condition required for the Boc deprotection. The mild acidic conditions used 
for the Boc group cleavage should leave intact both benzyl ester and allyl ester groups. 
Once the Boc group has been cleaved and a pendant arm has been introduced via a 
peptide coupling reaction, the two allyl groups can be selectively removed (Figure 34). 
As discussed above, the two allyl ester groups can be removed using Pd(OAc)2 and 
TPPTS as catalyst and an excess of diethylamine as scavenger. These reaction 
conditions should leave intact the benzyl ester group that can be removed, once two 
pendant arms have been introduced into the cyclen ring via a peptide coupling reaction 
to replace the two allyl ester groups. Finally, after the benzyl ester group removal via 
catalytic hydrogenation performed using 10% palladium on charcoal as catalyst and 
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gaseous molecular hydrogen (H2) as hydrogen donor, it is possible to introduce a further 
pendant arm via a peptide coupling reaction. 
 
Figure 34.  Schematic representation of an orthogonal deprotection strategy, applicable when using acid 
labile pendant arms. 
 
The two orthogonal deprotection strategies discussed so far allow the synthesis of 
asymmetrically substituted cyclen ligands starting from the DABBC (36) (generic ligand). 
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The flexibility that can be achieved in terms of using two different types of orthogonal 
deprotection strategies allows a synthesis of several different asymmetrically substituted 
cyclen-based ligands starting from the same intermediate molecule of generic ligand. In 
the next section the synthetic route that was applied to the synthesis of the generic ligand 
will be discussed.  
 
3.3.2 Synthesis of the 1-N-Boc-ethylamine-4,7-diallyl acetate-10-benzyl acetate-
1,4,7,10-tetraazacyclododecane (DABBC) (36): the generic ligand 
The synthetic route applied to the synthesis of the DABBC (36) or generic ligand is a 
multistep organic synthesis consisting of five steps (Figure 35). It requires that the four 
pendant arms attached to the general ligand have to be introduced via selective direct 
N-alkylation reactions. The arms in position 1, 4 and 7, containing respectively a Boc-
protected amino function and two allyl ester groups (Figure 32), were synthetized 
separately, while the arm in position 10, containing the benzyl ester group (Figure 32), 
was commercially available. 
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Figure 35. Synthesis of the 1-N-Boc-ethylamine-4,7 diallyl acetate-10-benzyl acetate-1,4,7,10-
tetraazacyclododecane (DABBC) (36). 
 
The first two steps of the synthesis of the DABBC (36), the generic ligand, were the same 
first two steps of the previous synthetic route, and are illustrated in the Figure 31 and 
described in detail in the section 3.1. The following three steps that led to the synthesis 
of the DABBC (36) (generic ligand) starting from N-Boc-ethylamine-1,4,7,10-
tetraazacyclododecane (20) are illustrated in the Figure 35. The synthesis of the DABBC 
(36) started with the introduction of two allyl ester groups on the N-Boc-ethylamine-
1,4,7,10-tetraazacyclododecane (20). The allyl ester groups were introduced as allyl 
bromoacetate (33), which was synthetized from allyl alcohol and bromoacetyl bromide 
[64]. The allyl esters introduction was performed using 1 equivalent of monosubstituted 
cyclen (20), 2 equivalents of allyl bromoacetate (33) and two equivalents of triethylamine 
as base [37]. The reaction was conducted in anhydrous acetonitrile under reflux 
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conditions and under argon atmosphere [34]. The product of this reaction, namely the 1-
N-Boc-ethylamine-4,7-diallyl acetate-1,4,7,10-tetraazacyclododecane (DABC) (34), was 
successfully synthesised and purified through the column chromatography. However, the 
yield obtained after the column was about 20% due to the loss of some product in the 
overlapping fractions containing both the DABC (34) and the 1-N-Boc-ethylamine-4,7,10-
triallyl acetate-1,4,7,10-tetraazacyclododecane (TABC) (47), a side product formed 
during the reaction. In order to increase the yield of the DABC (34) it was essential to 
prevent or at least reduce the formation of TABC (47). In this way the reaction mixture 
would have been less complex and easier to purify by column chromatography. In order 
to reduce the formation of TABC the reaction was repeated three more times changing 
some reaction parameters such as amount of TEA and reaction time, as shown in the 
Table 4. It was found that reducing the reaction time from 15 hours to 7 hours increased 
the yield from 20% to 50% since it reduced the formation of TABC, making the reaction 
mixture less complex and easier to purify via column chromatography. 
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N-Boc-
ethylamine-
1,4,7,10-
tetraazacyclodode
cane (20) (1 eq) 
Allyl 
bromoacetate 
(2 eq) 
TEA 
(eq) 
Time 
hour 
Product: DABC (34) Yield 
(%) 
 
 
2 15 
 
20% 
 
 
1 15 
 
20% 
 
 
0.5 15 
 
20% 
 
 
2 7 
 
50% 
 
Table 4. Results obtained with the synthesis of the DABC (34) changing some reaction parameters. 
 
The final step of the DABBC (36) synthesis was the introduction of the benzyl ester group 
on the DABC (34) (Figure 35). The benzyl ester group was introduced as benzyl 
bromoacetate (35), which was commercially available, and the reaction was performed 
using one equivalent of DABC (34), 1.2 equivalents of benzyl bromoacetate (35), 2 
equivalents of triethylamine as base and anhydrous acetonitrile as solvent. The reaction 
was kept under reflux conditions and argon atmosphere for about 24 hours. The DABBC 
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(36) (generic ligand), was successfully synthesized with a high degree of purity that did 
not require the column chromatography. 
 
3.3.3 Orthogonal deprotection strategy applied to the synthesis of asymmetrically 
substituted cyclen-based ligands 
In the previous section, the synthetic route applied to the synthesis of the DABBC (36) 
was described. In this section a description of the orthogonal deprotection strategy that 
starting from the DABBC (36) led to the synthesis of ligands, based on asymmetrically 
substituted cyclen containing two triphenylphosphonium cation moieties and a 
chromophore antenna, is provided. In this project, four ligands of this type were 
synthesised and their chemical structures are shown in Figure 36. They were named L1, 
L2, L3 and L4 (which L stands for ligand). As it is possible observe in the Figure 36, all 
ligands possess a common core structure formed by a cyclen ring functionalised with 
two arms containing a triphenylphosphonium derivative, one containing a benzyl ester 
group and one containing a variable chromophore antenna. They only differ from one 
other for the chromophore antenna. In L1 the dihydrofluorescein diacetate was used as 
sensitizer towards the visible emitting Eu(III) and Tb(III) and in meantime as ROS 
receptor unit. The coumarin 343 and the coumarin 3 carboxylic acid were used in L2 and 
L4 respectively as sensitizers of Eu(III) and Tb(III) and as ROS receptor unit. In L3 the 
rhodamine B was used for the sensitization of the near infrared emitting Nd(III) and Yb(III) 
and as ROS receptor unit. The triphenylphosphonium derivative was used to target the 
complexes to the mitochondria since, as discussed in the chapter 1, they represent the 
main source of ROS within the cells.   
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Figure 36. Chemical structures of the four ligands synthesised in this project, bearing two arms of a 
triphenylphosphonium derivative, a benzyl ester group and a chromophore antenna. 
 
The orthogonal deprotection strategy described in this section was applied to the 
synthesis of L1, L2, L3 and L4. Since all the steps involved in this orthogonal 
deprotection route were the same for all ligands (L1, L2, L3 and L4) with the exception 
of the last step, namely the coupling of the sensitizer antenna, in this section only the 
one that led to the synthesis of 1-N-(coumarin 343)ethylamide-4,7-di-
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(triphenylphosphonium bromide ethyl)acetamide-10-benzyl acetate-1,4,7,10-
tetraazacyclododecane (L2) is discussed in detail as representative of this ligand series. 
One of the orthogonal deprotection strategies discussed in the section 3.3.1 and shown 
in Figure 37, was applied to the synthesis of L2, as well as for L1, L3 and L4 synthesis.  
The strategy starting with the allyl ester groups’ removal was chosen as would have 
prevented the chromophore antenna, such as coumarin 343, being affected by reaction 
conditions required for the allyl ester groups’ removal. In fact, if the allyl ester and/or 
benzyl ester groups had been deprotected after cleaving the Boc group and incorporating 
the chromophore antenna, the unsaturated bond present on the antenna would have 
been reduced by the reducing agents employed for cleaving the allyl ester and/or benzyl 
ester groups. 
 
. 
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Figure 37. Schematic representation of the synthesis of (L2) starting from the generic ligand (36). 
The removal of the two allyl esters groups was successfully performed using a 
combination of palladium acetate Pd(OAc)2 and triphenylphosphinotrisulfonate sodium 
salt (TPPTS) as catalyst and the dimethylamine as scavenger [71]. However, an initial 
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procedure performed using tetrakis-(triphenylphosphine)-palladium and morpholine in 
dichloromethane at room temperature was unsuccessfully applied to the removal of the 
two allyl ester groups [68], [69], [70]. According to the initial procedure [68], [70] the 
reaction would have been kept under stirring for about three hours to achieve the allyl 
ester groups’ deprotection. Although the mass spectrum of the reaction mixture obtained 
after 24 hours confirmed that both the benzyl ester and the Boc groups were stable under 
the chemical conditions used for the deprotection, two main peaks were found in the 
mass spectrum. One peak at m/z 570 related to the mono allyl-removal product and one 
peak at m/z 530 related to the product derived from the deprotection of both allyl groups 
(Figure 38).  
 
 
Figure 38. The two main products formed during the allyl deprotection procedure performed using tetrakis-
(triphenylphosphine)-palladium as catalyst and morpholine as scavenger. 
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This indicated that, although the procedure involving the use of tetrakis-
(triphenylphosphine)-palladium and morpholine could be successfully applied to remove 
one allyl ester group, was not suitable for the simultaneous cleavage of two allyl ester 
groups. In fact, the reaction did not go to completion even though it was kept under 
stirring for 24 hours and repeated three times using increasing concentrations of tetrakis-
(triphenylphosphine)-palladium and morpholine, as it is shown in Table 5. 
Substrate (1eq) Catalyst 
(eq) 
Scavenger 
(eq) 
Solvent/s Time 
(hour) 
Product/s 
 
tetrakis-
(triphenylpho
sphine)-
palladium 
(0.2eq) 
Morpholine 
(10eq) 
CH2Cl2 24 Mono allyl 
deprotected 
(m/z 570) + 
Diallyl 
deprotected 
(m/z 530) 
 
tetrakis-
(triphenylpho
sphine)-
palladium 
(0.5eq) 
Morpholine 
(20eq) 
CH2Cl2 24 Mono allyl 
deprotected 
(m/z 570) + 
Diallyl 
deprotected 
(m/z 530) 
 
tetrakis-
(triphenylpho
sphine)-
palladium 
(1eq) 
Morpholine 
(20eq) 
CH2Cl2 24 Mono allyl 
deprotected 
(m/z 570) + 
Diallyl 
deprotected 
(m/z 530) 
 
Pd(OAc)2 
(0.02eq) 
TPPTS 
(0.04eq) 
Diethylamine 
(5eq) 
MeCN/ 
H2O 
2 Diallyl 
deprotected 
(m/z 530) 
 
Table 5. Results obtained with the deprotection of the allyl ester groups from the generic ligand (36) using 
different reaction conditions. 
 
After the allyl ester groups deprotection, it was possible to introduce the two moieties of 
triphenylphosphine on the two free carboxylic functions of the 1-N-Boc ethylamine-4,7-
diacetic acid-10-benzyl acetate-1,4,7,10-tetraazacyclododecane (DAABBC) (37) (Figure 
37). This was achieved by synthesising the (2-aminoethyl) triphenylphosphonium 
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bromide (39), a molecule containing both the triphenylphosphonium cation and the amino 
functions [69]. The latter was essential to obtain the formation of the amide bond with 
the free carboxylic function. The (2-aminoethyl) triphenylphosphonium bromide (39) was 
synthesised by stirring at reflux for 24 hours the 2-bromoethylamine hydrobromide (16) 
and triphenylphosphine in 1:1 ratio [72]. The two arms containing the 
triphenylphosphonium cations were successfully introduced through a peptide coupling 
reaction performed using HOBT and EDCI*HCl as coupling agent, DIPEA as base and 
anhydrous DMF as solvent [61], [73], [59]. The reaction mixture was kept under argon 
atmosphere and at room temperature for 24 hours. The desired product, 1-N-Boc-
ethylamine-4,7-di-(triphenylphosphonium bromide ethyl)acetamide-10-benzyl acetate-
1,4,7,10-tetraazacyclododecane (DTPPBBC) (40) (Figure 37), was obtained with 90% of 
yield and with a high degree of purity, as it was shown by the related mass spectrometry 
and carbon and proton NMR spectroscopy results. The synthesis of the final ligand 
proceeded with the cleavage of the Boc group from the amino function of DTPPBBC (40) 
to obtain the 1-ethylamine-4,7-di-(triphenylphosphonium bromide ethyl)acetamide-10-
benzyl acetate-1,4,7,10-tetraazacyclododecane (DTPPBC) (41) (Figure 37). The Boc 
cleavage was performed using trifluoroacetic acid and dichloromethane as solvent [56]. 
The mild acidic conditions used for the Boc group cleavage allowed a selective 
deprotection that did not affect the benzyl group and the two triphenylphosphonium 
cation containing moieties. DTPPBC (41) was used as starting material to couple several 
types of organic fluorophores such as fluorescein, rhodamine and coumarin derivatives. 
Figure 39 provides a schematic representation of the coupling reaction between the 
coumarin 343 (43) acid and DTPPBC (41). The reaction was performed using the same 
conditions described above [61], [73], [59], for the amide bond formation between the (2-
aminoethyl) triphenylphosphonium bromide (39) and the DAABBC (37). The coupling 
reaction shown in Figure 39 allowed obtaining the final ligand, namely the 1-N-(coumarin 
343)ethylamide-4,7-di-(triphenylphosphonium bromide ethyl)acetamide-10-benzyl 
158 
 
acetate-1,4,7,10-tetraazacyclododecane (L2), in high yield and with a high degree of 
purity, which did not require the use of column chromatography.  
 
Figure 39. Peptide coupling reaction between the coumarin 343 (43) and the DTPPBC (41). 
 
The orthogonal deprotection strategy applied to the synthesis of the DTPPBC (L2) 
starting from the DABBC (36) was successfully applied to the synthesis of all other 
ligands of the series, namely L1, L2, L3 and L4. This indicated that the synthetic route 
involving the synthesis of the intermediate ligand DABBC (36), can be applied to the 
asymmetrical functionalization of the cyclen ring and represents an alternative way to the 
synthesis of the asymmetrically substituted cyclen via direct N-alkylation when the 
stability and/or the steric hindrance of the pendant arms is an issue. The synthesis of 
four ligands, bearing two triphenylphosphonium derivatives, one benzyl ester group and 
one chromophore antenna has been described so far. Apart from these ligand series, 
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another series of ligands, which did not incorporate triphenylphosphonium derivatives, 
was synthesized in this project as “model ligands” used to investigate and understand 
the effect of the triphenylphosphonium derivatives on the lanthanide emission (see 
chapter 4). The following section describes the synthetic routes applied to the synthesis 
of three model ligands, not incorporating triphenylphosphonium derivatives. 
 
3.3.4 Synthesis of the ligands that did not incorporate triphenyl phosphonium 
derivatives 
In this section a description of the synthetic routes applied to the synthesis of the three 
model ligands is provided. These ligands were synthetized in order to investigate the 
effects of the triphenylphosphonium cations on the lanthanide emission. In particular, it 
was necessary to verify if the lack of lanthanide-based emission observed with both 
europium and terbium complexes of L1 and L2 could be attributable in some way to the 
presence of the triphenylphosphonium cations (see chapter 4 for a detailed description). 
Figure 40 shows the chemical structures of three model ligands that did not incorporate 
triphenylphosphonium derivative moieties. The 1-N-Boc-ethylamine-4,7-di-(coumarin 
151)-N-acetamide-10-benzyl acetate-1,4,7,10-tetraazacyclododecane (L5) is the first 
model ligand shown in Figure 40. L5 contains two coumarin 151 derivative moieties, 
which were chosen to sensitize the visible emitting lanthanide Eu(III). The remaining 
pendant arms contain a benzyl ester group and a Boc group to protect respectively the 
carboxylic and primary amino function. Either the benzyl ester and Boc groups were not 
cleaved off to prevent that the free carboxylic function and/ or the free amino function 
could have a quenching effect on the Eu(III) emission [20] thus interfering with the 
sensitization process.  
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Figure 40. Chemical structures of the ligands that did not contain the triphenylphosphonium derivative 
moieties. 
 
L5 was synthesized starting from the generic ligand, DABBC (36), by selectively 
removing both allyl ester groups and replacing them with two molecules of coumarin 151 
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(Figure 41). The allyl ester groups were removed using the same procedure described 
in the section, using Pd(OAc)2 and TPPTS as catalyst and dimethylamine as scavenger. 
The reaction was conducted in a mixture of MeCN and H2O at room temperature for two 
hours and was monitored by mass spectrometry via direct injection. The mass spectrum 
related to the reaction mixture after 2 hours of running indicated that the reaction went 
to completion within this time since only one two intense peaks at m/z = 580 [M+H]+ and 
m/z = 602 [M+Na]+, both related to the DAABBC (37),  were found. After cleaving the 
allyl ester groups, two molecules of coumarin 151 (46), which was commercially 
available, were coupled to both allyl-deprotected carboxylic functions of DAABBC (37) 
(Figure 41). The peptide coupling reaction between the two free carboxylic functions on 
DAABBC (37) and the primary amino function of each coumarin 151 molecule was 
performed using EDCI*HCl and HOBt as coupling agents and was conducted in DMF at 
room temperature for 24 hours.   
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Figure 41. Synthetic route that starting from DABBC (36) led to the synthesis of L5. 
 
The peptide coupling reaction between DAABBC (37) and coumarin 151 (46) was 
successfully performed, as it was shown by the proton and carbon NMR spectra obtained 
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after purifying the related reaction mixture with extraction. The second ligand shown in 
Figure 40 is the 1-N-(coumarin 343)ethylamide-4,7,10-triallyl acetate-1,4,7,10-
tetraazacyclododecane (L6). This model ligand was obtained starting from the TABC 
(47), a side product recovered after the chromatography column performed to purify the 
reaction mixture related to the synthesis of the DABC (34) (see section 3.3.2). The 
coumarin 343 used in L6 was chosen to sensitize the lanthanide Eu(III).  Figure 42 shows 
a schematic representation of the steps that led to the synthesis of L6 starting from the 
TABC (47). The first step of this synthesis was the removal of the Boc group from (47), 
which was performed in mild acidic condition using TFA. The reaction was conducted at 
room temperature in DCM and monitored by mass spectrometry via direct injection. The 
presence on the mass spectrum, obtained after 1 hour, of an intense peak at m/z = 960 
[M+H]+ and a small peak at m/z = 982 [M+Na]+, both related to the Boc-cleaved product, 
and the absence of the peak at m/z = 610 [M+H]+ and its sodium adduct at m/z = 632, 
which were related to the starting material (47) and both observed at the beginning of 
reaction monitoring, confirmed that the reaction went to completion in 1 hour. Indeed, 
the absence of any peak related to the either mono-, di- and tri-allyl ester-cleaved 
products confirmed that the Boc group could be selectively removed using mild acidic 
condition (TFA/DCM) without affecting the stability of the allyl ester group.  
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Figure 42. Synthetic route that starting from the TABC (47) led to the synthesis of L6. 
 
After the Boc removal from TABC (47), the coumarin 343 (43) was coupled to the free 
amino function of 1-ethylamine-4,7,10-triallyl acetate-1,4,7,10-tetraazacyclododecane 
TAC (48), using the same peptide coupling procedure previously described for the last 
step of L5. The peptide coupling reaction between was successfully performed and the 
desired product (L6), was obtained with a high degree of purity and without preforming 
165 
 
the column chromatography. The synthetic steps involved in the synthesis of the 1-N-
(dihydrofluorescein diacetate)ethylamide-4,7-diallyl acetate-10-benzyl acetate-1,4,7,10-
tetraazacyclododecane  (L7) are shown in Figure 43. The first step of the synthesis was 
the Boc group removal using TFA and DCM. The reaction was monitored by mass 
spectrometry via direct injection. The mass spectrum related to the reaction mixture after 
1 hour showed only the presence of an intense peak at m/z = 560 [M+H]+, which was 
related to the 1-ethylamine-4,7-diallyl acetate-10-benzyl acetate-1,4,7,10-
tetraazacyclododecane (DABnC) (49), and a small peak at m/z = 582, which was related 
to its sodium adduct. This indicated that under the mild acidic conditions used to cleave 
the Boc group off either the allyl ester and the benzyl ester groups remained unaffected. 
This was an important result since it proved that the orthogonal deprotection strategy 
applied to the generic ligand (36), which was discussed in the section 3.2.1 and shown 
in the Figure 33, could effectively start from the Boc group removal and the incorporation 
on the cyclen ring of acidic labile moiety. The Boc deprotection was followed by the 
peptide coupling reaction between the DABnC (49) and the dihydrofluorescein diacetate 
(42). Also in this case the coupling reaction was performed in DMF and performed using 
EDCI*HCl and HOBt as coupling agents.  
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Figure 43. Synthetic route that starting from the DABBC (36) led to the synthesis of (L7). 
 
The new synthetic route, based on the orthogonal deprotection strategy, overcame the 
issues encountered with the direct N-alkylation strategy and synthesising different types 
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of ligands, based on asymmetrically substituted cyclen, whose synthesis have been 
described so far. However the goal of producing reversible redox systems able to 
distinguish between transient increase of ROS production and chronically elevated ROS 
levels was not achieved and a detailed explanation to this follows in the next section.  
 
3.4 Benzyl ester group removal 
As discussed in the section 3.2.3, four ligands (L1, L2, L3 and L4), based on 
symmetrically substituted cyclen and bearing two pendant arms containing a 
triphenylphosphonium cation as mitochondria targeting moiety and one pendant arm 
containing a sensitizer antenna that in the meantime could react with ROS species, were 
successfully synthesised in this project. However it was not possible to introduce a 
further antenna that could have generated a reversible system of antennae described in 
the section 3.1. This was due to the fact that one step of the multistep orthogonal 
deprotection strategy, which started from the DABBC (36) led to the synthesis of L1, L2, 
L3 and L4, did not work even if many attempts were made. Figure 44 is a schematic 
representation of the orthogonal deprotection strategy step involving the benzyl ester 
group removal from the 1-N-Boc-ethylamine-4,7-di-(triphenylphosphonium bromide 
ethyl)acetamide-10-benzyl acetate-1,4,7,10-tetraazacyclododecane (DTPPBBC) (40). 
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Figure 44. Schematic representation of the benzyl ester group removal. 
 
Two synthetic procedures were applied to the cleavage of the benzyl ester group but 
they were both unsuccessful. The first synthetic procedure that was applied to the benzyl 
ester group removal was a catalytic hydrogenation reaction. The reaction was performed 
by treating the compound containing the benzyl ester group to be cleaved, the DTPPBBC 
(40), with 10% Palladium on charcoal and bubbling gaseous molecular hydrogen (H2) 
into the reaction mixture [59]. The palladium on charcoal would have acted as catalyst 
and the molecular hydrogen as reducing agent. The reaction was conducted using 
anhydrous methanol as solvent at room temperature (Table 6) and was monitored 
through TLC and mass spectrometry via direct injection. The TLC (DCM/isopropylamine 
9.5:0.5) and mass spectrometry results of the reaction monitoring obtained after 1, 6, 12 
and 24 hours from the starting time confirmed that no product was formed and the 
starting material was quantitatively recovered unaffected by filtering the reaction mixture 
through a celite pad. The reaction was repeated a second time by gently heating the 
reaction mixture (Table 6) but no product formation was observed and the starting 
material was recovered via celite pad filtration. Since the conventional procedure used 
to cleave the benzyl ester group [59] was unsuccessful, a different synthetic procedure 
was applied [74] where molecular hydrogen was replaced by a hydrogen donor, the 
triethylsilane, the palladium on charcoal at 10% was used as catalyst and the anhydrous 
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methanol was used as solvent [74] (Table 6). When the reaction was performed at room 
temperature no product formation was observed. The same results were obtained after 
repeating the reaction by gently heating the reaction mixture (Table 6) since no product 
formation was observed.  
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Palladium on 
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Table 6. Summary of the reaction conditions used for the benzyl ester group removal. 
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Since after each attempt the starting ligand (40) was quantitatively recovered unaffected 
by celite pad filtration, the unsuccessful benzyl ester removal could be due to an 
adsorption of the ligand on the palladium catalyst surface, in such a way as to prevent 
allyl arms from reaching the surface. Alternatively the tetrafunctionalized cyclen ring may 
assume a conformation hinders the approach of hydrogen to the double bond  
 
 
3.5 Complexation of ligands with lanthanide ions 
L2, L3, L4, L5 and L6 were successfully complexed with trivalent lanthanide ions, giving 
rise to eleven lanthanide complexes:  
1. L2 was complexed with Eu(III) and Tb(III) to give EuL2 and TbL2 respectively 
(Figure 45) 
2. L4 was complexed with Eu(III) and Tb(III) to give EuL4 and TbL4 respectively 
(Figure 47) 
3. L5 and L6 were complexed with Eu(III) to give EuL5  and EuL6 respectively 
(Figure 48). 
4.  L3 was complexed with near infrared Nd(III) and Yb(III) to give NdL3 and YbL3 
respectively (Figure 46).  
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Figure 45. Chemical structures of the lanthanide complexes EuL2 and TbL2. 
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Figure 46. Chemical structures of the lanthanide complexes NdL3 and YbL3. 
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Figure 47. Chemical structures of the lanthanide complexes EuL4 and TbL4. 
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Figure 48. Chemical structures of the lanthanide complexes EuL5 and EuL6. 
 
The general synthetic procedure applied to the complexation of each ligand synthetized 
in this project with the related lanthanide ion was performed by reacting the free ligand 
and anhydrous lanthanide chloride (LnCl3) in 1:1 ratio, in anhydrous methanol, under 
reflux conditions and under argon atmosphere for 15 hours [75]. The complexation 
reaction was monitored through TLC (DCM/isopropyl amine 95:0.5) and mass 
spectrometry via direct injection. The reaction was stopped when no free ligand peak 
was observed in the mass spectrum related to the reaction mixture and no spot related 
to the free ligand was observed on TLC plate.  After the reaction went to completion, 
most of the methanol was removed under vacuum leaving only a minimal amount 
necessary to dissolve the mixture. Then cold diethyl ether was added and the formation 
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of a precipitate was observed [75]. The precipitate was allowed to settle down and the 
reaction mixture was centrifuged. The supernatant was removed, the precipitate was 
dissolved in a minimum amount of water and the aqueous solution was freeze-dried 
overnight. The lanthanide complexes were characterized by mass spectrometry (see 
chapter 2) and absorption and emission spectroscopy (see chapter 4).  
 
3.5.1 Complexation of L1 and L7 with Eu(III) 
The general procedure described in the previous section and applied to the complexation 
of the L(III) ions with the ligands synthesised in this project was also applied to the 
complexation of L1 with Eu(III) and Tb(III), and L7 with Eu(III). However in this case the 
loss of the acetate groups was observed after the complexation reaction. This could be 
due to a transesterification reaction that occurred during the complexation of L1 and L7 
with the Ln(III), which was performed using methanol as the solvent. The hydroxyl 
function of methanol could probably replace the hydroxyl functions of the 
dihydrofluorescein molecules resulting in the loss of the acetate groups from L1 and L7. 
This hypothesis was confirmed by the mass spectrometry data reported in chapter 2 and 
photophysical data discussed in chapter 4. The chemical structures of EuL1 and TbL1, 
obtained after the complexation of L1 with EuCl3 and TbCl3 respectively are reported in 
Figure 49, whilst the chemical structure of EuL7, which was obtained after the 
complexation of L7 with EuCl3, is reported in Figure 50. 
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Figure 49. Chemical structures of the lanthanide complexes EuL1 and TbL1. 
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Figure 50. Chemical structures of the lanthanide complex EuL7. 
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4. Photophysical properties of Lanthanide Complexes 
 
This chapter describes the photophysical studies performed on the lanthanide 
complexes that were synthesised in this project starting from the asymmetrically 
substituted cyclen-based ligands described in the chapter 3. The trivalent lanthanide ions 
europium and terbium were used in the complexes described in this chapter, while 
different types of organic chromophores, such as fluorescein and coumarin derivatives, 
were used as antennae-sensitizers of the Ln3+. The use of a sensitizer antenna is 
required for an effective excitation of Ln3+ since, because of their low molar absorption 
coefficient, direct excitation of lanthanide ions only produces weak Ln3+-based emission 
[76]. In some cases no lanthanide emission is achieved upon Ln3+ direct excitation. The 
function of the sensitizing group or “antenna” is to absorb strongly at a suitable 
wavelength and to transfer this excitation energy to the Ln3+ which may then emit its 
characteristic luminescence [76]. The photophysical properties of all Eu(III) and Tb(III) 
complexes synthesized in this project were measured with absorption and emission 
spectroscopy. The absorption spectroscopy was also applied to measure the 
absorbance of the fluorescein and coumarin derivatives used as sensitizer of Eu(III) and 
Tb(III) emission. Moreover the emission properties of two Eu(III) complexes were also 
investigated in presence of different concentrations of H2O2, in order to verify whether or 
not these complexes were able to detect the presence of H2O2 through changes in the 
Eu(III) -based luminescence. 
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4.1 EuL1 and TbL1 photophysical studies 
EuL1 and TbL1 were synthetized starting from the L1 ligand, containing two arms of 
triphenyl phosphonium, one benzyl ester group and one moiety of dihydrofluorescein 
diacetate. The ligand was complexed with Eu(III) in EuL1 and Tb(III) in TbL1 (Figure 51). 
 
Figure 51. Chemical structure of EuL1 and TbL1. 
The dihydrofluorescein diacetate was used as sensitizer antenna towards both trivalent 
lanthanide ions. Since the excitation wavelengths used during the emission acquisition 
of all complexes corresponded to the maximum peaks found in the absorption spectrum 
of each complex and the absorption spectrum of the related chromophore antenna, the 
absorption spectra of each complex will be described together with the absorption 
spectrum related to the antenna used.  The absorption spectra of EuL1 and TbL1 
showed a similar trend with a maximum peak at 489 nm, which was related to the 
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chromophore antenna, and an intense absorbance region between 250 and 350 nm 
(Figure 52).  
 
Figure 52. Absorption spectrum of EuL1 (3 mL 0.3 mM in H2O). 
 
The dihydrofluorescein acetate absorbance was measured in ethanol, due to its poor 
solubility in H2O. The dihydrofluorescein diacetate absorption spectrum showed a 
maximum peak at 275 nm and a broad region between 220 and 260 nm (Figure 53). 
However no peaks were found above 310 nm. 
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Figure 53. Absorption spectrum of dihydrofluorescein diacetate (3 mL 0.3 mM in ethanol). 
 
The absence of a peak at 489 nm in the dihydrofluorescein diacetate absorption 
spectrum did not confirm the hypothesis that the peak at 489 nm, found in the EuL1 and 
TbL1 absorption spectra, was related to the chromophore antenna. This suggested 
indeed that the peak at 489 nm could be related to the formation of a conjugated system 
on the dihydrofluorescein diacetate that could be due to its oxidation. The formation of a 
conjugated system would have explained the long absorption wavelength at 489 nm 
present in the EuL1 and TbL1 absorption spectra. Another possibility could be that the 
dihydrofluorescein diacetate derivative lost the acetate groups and the resulting 
dihydrofluorescein derivative showed a maximum absorption peak around 489 nm. 
Therefore it was necessary to investigate the photophysical properties of the 
dihydrofluorescein diacetate in order to understand what gave rise to the presence of an 
absorption peak at 489 nm on the EuL1 and TbL1 absorption spectra.  
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4.1.1 Photophysical properties of dihydrofluorescein diacetate 
In order to further investigate the photophysical properties of the dihydrofluorescein 
diacetate, its absorbance was recorded in absence and presence of NaOH and H2O2. 
The NaOH was used to favour the cleavage of the acetate groups that would have 
converted the dihydrofluorescein diacetate to dihydrofluorescein. This choice was made 
since one of the procedures used for the acetate group removal involves the treatment 
of the compound whose hydroxyl functions are protected with acetate groups with a KOH 
or NaOH methanol solution [77]. The H2O2 was used as oxidant species that should have 
been able to oxidise the dihydrofluorescein to fluorescein and generate a conjugated 
system. According to the data reported in the literature [78], the dihydrofluorescein 
diacetate is a not fluorescent molecule that is used as probe for detecting a broad range 
of intracellular oxidants, such as H2O2 [79]. The dihydrofluorescein diacetate represents 
the reduced form of the fluorescein, whose two hydroxyl functions are protected as 
acetate groups. The reduced form of the fluorescein, namely the dihydrofluorescein 
diacetate, is a non-fluorescent molecule, which upon the cleavage of the acetate groups 
and oxidation by an intracellular oxidant, such as H2O2, becomes fluorescent [78]. The 
dihydrofluorescein does not absorb light at 500 nm but its oxidation to fluorescein by 
H2O2, which is possible only after the cleavage of the acetate groups by cellular esterases 
or OH-, generates a conjugated system responsible for the longer absorption wavelength 
at 500 nm (Figure 54) [79]. It is known from the literature [80] that the conjugation causes 
a red shift (a so-called bathochromic shift) of the absorption and emission maximum 
peaks of a molecule. This means that when a conjugated system is generated, the 
molecule will absorb and emit light to longer wavelengths depending on the nature of the 
conjugated system that has been generated [80]. The strong emission from the 
fluorescein at 512 nm upon the oxidation of the dihydrofluorescein diacetate indicates 
the presence of oxidant species [78]. 
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Figure 54. Oxidation of the dihydrofluorescein diacetate to fluorescein upon removal of the acetate groups 
by OH- or cellular esterases.  
 
 
It is evident from the literature that the oxidation of the dihydrofluorescein diacetate is 
responsible for the red shift observed in the absorption spectrum of its oxidised form. 
However it does not give any information regarding the possibility that the cleavage of 
the acetate groups on the fluorescein diacetate could be also responsible for the red 
shift. In order verify whether the presence of a peak at 489 nm observed in the EuL1 and 
TbL1 absorption spectra was due to the dihydrofluorescein diacetate oxidation or the 
loss of its acetate groups, the absorption of the dihydrofluorescein diacetate was 
measured at different conditions. In particular the absorption of the dihydrofluorescein 
diacetate (3 mL 0.3 mM in ethanol) was recorded upon the addition of 20 uL of 5 M NaOH 
aqueous (Figure 55) to verify if the cleavage of the acetate groups, favoured by the basic 
NaOH solution, could cause any changes in the absorption spectrum.  
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Figure 55. Absorption spectra of dihydrofluorescein diacetate (3 mL 0.3 mM in ethanol) recorded in absence 
and presence of 20 uL of 5 M NaOH.  
 
The fluorescein diacetate absorption spectrum was also recorded upon the addition of 
20 uL of 30% H2O2 to the main solution, already containing the NaOH, and it was 
monitored after 1 hour and 6 hours (Figure 56). 
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Figure 56. Absorption spectra of dihydrofluorescein diacetate (3 mL 0.3 mM in ethanol) recorded in absence 
and presence of 20 uL of 5 M NaOH and 20 uL of 30% H2O2. 
 
The absorption spectrum of the dihydrofluorescein diacetate recorded immediately after 
the addition of 20ul of 5M NaOH aqueous solution showed a strong absorption peak at 
500 nm (Figure 55), suggesting that the cleavage of the acetate groups by NaOH was 
responsible for the red shift at 500 nm. The dihydrofluorescein absorption spectrum was 
also recorded immediately upon the addition of the H2O2 and after 1 hour and 6 hours 
form added H2O2. No changes in the dihydrofluorescein diacetate absorption spectrum 
in the region between 450 and 610 nm were observed after 1 hour from the H2O2 addition 
compared to the absorption spectrum recorded upon NaOH addition. However an 
increase of the absorbance intensity at 500 nm was observed after 6 hours and this was 
accompanied by a broad absorption band between 320 and 450 nm, with a maximum 
absorption peak at 397 nm (Figure 56). The presence of a peak at 489 nm and the 
absence of a broad absorption region between 320 and 450 nm in EuL1 and TbL1 
absorption spectra suggested that the peak at 489 nm was related to the cleavage of the 
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acetate groups and not to the formation of a conjugated system on the dihydrofluorescein 
diacetate derivative caused by its oxidation. The cleavage of the acetate groups on EuL1 
and TbL1 could take place during the complexation reaction of L1 with the LnCl3. Since 
the complexation reaction was performed by refluxing L1 with the related LnCl3 in 
methanol for about 15 hours, it was likely that a transesterification reaction was 
responsible for the acetate groups’ removal, as discussed in section 3.5.1. 
 
4.1.2 EuL1 and TbL1 emission profiles 
The emission of EuL1 was recorded upon excitation at 489 nm, 275 nm and 397 nm. 
The excitation wavelength of 489 nm was used since it was the one of the maximum 
peak found in the EuL1 absorption spectrum that, as discussed above, could be probably 
due to the dihydrofluorescein, whilst 397 nm was used as it is the typical wavelength 
employed for the direct excitation of Eu(III) [81]. The excitation at 275 nm was used to 
excite the dihydrofluorescein antenna. The emission spectrum of EuL1 recorded upon 
exciting the antenna at 275 nm did not show the characteristic Eu(III)-based 
luminescence, indicating that no sensitization of europium was achieved using the 
dihydrofluorescein as antenna. No Eu(III) emission was observed upon Eu(III) direct 
excitation at 397 nm. Similar results were obtained upon exciting the antenna at 489, 
indicating that the dihydrofluorecein derivative, formed as consequence of the acetate 
groups’ cleavage, was not able to sensitize the lanthanide emission.   
The emission of TbL1 was recorded using different excitation wavelengths according to 
the data obtained with the absorption spectra of TbL1 and the dihydrofluorescein. The 
emission of TbL1, recorded upon excitation of the dihydrofluorescein antenna at 275 nm, 
did not show the characteristic Tb(III)-based emission profile, indicating that no 
sensitization of Tb(III) was achieved using the dihydrofluorescein as antenna. Similar 
results were obtained upon Tb(III) direct excitation at 378 nm [81] and dihydrofluorescein 
at 489 nm. 
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4.2 EuL2 and TbL2 photophysycal studies 
EuL2 and TbL2 were synthetized starting from L2 containing two arms of triphenyl 
phosphonium derivatives, one benzyl ester group and one moiety of coumarin 343. The 
ligand was complexed with Eu(III) in EuL2 and Tb(III) in TbL2 (Figure 57).  
 
 
Figure 57. Chemical structure of EuL2 and TbL2. 
 
The coumarin 343 was used to act as sensitizer toward the lanthanide ions via antenna 
effect. The absorption spectrum of the coumarin 343, the chromophore antenna used in 
EuL2 and TbL2, was recorded in water in order to have information about which 
wavelengths should be used to excite the chromophore antenna in EuL2 and TbL2 
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during their emission profiles acquisition. The absorption spectrum of the coumarin 343 
showed two intense peaks at 418 nm and 275 nm and a less intense peak at 264 nm 
(Figure 58). 
 
    
 
Figure 58. Coumarin 343 absorption spectrum (3 mL 0.03 mM in H2O). 
 
The absorption spectra of EuL2 and TbL2 showed an intense peak at 447 nm, which 
was related to the coumarin 343 chromophore antenna. The emission of EuL2 was 
recorded at different excitation wavelengths. The excitation wavelengths used during the 
emission acquisition of EuL2 were the ones corresponding to the maximum peaks found 
in the EuL2 (447 nm) and coumarin 343 (217 nm, 264 nm and 418 nm) absorption 
spectra. It was also used as the excitation wavelength normally used to directly excite 
Eu(III) (397 nm) [81]. The characteristic Eu(III)-based emission was not observed upon 
excitation of EuL2 at 447 nm, indicating that no sensitization of Eu(III) was achieved at 
447 nm. No emission from the Eu(III) was observed upon Eu(III) direct excitation at 397 
nm. Similar results were obtained upon excitation of EuL2 at 217 nm, 264 nm and 418 
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nm, namely the wavelengths corresponding to the maximum peaks found in the 
absorption spectrum of coumarin 343, indicating that no sensitization of Eu(III) was 
achieved using the coumarin 343 derivative as antenna. The emission of TbL2 was 
recorded using the same excitation wavelengths employed for EuL2, except the direct 
excitation wavelength of the lanthanide ion. While an excitation wavelength of 397 nm 
was used to direct excite Eu(III) in EuL2 [81], in TbL2 the Tb(III) direct excitation was 
achieved using 378 nm [81]. Also with TbL2, no emission from Tb(III) was observed upon 
excitation at 447 nm, indicating that no sensitization of Tb(III) was achieved at 447 nm. 
Similar results were obtained upon Tb(III) direct excitation at 378 nm and coumarin 343 
excitation at 217 nm, 264 nm and 418 nm, indicating that the coumarin 343 could not be 
able to act as Tb(III) sensitizer antenna. The absence of lanthanide emission in EuL1, 
TbL1, EuL2 and TbL2 could be due to a number of factors. It was hypothesized that the 
two triphenyl phosphonium containing moieties could be responsible for the lanthanide 
luminescence quenching. It was also hypothesized that the linker spacer that separated 
the antenna from the lanthanide could affect the efficiency of the energy transfer process 
from the antenna to the lanthanide ion. In this case the energy content of the photon 
absorbed by the antenna would have been emitted rather than transferred to the 
lanthanide. Another explanation to the absence of lanthanide emission could be that the 
energy gap between the lowest energy level of the ligand triplet state and the receiving 
energy level of the Ln3+ was too small. This means that upon excitation of the ligand, 
although an energy transfer process could occur from the ligand triplet state to the Ln3+ 
emissive state, it could be followed by a thermally activated back energy transfer from 
the Ln3+ excited state to the ligand [82].  
 
4.3 Photophysical properties of a new series of lanthanide complexes 
In order to fully understand the photophysical behaviour of the lanthanide complexes 
examined so far and find a solution to overcome the problem of the lack in lanthanide 
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emission, a new series of lanthanide complexes was synthetized and their photophysical 
properties were measured. The new series comprised four different complexes that were 
named EuL4, EuL5, EuL6 and EuL7. The Ln3+ used in the new series of complex was 
Eu(III). In the following sections, the photophysical properties of the new series of 
lanthanide complexes will be analysed. 
 
4.3.1 EuL6 and EuL7 photophysical properties 
The first lanthanide complexes of the new series synthesized in this project were EuL6 
and EuL7 (Figure 59). EuL6 and EuL7 were Eu(III) based complexes obtained starting 
from L6 and L7 respectively.  
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Figure 59. Chemical structures of EuL6 and EuL7. 
 
As it is shown in Figure 59, EuL6 and EuL7 did not contain any pendant arms bearing 
triphenyl phosphonium derivatives, which were indeed present on EuL1, TbL1, EuL2 
and TbL2. This choice was made in order to assess whether or not the two triphenyl 
phosphonium derivatives could be responsible for the absence of the Ln3+ luminescence 
in EuL1, TbL1, EuL2 and TbL2. It was also important at this stage using the same 
chromophore antennae used in EuL1, TbL1, EuL2 and TbL2 placed at the same 
position. This would have allowed to understand if the absence of Ln3+ emission in EuL1, 
TbL1, EuL2 and TbL2 could be due to the type of antenna used and/or to the linker 
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spacer length separating it from the Ln3+. For this reason the sensitizer antenna used in 
EuL6 was the same used in EuL2 and TbL2, namely the coumarin 343, while the 
sensitizer antenna used in EuL7 was the same used in EuL1 and TbL1, namely the 
dihydrofluorescein diacetate.  
 
4.3.1.1 EuL6 absorption and emission properties 
The EuL6 absorption spectrum showed a maximum peak at 452 nm and a broad 
absorption band between 260 and 310 nm, with a maximum at 275 nm, which were likely 
due to the absorbance of the coumarin 343 moiety (Figure 60). 
 
 
Figure 60. EuL6 absorption spectrum (3 mL 0.3 mM in H2O). 
 
The EuL6 emission recorded upon excitation of the chromophore antenna at 452 nm did 
not show the characteristic Eu(III) emission, indicating that no energy transfer process 
occurred from the coumarin 343 to the Eu(III). Therefore it was tried to achieve the 
sensitization of Eu(III) emission by changing the excitation wavelengths of the coumarin 
343 moiety at 275 nm and 310 nm. However also in these cases no Eu(III) emission was 
observed, indicating that the coumarin 343 was not able to act as sensitizer antenna of 
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Eu(III). This could be due to the too small energy gap between the between the lowest 
energy level of the ligand triplet state and the receiving energy level of the Eu(III) or to 
the linker spacer length separating the chromophore antenna from the Eu(III) core. 
These results also suggested that the triphenyl phosphinium derivatives were not 
responsible for the absence of Ln3+ emission in EuL1, TbL1, EuL2 and TbL2 since no 
Eu(III) emission was observed in EuL6 despite it did not contain any triphenyl 
phosphonium derivatives. 
 
4.3.1.2 EuL7 absorption and emission properties  
The photohysical properties of EuL7 were measured in order to understand the 
photophysical behaviour of EuL1 and TbL1 that, as mentioned before, contained the 
same chromophore antenna of EuL7. As it was hypothesized in the sections 3.5.1 and 
4.1.1, the cleavage of the acetate groups of dihydrofluorescein diacetate could be 
responsible for the absence of Ln3+-based emission in EuL1 and TbL1 since the new 
antenna generated upon the acetate groups cleavage, namely the dihydrofluorescein, 
was not able to act as sensitizer toward Eu(III) and Tb(III). For this reason, the 
complexation of L7 with EuCl3 that led to the formation of EuL7 was performed by 
heating the starting materials for 6 hours rather than for 15 hours, as it was made for 
EuL1 and TbL1. It was thought that lowering the reaction time would have prevented the 
cleavage of the acetate groups from the dihydroluorescein diacetate in EuL7. The EuL7 
absorption spectrum showed an intense peak at 280 nm and, similarly to EuL1 and 
TbL1, a less intense peak at 489 nm (Figure 61). The peak at 489 nm suggested that 
the acetate groups present on the dihydrofluorescein diacetate in EuL7 were cleaved.  
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Figure 61. EuL7 absorption spectrum (3 mL 0.3 mM in H2O). 
 
However, the peak at 489 nm in EuL7 was much lower in intensity compared to the peak 
intensity at 489 nm observed in the EuL1 and TbL1 absorption spectra, despite the 
absorbance of EuL7, EuL1 and TbL1 was recorded starting from the same concentration 
of complexes, namely 0.3 mM. This suggested that EuL7 was probably a mixture of two 
complexes, one containing the dihydrofluorescein diacetate and the other one containing 
the dihydrofluorescein, namely the product of the acetate groups’ cleavage. The EuL7 
emission, recorded upon exciting the dihydrofluorescein diacetate at 275 nm, did not 
show the characteristic Eu(III) based luminescence (Figure 62).  
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Figure 62. EuL7 emission spectrum recorded upon excitation at 275 nm  (3 mL 3 mM in H2O). 
 
However some features characteristic of Eu(III) emission were observed. This is 
particularly evident in Figure 63, where the EuL7 emission profile is compared with the 
EuCl3 emission profile recorded upon Eu(III) direct excitation at 397 nm. 
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Figure 63. EuL7 Emission spectrum recorded upon excitation at 275 nm (solid blue line) and the EuCl3 
emission spectrum recorded upon Eu(III) direct excitation at 397 nm (dashed red line).  
(EuL7 and EuCl3 3 mL 3 mM in H2O) 
 
  
The presence of some features characteristic of Eu(III) emission profile observed in 
EuL7 emission spectrum indicated that a very low antenna effect was achieved upon 
excitation of dihydrofluorescein diacetate at 275 nm. This low antenna effect could be 
due to a low amount of dihydrofluorescein diacetate that survived to the acetate group’s 
cleavage, which was hypothesized to occur during the complexation reaction. Similarly 
to EuL1 and TbL1, the emission of EuL7 recorded upon excitation at 489 nm did not 
show the characteristic Eu(III) emission, indicating that no antenna effect was achieved 
upon excitation of the dihydrofluorescein antenna at 489 nm. The results obtained with 
the photophysical properties studies of the Ln3+ complexes described so far, namely 
EuL1, TbL1, EuL2, TbL2, EuL6 and EuL7 suggested that: 
 The absence of the Ln3+-based luminescence in EuL2 and TbL2 was due to the 
type of chromophore antenna used to achieve the Eu(III) and Tb(III) sensitization, 
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namely the coumarin 343, rather than a Ln3+ luminescence quenching by the 
triphenyl phosphonium moieties. This was confirmed by the fact that no Eu(III) 
emission was achieved using the coumarin 343 as sensitizer antenna in EuL6, 
despite the latter did not contain any triphenyl phosphonium moieties. 
 The absence of the Ln3+-based luminescence in EuL1 and TbL1 was due to the 
fact that the dihydrofluorescein diacetate could undergo removal of acetate 
groups and the resulting diacetate-deprotected product, namely the 
dihydrofluorescein, was not able to sensitize the Eu(III) and Tb(III) emission. The 
acetate group removal probably occurred during the complexation reaction 
performed by treating L1 with the LnCl3 in methanol at reflux for about 15 hours. 
In this case the long exposure at refluxing conditions of L1 to the LnCl3 methanol 
solution could favour the acetate groups’ cleavage. The results obtained with 
EuL1 and TbL1 photophysical properties studies were in line with the results 
obtained with the photophysical properties studies performed on EuL7, which 
contained the same chromophore antenna used in EuL1 and TbL1. Although no 
Eu(III) emission was observed upon exciting the dihydrofluorescein diacetate 
antenna at 275 nm, some features characteristic of the Eu(III) emission profile 
were observed in EuL7 emission spectrum. This was probably due to a low 
fraction of the dihydrofluorescein diacetate that did not undergo to the acetate 
groups’ removal during the complexation reaction. This could be also an 
indication that that dihydrofluorescein diacetate would have been a suitable 
Eu(III) sensitizer if it would have not been converted into its diacetate-deprotected 
product. However it could not be excluded that the low Eu(III) sensitization 
achieved upon exciting EuL7 at 275 nm (Figure 62) could be due to a low Eu(III) 
sensitization by the carbonyl functions rather than a possible low fraction of 
dihydrofluorescein diacetate survived to the acetate cleavage since the typical 
wavelength used to excite the carbonyl functions is 280 nm.  
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The inability of the coumarin 343 and the diacetate-deprotected product of the 
dihydrofluorescein diacetate to act as sensitizer antennae towards Eu(III) and Tb(III) was 
due to their relatively long absorption wavelengths, which were respectively 418 and 489 
nm. This was in line what was found in the literature [83].  According to the data reported 
by Steemers et al. [83], the long wavelength absorption edge of the antenna cannot be 
much above 346 nm for Tb3+ or above 385 nm for Eu3+ complexes in order to obtain a 
fast and irreversible energy transfer process from the antenna to the lanthanide ion [83]. 
Since no Ln3+ emission was observed with the complexes examined so far due to the 
absorption properties of chromophore antennae used in these complexes, it was 
necessary to synthesize another complex bearing a different sensitizer antenna. The 
following section describes the photophysical properties of EuL5, which was synthesized 
with the aim to investigate the sensitization of Eu(III) with a chromophore antenna 
absorbing the light at shorter wavelengths compared to the chromophore antennae used 
in the complexes examine so far.  
 
4.3.2 EuL5 Photophysical Studies 
EuL5 was synthesized starting from the ligand L5 and complexing it with Eu(III). As it is 
shown in Figure 64, EuL5 contained two chromophore antennae of coumarin 151 used 
to sensitize the Eu(III) emission. The coumarin 151 was used to have an antenna that 
absorbed the light at shorter wavelength compared to the coumarin 343 used in EuL2, 
TbL2 and EuL6 that showed a maximum absorption peak at 418 nm. This would have 
allowed to overcome the issue of the long-wavelength absorption chromophore antenna 
responsible for the absence of Ln3+ emission in the previous complexes. 
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Figure 64. Chemical structure of EuL5.  
 
The absorption spectrum of EuL5 (Figure 65) showed one peak at 339 nm and a very 
intense peak in the region comprises between 200 and 230 nm. The peak at 339 nm was 
related to the absorbance of the coumarin 151 antenna, which is known to absorb the 
light at around 350 nm.  
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Figure 65. Electronic absorption spectrum of EuL5 (3 mL 0.3 mM in H2O). 
 
No emission from the lanthanide europium was observed following Eu(III) direct 
excitation at 397 nm, whilst the characteristic Eu(III)-based luminescence was observed 
following excitation of the chromophore antennae at 339 nm (Figure 66). This indicated 
that the coumarin 151 antenna was able to sensitize the Eu(III) emission. The EuL5 
emission spectrum presented the five bands ΔJ = 0, ΔJ = 1, ΔJ = 2, ΔJ = 3 and ΔJ = 4 
characteristic of the Eu(III) emission and that arise from 5D0→7FJ transitions [84], [20], 
[24] (Figure 66).  
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Figure 66. Emission spectrum of EuL5 (3 mL 3 mM in H2O) recorded upon excitation of the coumarin 151 
antennae at 339 nm. The ΔJ values are shown on the spectrum. 
 
 
The fact that the sensitization of the Eu(III) emission in EuL5 was achieved using the 
coumarin 151 as sensitizer antennae having a maximum absorption peak below 385 nm 
was consistent with the data reported in the literature by Steemers et al. [83], which were 
discussed above. This was also a further proof that in the previous complexes, namely 
EuL1, TbL1, EuL2, TbL2, EuL6 and EuL7 the Eu(III) and Tb(III) sensitization were not 
achieved using the coumarin 343 and the dihydrofluorescein diacetate as sensitizer 
antennae because of their absorption properties. The coumarin 343 was not able to 
sensitize the Eu(III) and Tb(III) emission because of its  relative long absorption 
wavelength at 418 nm, while the absence of Ln3+ emission in EuL1, TbL1 and EuL7 was 
due to the cleavage of the acetate groups of the dihydfrofluorescein diacetate, probably 
occurring during the complexation reaction, which converted it into its diacetate 
deprotected product, the dihydrofluorescein, which could not act as Eu(III) and Tb(III) 
sensitizer since it presented a maximum absorption peak at 489 nm.  
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The EuL5 excitation spectrum (Figure 67) was recorded by monitoring the Eu(III) 
emission at 616 nm, which is the emission wavelength corresponding to the electric-
dipole allowed transition 5D0→7F2 [81], [84]. It showed an intense band between 340 and 
360 nm. The similarity between the EuL5 absorption and excitation spectra confirmed 
that the energy transfer process from coumarin 151 to Eu(III) was not efficient. 
  
 
Figure 67. Excitation spectrum of EuL5 (3 mL 3 mM in H2O) recorded by monitoring the Eu(III) emission at 
616 nm.  
 
From the results examined so far, it was evident that the triphenyl phosphonium 
derivatives in EuL1, TbL1, EuL2 and TbL2, as well as the spacer length separating the 
antenna from the Ln3+ core in EuL1, TbL1, EuL2, TbL2, EuL6 and EuL7, were not 
responsible for the absence of the characteristic Ln3+ based emission observed with 
these complexes. It was demonstrated that for an efficient Eu(III) sensitization the use of 
a chromophore antenna absorbing below 389 nm was essential to obtain a fast and 
irreversible energy transfer process from the antenna to the lanthanide ion [83]. With this 
in mind, two complexes, EuL4 and TbL4, were synthesized starting from the same ligand 
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L4, which was functionalised with two pendant arms containing the triphenyl 
phosphonium derivatives and a pendant arm containing a low-wavelength absorbing 
sensitizer antenna, separated from the Ln3+ with the same spacer used in EuL1, TbL1, 
EuL2, TbL2, EuL6 and EuL7. L4 was complexed with Eu(III) in EuL4 and with Tb(III) in 
TbL4. The photophysical properties of EuL4 and TbL4 will be discussed in the following 
section. 
 
4.3.3 EuL4 and TbL4 Photophysical Studies 
The chemical structures of EuL4 and TbL4 are shown in the figure 68.  
 
 
Figure 68. Chemical structure of EuL4 and TbL4. 
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The coumarin 3 carboxylic acid was used as Eu(III) sensitizer antenna in EuL4 and as 
Tb(III) sensitizer antenna in TbL4. To sensitize the Ln+3 emission in EuL4 and TbL4 it 
was necessary to use an antenna absorbing the light below 385 nm. This was achieved 
using the coumarin 3 carboxylic acid since it contained a free carboxylic function that 
could be coupled to the free primary amino function of the (DTPPBC) (41) during the 
final step of L4 synthesis and presents two intense absorption peaks at 214 and 290 nm 
and lower intense peak at 329 nm, as shown in Figure 69. 
 
 
Figure 69. Absorption spectrum of coumarin 3 carboxylic acid (3 mL 0.3 mM in H2O). 
 
The absorption spectrum of EuL4 (Figure 70) presented a relative intense absorption 
peak at 298 nm, which was related to the coumarin 3 carboxylic acid antenna, and 
another intense absorption peak at 206 nm. 
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Figure 70. Absorption spectrum of EuL4 (3 mL 0.3 mM in H2O). 
 
 
The characteristic Eu(III)-based luminescence was observed with EuL4 following Eu(III) 
direct excitation at 397 nm. However, as expected, the five Eu(III) emissive bands (ΔJ = 
0, ΔJ = 1, ΔJ = 2, ΔJ = 3 and ΔJ = 4) were low in intensity due to the Eu(III) low molar 
absorption coefficient. After recording the emission of EuL4 by setting the excitation 
wavelength at 298 nm, which corresponded to longest wavelength absorption peak 
observed in EuL4 absorption spectrum, an intense Eu(III) based luminescence was 
achieved (Figure 71). 
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Figure 71. Emission spectrum of EuL4 (3 mL 3 mM in H2O) recorded upon excitation of the coumarin 3 
carboxylic acid antenna at 298 nm. The ΔJ values are shown on the spectrum. 
 
 
The increasing in the intensity of the five europium emissive bands was due to an 
antenna effect exerted by the coumarin 3 carboxylic acid towards Eu(III). The 
sensitization of the Eu(III) emission in EuL4 achieved using the coumarin 3 carboxylic 
acid as Eu(III) sensitizer antenna confirmed that the triphenyl phosphonium derivatives 
as well as the linker spacer length separating the antenna from the lanthanide ion did 
not affect the lanthanide emission. The EuL4 excitation spectrum was recorded by 
monitoring the europium emission at 616 nm (Figure 72).   
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Figure 72. Excitation spectrum of EuL4 (3 mL 3 mM in H2O) recorded by monitoring the Eu(III) emission at 
616 nm. 
 
 
EuL4 excitation spectrum showed a maximum peak at 355 nm. The difference between 
EuL4 absorption and excitation spectra was indicative of a partial energy transfer 
process from the coumarin 3 carboxylic acid to the Eu(III). This could be due to a partial 
absorption of the incident light by the phenyl rings present on the benzyl ester group and 
the triphenyl phosphonium moieties.  
The photophysical properties of TbL4 were not measured due to a very low amount of 
complex obtained that did not allowed to make enough concentrated solution to record 
its absorption, emission and excitation profiles.  
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4.4 Photophysical properties of EuL4 and EuL5 measured in the presence 
of H2O2 and Fe(II) perchlorate 
As discussed so far, EuL4 and EuL5 were the only lanthanide complexes that, among 
those synthesized in this project, exhibited the characteristic Eu(III)-based 
luminescence. Therefore EuL4 and EuL5 were chosen among the complexes examined 
so far to be evaluated for their response to the presence of ROS species. In order to 
verify whether or not EuL4 and EuL5 were able to sense the presence of ROS, their 
photophysical properties were measured in the presence of H2O2 by using emission 
spectroscopy. The test was performed in a cuvette containing 500 μL of a EuL4 and 
EuL5 3 mM aqueous solution. The europium emission of EuL4 and EuL5 were recorded 
in absence and presence of added H2O2 and Fe(II) perchlorate. The Fe(II) perchlorate 
should be able to catalyse the formation of hydroxyl radicals from H2O2, which are ROS 
species, as to mimic what happens within the cells during the Fenton reaction catalysed 
by Fe(II)-containing enzymes  (see chapter 1, section 1.3.2). While the concentration of 
Fe(II) perchlorate was kept constant at 30 μM, the H2O2 was tested at 120 μM and 720 
μM according to the protocol [85]. Figure 73 shows the EuL4 emission recorded in the 
presence of increasing amount of H2O2 and upon excitation of the sensitizer antenna, 
the coumarin 3 carboxylic acid derivative, at 324 nm.  
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Figure 73. EuL4 emission spectra recorded in absence athe presence of increasing concentration of H2O2 
upon excitation at 324 nm. 
 
As it is possible to see in Figure 73, a dose dependent increase of the Eu(III)-based 
emission intensity was observed upon the addition H2O2, while no changes in the Eu(III) 
emission profile form were observed, indicating that there were no changes of that the 
Eu(III) coordination environment. The intensity of the ∆J = 1 transitions (around 588 nm) 
is known to be insensitive to changes in Eu(III) coordination environment, whilst the 
intensity of the ∆J = 2 (around 618 nm) and ∆J = 4 (around 702 nm) transitions changes 
considerably [86]. For example, changes in the ∆J = 2/∆J = 1 could be indicative of 
changes in the Eu(III) coordination environment, such as those caused by the 
replacement of the solvent molecule involved in the coordination with another 
coordinating species, such as an anionic analyte [83]. The fact that no changes of the 
Eu(III) emission profile form were observed in EuL4 upon H2O2 and Fe(II) perchlorate, 
suggested that no changes in the Eu(III) coordination took place, meaning that the 
solvent molecule involved in the coordination were not replaced by H2O2 or hydroxyl 
radicals generated in solution. The increase in the Eu(III) emission could be the 
consequence of changes in the photophysical properties of the Eu(III) sensitizer, namely 
210 
 
the coumarin 3 carboxylic acid, induced by the hydroxyl radicals generated in situ by 
Fe(II) perchlorate and H2O2. It is well known in fact that the coumarin 3 carboxylic acid 
could be hydroxylated in the presence of hydroxyl radicals generating compounds, with 
the position 7 of the coumarin ring representing the most favourable hydroxylation site. 
Opposite results were obtained with the Eu(III)-based complex EuL5, where a slight dose 
dependent decrease of the Eu(III)-based luminescence was observed upon the addition 
of H2O2, as it is possible to note in Figure 74. The EuL5 emission was recorded in 
absence and presence of added Fe(II) perchlorate and H2O2 by exciting the chromophore 
antennae, namely the two coumarin 151 derivatives, at 339 nm. 
 
 
Figure 74. EuL5 emission spectra recorded in absence and presence of H2O2 and Fe(II) perchlorate upon 
excitation at 339 nm. 
 
Also in this case, no changes in the Eu(III) emission spectral form were observed 
suggesting that there were no changes in the Eu(III) coordination sphere. The slight dose 
dependent quenching of Eu(III) emission in EuL5 could be attributable to changing in the 
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photophysycal properties of the two sensitizer antennae, namely the two coumarin 151 
derivatives, caused by the hydroxyl radicals generated by Fe(II) perchlorate and H2O2. 
While the hypothesized hydroxylation of the coumarin 3 carboxylic acid derivative could 
improve the sensitization of the Eu(III) emission in EuL4, a probable hydroxylation of the 
coumarin 151 derivatives could be responsible indeed of reducing the efficiency of the 
Eu(III) sensitization in EuL5, explaining why in this case a slight decrease of the Eu(III)-
based emission was observed. It was also hypothesized that the changes of the 
photophysical properties of the coumarin 151 derivatives could be due to the 
replacement of one or more fluorine atoms of the CF3 function present on the coumarin 
151 derivatives rather than the hydroxylation of the coumarin ring. 
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5. Results and Discussion: testing the lanthanide complexes on 
cells and isolated mitochondria. 
 
This chapter describes three types of test that were performed on the lanthanide 
complexes synthesised in this project. The first two tests assess the impact of the 
lanthanide complexes on the functioning of the mitochondria as it is important to 
determine if the sensor is in itself toxic to cells. The first of these is mitochondrial stress 
test (MST) that was performed by measuring key parameters of mitochondrial function, 
by directly measuring the oxygen consumption rate (OCR) of cells, and of the glycolytic 
function by measuring the extracellular acidification rate (ECAR) of the medium 
surrounding the cells [87]. The second test, the calcium loading capacity assay, was 
performed on isolated mitochondria with the aim of investigating the effect of the 
lanthanide complexes synthesized in this project on the mitochondrial capability to 
uptake and internalize Ca2+. The third and final test was a cellular ROS assay that 
evaluated the complexes ability to respond to changes in ROS in a cellular environment. 
This was performed on the lanthanide complexes EuL4 and EuL5 to evaluate whether 
or not these complexes were responsive to ROS species, such as H2O2 and OH∙, in a 
cellular environment by measuring changes in their luminescence intensity eventually 
caused by increased ROS levels. The choice of testing EuL4 and EuL5 with the cellular 
ROS assay was made based on the results obtained with the photophysical studies 
discussed in the chapter 4, where it was evident that EuL4 and EuL5 were the only 
complexes among those synthesised in this project that exhibited the characteristic 
lanthanide-based luminescence. All the other complexes were not tested with the cellular 
ROS assay since, as discussed in the chapter 4, they did not show the typical lanthanide-
based luminescence. 
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5.1 Mitochondrial Stress Test (MST) 
The MST is a cell-based test used to predict the toxicity of a compound by measuring its 
effects on mitochondrial function. An important advantage of the MST is that it allows the 
simultaneous measurements of the oxygen consumption rate (OCR) and extracellular 
acidification rate (ECAR) of cells as indicators of mitochondrial respiration and glycolysis, 
respectively [87]. In the MST, the OCR and the ECAR of the cells are measured following 
the sequential addition of several compounds, each capable of modulating a specific 
component of the mitochondrial ETC (Figure 75), a detailed description has been 
provided in the chapter 1 (section 1.3.1).  
 
 
Figure 75. The picture illustrates the complexes of the ETC and the target of action of all of the compounds 
used in the Seahorse assay acting as modulators of the ETC. 
 
The compounds that are sequentially injected into the wells containing the cells and the 
compounds to be tested for their toxicity are: oligomycin, carbonyl cyanide-4 
(trifluoromethoxy) phenylhydrazone (FCCP) and a mixture of antimycin A, rotenone and 
glucose. Oligomycin inhibits ATP synthase (complex V) [88] and results in a decrease in 
OCR (Figure 75). FCCP is a protonophore (H+ ionophore) that acts as mitochondria 
uncoupler since it causes an increase in proton (H+) conductance through the inner 
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mitochondrial membrane, collapses the proton gradient and dissipates the mitochondrial 
membrane potential generated during the mitochondrial ETC [89]. As a consequence, 
the electron flow through the ETC increases in a futile attempt to restore the proton 
gradient and mitochondrial membrane potential across the inner mitochondrial 
membrane, and consequently oxygen is highly consumed by complex IV (Figure 75). 
Mitochondrial uncoupling is any process by which electron transport is not exploited to 
synthesize ATP or exert other important functions such as ion transport. All processes 
that allow protons to enter the matrix independently of ATP synthase are said to 
“uncouple” the substrate oxidation from ATP synthesis [90]. Rotenone is a complex I 
inhibitor [91] while antimycin A acts as complex III inhibitor [92] (Figure 75). The 
combination of rotenone and antimycin A blocks the mitochondrial ETC and allows the 
calculation of non-mitochondrial respiration, which is driven by any process outside the 
mitochondria [93] (Figure 70). In these experiments glucose was also included in the 
final injection. If cells switched to glycolysis following the rotenone and antimycin injection 
it could be inferred that there was no cytotoxicity and any effects seen in the traces were 
due to a direct effect on mitochondrial function. Figure 76 shows a typical cellular OCR 
profile measured with the MST.  
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Figure 76. Profile of the key parameters of mitochondrial respiration. 
 
 
5.1.1 Parameters of mitochondrial respiration measured with the MST 
The OCR of cells measured during the first 60 minutes following injection of the 
lanthanide complexes of interest without addition of ETC modulators compounds, 
represents the basal respiration (Figure 76). Basal respiration represents the oxygen 
consumption used to meet cellular ATP demand under baseline conditions [93] and is 
due to two processes: ATP production and mitochondrial proton leak [94]. ATP 
production occurs in Complex V, as described above. Proton leak is the process by which 
protons (H+) can return from the mitochondrial inner membrane space to the matrix 
independently of ATP synthase [95]. An increase in proton leak can occur when the 
integrity of the membrane has been disturbed and in general mitochondrial toxins tend 
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to increase proton leak.  Although the precise mechanism of basal proton leak is not fully 
understood, it may be due to adenine nucleotide translocase (ANT), a transmembrane 
protein responsible for exchanging ADP for ATP across the mitochondrial inner 
membrane [96]. A decrease in the OCR is observed after the injection of oligomycin, an 
ATP synthase inhibitor. This enables the measurement of ATP- and proton leak-driven 
respiration [94].  
5.1.1.1 Spare respiratory capacity: FCCP injection 
The injection of FCCP causes a huge increase in the OCR (Figure 76). FCCP stimulates 
the respiratory chain to operate at its maximum capacity, which causes a rapid oxidation 
of substrates, such as sugars, fats and amino acids, to cope with this metabolic demand. 
The maximum level of OCR observed after FCCP injection represents the maximum rate 
of respiration that cells can achieve [93]. It is used to calculate the spare respiratory 
capacity, which is defined as the difference between maximal respiration and basal 
respiration. The spare respiratory capacity is a measure of the ability of the cell to 
respond to increased energy demand, indicating how closely the cell is working to its 
maximum limit. The cell's ability to respond to high energy demand can be an indicator 
of cell healthy, while the lack of spare capacity indicates a mitochondrial dysfunction [93]. 
5.1.1.2 Non-mitochondrial respiration: rotenone and antimycin A injection 
The last injection, which is a mixture containing rotenone and antimycin A, causes a 
decrease in the OCR, due to the block of the ETC via inhibition of the complex I and III 
exerted respectively by rotenone and antimycin A (Figure 76). The oxygen consumption 
that persists after rotenone and antimycin A injection is due to cellular enzymes that 
continue to consume oxygen and is defined as “non-mitochondrial oxygen consumption”. 
The non-mitochondrial respiration is an important parameter since it enables an accurate 
measurement of mitochondrial respiration by subtracting the non-mitochondrial 
respiration from the total OCR [93].  
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5.1.1.3 Extracellular acidification rate: glycolytic activity of the cells 
The ECAR measured simultaneously with the OCR gives important information about 
the glycolytic activity of the cells. Glycolysis is the metabolic pathway that converts 
glucose to pyruvate and occurs in most organisms in the cytosol of the cell. When the 
oxygen level is low, pyruvate is converted to lactate with the subsequent production of 
ATP and protons (H+). The protons (H+) are transported outside the cell to keep constant 
the intracellular pH and the accumulation of the protons (H+) into the extracellular 
medium causes an extracellular acidification [94].  An advantage of the MST is that it 
allows the simultaneous calculation of the cellular OCR and ECAR. This is an important 
advantage since it allows identification of compounds that have effects on the 
mitochondrial functions via OCR, as well as compounds that have effects on the 
glycolytic function of the cells via ECAR [94]. In many cases the OCR and ECAR 
measurements are complimentary with inhibition of ATP production by oxidative 
phosphorylation causing a parallel increase in ATP production by glycolysis and vice 
versa. Concurrent drops in both OCR and ECAR may be indicative of compound 
cytotoxicity.  
 
5.1.2 Understanding the effects of the lanthanide complexes on cellular and 
mitochondrial functions using the MST 
A MST was performed on the lanthanide complexes EuL1, TbL1, EuL2, TbL2, NdL3, 
YbL3, EuL4 and TbL4 synthesised in this project in order to understand their effects on 
the cellular and mitochondrial functions. All the complexes were tested at concentrations 
of 200 μM, 50 μM, 12.5 μM, 3.1 μM and 0.8 μM and their related OCR and ECAR profiles 
were recorded in presence and absence of cells (HepG2 liver cancer cell line). The OCR 
(pmol/min) was recorded in real time upon the sequential injections described above. 
The ECAR profiles were recorded in order to measure the compounds’ effect on the 
glycolytic activity of the cells. The ECAR profiles were recorded in real time upon the 
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same sequential injection of the compounds seen above for the OCR profiles recording 
with the difference that in the last injection (injection 4) the glucose was added together 
with rotenone and antimycin A to stimulate glycolysis. In all graphs injection 1 refers to 
the test compound injection, while injections 2, 3 and 4 correspond to the oligomycin, 
FCCP and rotenone/antimycin A/glucose injections respectively. All OCR and ECAR 
profiles recorded in the presence of cells were compared to the OCR profile related to 
the control, which contains just the cells and DMSO vehicle and appears in all diagrams 
as a bold blue line. The OCR and ECAR profiles were also recorded in absence of cells 
to see if there were any compounds’ interference when the cells were not present, such 
as saturation of OCR and /or ECAR fluorophores.  
 
5.1.2.1 MST results of the lanthanide complexes analysed with the MST test 
Table 7 and 8 show a summary of the MTS data related to all lanthanide complexes 
analysed with this test and provide a direct comparison between the data of all 
complexes.  
OCR RATE measured in presence of cells 
Compound OCR RATE 
after 
compound 
injection 
(injection 1): 
basal 
respiration 
OCR RATE 
after 
oligomicyn 
injection 
(injection 2): 
proton leak 
OCR RATE 
after FCCP 
injection 
(injection 3): 
spare 
respiratory 
capacity 
OCR RATE after 
rotenone/antimycin 
A injection 
(injection 4): 
non-mitochondrial 
respiration 
EuL1 / TbL1 increase increase erosion increase 
EuL2 / TbL2 erosion no effect erosion no effect 
NdL3 / YbL4 increase increase erosion increase 
EuL4 / TbL4 no effect no effect no effect no effect 
 
Table 7. Summary of compounds effect on the parameters of mitochondrial respiration recorded in presence 
of cells. 
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Compound OCR LEVEL in 
absence of cells: 
interference of 
compound on OCR 
fluorophore 
ECAR LEVEL in 
absence of cells: 
interference of 
compound on the 
ECAR (pH) 
fluorophore 
 
ECAR RATE in 
presence of cells: 
glycolysis recovery 
EuL1 and TbL1 observed observed observed for 3.1 and 
0.8 μM 
EuL2 and TbL2 not observed observed observed for 3.1 and 
0.8 μM 
NdL3 and YbL4 observed observed observed from 12.5 
to 0.8 μM 
EuL4 and TbL4 not observed slight effect observed 
for 200 and 50 μm 
observed from 12.5 
to 0.8 μM 
 
Table 8. Summary of compounds effect on OCR and ECAR fluorophores and glycolysis recovery. 
 
5.1.2.2 OCR profiles of EuL1 
Figure 77 shows the OCR RATE profile related to EuL1 recorded in presence of cells.  
 
 
Figure 77. OCR RATE of cells measured during the MST performed on EuL1 in presence of cells . Injection 
1 corresponds to EuL1 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds 
to FCCP injection and injection 4 corresponds to rotenone/antimycin A injection.  
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Looking at the diagram shown in Figure 77 it seemed that EuL1 injection (injection 1) 
had an uncoupling effect since an initial high dose dependent increase of OCR was 
observed. However the supposed uncoupling effect by EuL1 cannot be confirmed 
looking at the EuL1 OCR RATE profile recorded in absence of cells shown in Figure 78 
since a large increase of oxygen consumption by EuL1 down to 3.1 μM was observed 
even when cells were not present.  
 
Figure 78. EuL1 OCR RATE measured during the MST in absence of cells. Injection 1 corresponds to 
EuL1 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
The oxygen consumption observed for EuL1 in absence of cells could be due to its ability 
to incorporate oxygen or a gradually accumulating effect on the OCR fluorophore. 
However there was no further evidence to support either of these hypothesis. The 
diagram in Figure 79 shows the EuL1 OCR LEVEL recorded in absence of cells. 
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Figure 79. EuL1 OCR LEVEL measured during the MST in absence of cells. Injection 1 corresponds to 
EuL1 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
 
Whilst there was not an instantaneous decrease in oxygen level, EuL1 caused a dose 
dependant drop in oxygen levels in absence of cells. This was a further evidence that 
the huge increase in OCR RATE recorded in presence of cells (Figure 77) could not be 
interpreted as uncoupling effect as it was a systematic effect caused by EuL1. Looking 
back at EuL1 OCR in presence of cells (Figure 77) it is possible to note that, despite the 
compound interference, it had a deleterious effect on maximal respiration, recorded upon 
FCCP injection (injection 3). In particular 200 μM, 50 μM and 12 μM of EuL1 showed an 
erosion of the spare respiratory capacity (maximal respiration) indicating that EuL1 had 
a toxic effect on cells from 200-12.5 μM. From figure 77 it is also possible to note that 
there was an increase in non-mitochondrial respiration following rotenone and antimycin 
A (injection 4) suggesting that EuL1 was in some way consuming oxygen from the 
system as this was also seen in wells without cells. However it could not be ruled out 
that there was a gradual cumulative effect of EuL1 on the OCR fluorophore with time 
that appeared to give the impression of oxygen removal from the system. 3.1 and 0.8 
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μM of EuL1 however showed a trend similar to the controls so they can be considered 
‘non-toxic’.  
5.1.2.3 ECAR profiles of EuL1  
Looking at the ECAR LEVEL of EuL1 recorded in absence of cells (Figure 80), it is clear 
that EuL1 had an immediate effect on ECAR LEVEL without cells meaning that EuL1 
caused by an immediate interference with the absorbance of the ECAR fluorophore down 
to 0.8 μM. 
 
 
Figure 80. EuL1 ECAR  LEVEL measured during the MST in absence of cells. Injection 1 corresponds to 
EuL1 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection. 
 
The EuL1 interferece with the ECAR fluorophore made the interpretation of the ECAR 
RATE profile recorded in presence of cells (Figure 81) difficult with response flatling at 
almost all concentrations of EuL1. 
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Figure 81. EuL1 ECAR  RATE measured during the MST in presence of cells. Injection 1 corresponds to 
EuL1 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection. 
 
However for concentrations of 3.1 and 0.8 μM an elevation in ECAR was observed 
following injection of rotenone/antimycin A, which also included glucose to stimulate the 
glycolysis, indicating that the cells were still alive and switched to glycolysis. This means 
that EuL1 two lower doses were not cytotoxic and this is consistent with the OCAR data. 
Since the TbL1 MST results were the same seen for EuL1, they have not been discussed 
in this section. The similarity in the MST results obtained for EuL1 and TbL1 was due to 
the similar chemical structure of both compounds. However the MST data related to 
TbL1 can be found in Appendix A.1.1 for a direct comparison. In the following sections, 
a summary of the MTS results of EuL2, TbL2, NdL3, YbL3, EuL4 and TbL4 is provided 
and their related OCR and ECAR profiles can be found in Appendix A.1. 
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5.1.2.4 MST results of the lanthanide complexes EuL2 and TbL2. 
The highest two doses of EuL2, 200 and 50 μM, caused an impairment of oxidative 
phosphorylation since a decrease of the basal OCR and an erosion of the spare 
respiratory capacity were observed (see Figure 104 in Appendix A.1.2). All the other 
concentrations (from 12.5 - 0.8 μM), did not cause any effect on mitochondrial function, 
indicating that EuL2 was not mitotoxic at the lowest three doses. The impairment of 
oxidative phosphorylation by EuL2 at two top doses was confirmed by the results 
obtained with the OCR measured in absence of cells (see Figure 105 in Appendix A.1.2) 
as no significant effect on the OCR were shown by EuL2 in absence of cells. This 
indicated that EuL2 did not interfere with the OCR fluorophore and the results related to 
the OCR measured in presence of cells were actual rather than a consequence of 
compound interference. EuL2 had an interference with the ECAR fluorophore (see 
Figure 106 in Appendix A.1.2). However, despite the interference with the ECAR 
fluorophore, a complete recovery of the glycolysis was observed for the EuL2 lowest two 
doses (3.1 and 0.8 μM) upon injection of rotenone/antimycin A (see Figure 107 in 
Appendix A.1.2), indicating that EuL2 was not cytotoxic at these concentrations. The 
TbL2 MST results were the same seen for EuL2 and can be found in Appendix A.1.2. 
 
5.1.2.5 MST results of the lanthanide complexes NdL3 and YbL3. 
NdL3 caused an increase of OCR after injection 1 and 2 (see Figure 112 in Appendix 
A.1.3) that could be interpreted as uncoupling effect. However, similarly to what was 
seen for EuL1, the supposed uncoupling effect was not confirmed by the OCR measured 
in absence of cells, since a large increase of oxygen consumption by NdL3 down to 3.1 
μM was observed even when cells were not present (see Figures 113 and 114 in 
Appendix A.1.3). This indicated that the increase of oxygen consumption observed in 
presence of cells could not be interpreted as uncoupling effect as it was due to compound 
interference with the OCR fluorophore. However, despite the compound interference, 
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NdL3 had a deleterious effect on maximal respiration recorded upon FCCP injection 
(injection 3) (see Figure 112 in Appendix A.1.3). In particular 200 μM, 50 μM and 12 μM 
of NdL3 showed an erosion of the spare respiratory capacity (maximal respiration) 
indicating that NdL3, similarly to EuL1, had a toxic effect on cells from 200-12.5 μM. 
Similarly to EuL1, NdL3 also had an interference with the ECAR fluorophore (see Figure 
115 in Appendix A.1.3), which made the interpretation of the ECAR RATE profile 
recorded in presence of cells quite difficult. However there was some recovery of 
glycolysis exhibited even at 50 μM following rotenone/animycin A addition. All other 
concentrations (from 12.5-0.8 μM) demonstrated a better glycolysis recovery (see Figure 
116 in Appendix A.1.3), but never quite reached control levels indicating a possible dose 
dependent cytotoxicity or a dose dependant effect of the compound on the pH 
fluorophore. The YbL3 MST results were the same seen for NdL3 and can be found in 
Appendix A.1.3. 
 
5.1.2.6 MST results of the lanthanide complexes EuL4 and TbL4. 
EuL4 did not exhibit any mitochondrial and cellular toxicity with the slight exception of 
200 µM which showed a small erosion of oxygen consumption at basal and maximal 
respiration (see Figure 122 in Appendix A.1.4). The TbL4 MST results were the same 
seen for EuL4 and can be found in Appendix A.1.4.  
The MST data  for EuL4 and TbL4 demonstarted a far superior mitochondrial and cellular 
toxicty profile and therefore they represent the most promising compounds for future 
development. Whilst the interpretation of the other complexes was complicated by the 
various effects on the ECAR and OCR flurophores, it appeared clear that they all cause 
imapirment of mitochondrial and cellular function at lower levels than EuL4 and TbL4.  
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5.2 Calcium Loading Capacity Assay 
In order to further investigate the effect of the lanthanide complexes on mitochondrial 
function, a calcium loading assay was performed. The aim of this assay was to identify 
compounds with potential mitochondrial toxicity, through a decrease of the mitochondrial 
calcium loading capacity (CLC), as they are likely to cause mitochondrial dysfunction. 
Ligands that can bind lanthanide ions also show high affinity for calcium.  
5.2.1 Mitochondrial calcium influx and efflux  
Before introducing the calcium loading capacity assay, it is important to briefly introduce 
the mechanisms that regulate the calcium uptake and efflux within the mitochondria. 
Calcium enters the mitochondria manly through the mitochondrial calcium uniporter 
(MCU) [97], however other influx pathways are involved in the transport of the calcium 
from the inner membrane space to the matrix. These include, for example, the leucine 
zipper-EF-hand containing transmembrane protein 1 (LETM1), which is an H+/Ca2+ 
exchanger [98], [99]. The driving force that allows the calcium to accumulate into the 
mitochondrial matrix through the MCU is the negative membrane potential across the 
inner mitochondrial membrane, which is generated by the proton flow from the matrix to 
the inner membrane space during the ETC [99]. This means that the mitochondria 
calcium uptake and the ETC are linked. Therefore, not only compounds that cause a 
direct MCU inhibition, but also compounds that interfere with the mitochondrial 
membrane potential, such as uncouplers and ETC inhibitors, could be responsible for 
compromising the mitochondrial calcium loading capacity and as consequence could 
cause mitochondrial dysfunction.  
5.2.1.1 Mitochondrial calcium efflux mechanisms 
Two mechanisms are involved in the calcium efflux: the Na+-dependent (mNCX) and the 
Na+-independent Ca2+ efflux [100]. In addition to these mechanisms, the calcium as well 
as other small ions and molecules may leave mitochondria through the mitochondria 
permeability transition pore (MPTP), which are proteinaceous pores located in both the 
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inner and outer mitochondrial membrane [100]. The MPTP opening occurs when large 
quantities of calcium accumulates into the mitochondrial matrix and interact with 
cyclophilin D [100], which is a protein located in the mitochondrial matrix that has a 
modulatory activity on the MPTP [101]. 
 
5.2.2 Calcium Loading Capacity Assay Background 
Figure 82 shows the CLC profile of isolated mitochondria and the effect that cyclosporine 
A and antimycin A have on the mitochondrial CLC. 
  
 
Figure 82. Mitochondrial Calcium Loading Capacity (CLC) assay profile related to the effect of the antimycin 
A and cyclosporin A on the mitochondrial CLC. This picture has been provided by GSK pharmaceutical 
company.   
 
The CLC profile represents the variation of the calcium concentration in the extra 
mitochondrial medium. Variations in calcium concentrations were followed by measuring 
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changes in the absorbance spectrum of arsenazo III, a metallochromic dye used in the 
determination of calcium in biological samples [102], [103]. The free calcium (Ca2+) 
concentration can be determined by directly measuring the absorbance of the Ca2+- 
arsenazo III complex at 600-660 nm [102], [103]. As it is shown in Figure 82, upon the 
addition of calcium to the wells containing the isolated mitochondria and the medium, a 
strong absorption of the arsenazo III was observed. After the injection of calcium, 
succinate was added to the medium in order to provide a substrate for the mitochondrial 
ETC. Succinate is a substrate that stimulates the ETC at the level of complex II. Here 
the succinate is converted into fumarate by the catalytic activity of the succinate 
dehydrogenase, also called complex II (see the chapter 1 for more explanation). The 
increasing polarization of the mitochondrial membrane caused by the addition of 
succinate allows the calcium to enter the mitochondria through the MCU, and this was 
detected by a decrease of arsenazo III absorbance as consequence of lowered calcium 
medium concentration (Figure 82). When the calcium reaches a critical concentration 
within the mitochondria matrix, the MPTP opens and calcium is released back into the 
medium. This was indicated by an increase of the arsenazo III absorbance as 
consequence of the increased calcium concentration in the medium (Figure 82). Figure 
82 shows the effect of the antimycin A and the cyclosporine A on the mitochondrial CLC. 
Antimycin A, which is a complex III inhibitor, caused a significant erosion of the 
mitochondrial CLC (Figure 82). This effect was due to the depolarization of the inner 
mitochondrial membrane generated by a slowdown of the proton pumping during the 
ETC as consequence of the complex III inhibition by antimycin A. This in turn prevented 
the opening of the calcium influx pathway through the MCU. Cyclosporin A inhibits the 
formation of the MPTP and thus does not stop mitochondria uptaking calcium but inhibits 
its release upon reaching concentration that would normally trigger the MPTP. In Figure 
82 calcium uptake was observed upon the addition of the cyclosporin A, as indicated by 
a large decrease of arsenazo III absorbance. The increased calcium uptake by 
mitochondria induced by cyclosporine A is caused by the cyclosporine A ability to bind 
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the mitochondrial cyclophilin D, which in turn inhibits the MPTP [104]. As a consequence 
the calcium cannot exit the mitochondria upon its internalization into the matrix and is 
not returned to the media.  
 
5.2.3 Lanthanide Complexes Calcium Loading Capacity Assay results 
A calcium loading assay was performed on the same lanthanide complexes tested with 
the MST. All complexes were tested at concentration of 250 µM, 125 µM, 62.5 µM, 15.6 
µM, 3.9 µM and 0.9 µM. Figure 83 shows the calcium loading capacity profile measured 
for EuL1. EuL1 caused a significant erosion of the mitochondrial CLC down to 15.6 μM. 
In fact EuL1 15.6 µM, 3.9 µM and 0.9 µM showed a profile similar to the control, 
indicating that these concentrations did not affect the capacity of mitochondria to 
internalize the calcium.  
 
Figure 83. Calcium loading profile of EuL1. 
The significant CLC erosion caused by EuL1 could be due to several factors. However 
it was initially noted from the calcium loading traces that there was a calcium chelating 
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effect with all compounds (EuL1-TbL4) (see Figure 84 showing the calcium chelating 
effect of EuL1, the calcium chelating traces related to the other complexes can be found 
in Appendix A.3).  
 
Figure 84. Calcium chelation of EuL1. 
 
However the calcium loading traces performed with the uncomplexed generic ligand, 
shown in Figure 85, showed no reproduction of this trend which suggests this chelating 
effect is not arising from direct competition for the ligands between the Ca2+ and the Ln3+. 
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Figure 85. Calcium chelation of the uncomplexed generic ligand. 
 
In Figure 83 it is important to note that, whilst the calcium chelation alters the calcium 
absorbance value of the CLC profile before succinate addition, all concentrations of 
EuL1 still triggered the MPTP with the exception of 250 µM. Even in this instance for the 
250 µM CLC trace to be caused by calcium chelation alone, almost all of the calcium 
would have to be removed from the system. This was clearly not the case as Figure 84 
shows the calcium absorbance only dropped to approximately 80% of control so the 
majority of calcium remained. Therefore it could be inferred that the calcium was not 
chelated enough to become limiting in these experiments. This suggested that the effect 
seen at the 250 µM level could be due to mitochondrial toxicity or complete inhibition of 
mitochondrial calcium uptake. Whilst all compounds demonstrated inhibition of 
mitochondrial calcium loading (see Appendix A.2, where TbL2-YbL3 CLC profiles are 
reported), it should be noted that even at 250 µM EuL4 and TbL4 still demonstrated a 
degree of calcium loading compared to the other 6 complexes (see Figures 86 and 87) 
and appeared to slightly less potent in their effects on calcium loading. This was in 
correlation with the MST data that suggested that EuL4 and TbL4 showed the lowest 
toxicity and are the most promising complexes for future development.  
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Figure 86. Calcium loading profile of EuL4. 
 
Figure 87. Calcium loading profile of TbL4. 
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5.3 Cell-based test to measure the photophysical properties of the 
lanthanide complexes in vitro 
A cell-based test was performed on two europium complexes that were synthesized in 
this project, namely the EuL5 and EuL4 since, as discussed in the chapter 4, they were 
the only compounds among those synthesized that exhibited a strong europium-based 
luminescence. The aim of this test was to evaluate whether or not these complexes could 
sense high ROS levels in a cellular environment by measuring changes in their 
fluorescence intensity. Two pendant arms of coumarin 151 were attached to the cyclen 
ring to sensitize the Eu(III) emission in EuL5. The coumarin 151 moieties should also be 
able to interact with OH∙ or other ROS species, and this interaction should cause 
changes of the coumarin 151 photophysical properties and consequently changes in the 
Eu(III) emission. Whilst in EuL4 the coumarin 3 carboxylic acid was used as sensitizer 
antenna of Eu(III) and receptor unit for ROS species. The coumarin 3 carboxylic acid 
should be able to react with ROS species, such as OH∙, and changes in its photophysical 
properties caused by this interaction should induce changes in the Eu(III) emission [105]. 
In order to evaluate the response of EuL5 and EuL4 to high ROS levels, a cell-based 
test was performed on both complexes. The cell line used in this test was HSC-3 (human 
squamous cell carcinoma cell line). H2O2 and tBHP (tert-Butyl Hydroperoxide) were used 
as ROS generator compounds, since they are able to induce an oxidative stress within 
the cells by increasing the ROS production [106]. MitoSOX, which is a fluorogenic ROS-
sensing dye that is targeted to mitochondria in live cells, was used as probe positive 
control. Oxidation of MitoSOX by superoxide produces red fluorescence [107]. The assay 
was performed on a 96 well plate containing HSC-3 cells at a density of 100000 cells/well 
(Figure 88).  
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Figure 88. Example of a 96 well plate used to measure the fluorescence intensity of EuL5 and EuL4 in vitro. 
 
Figure 88 shows how a 96 well plate was filled to measure the fluorescence intensity of 
EuL5 and EuL4 in vitro. Apart from the wells that were filled only with 100 µl of EuL5 
and EuL4 dissolved in medium at concentration of 1 µM, 10 µM and 100 µM, all the other 
wells contained cells. The wells containing just the cells and medium were used as 
control, while the wells containing the cells and 1 µM, 10 µM and 100 µM of EuL5 and 
EuL4 were used to measure the fluorescence intensity of EuL5 and EuL4 within the 
cells in absence of ROS generator compounds. The wells containing the cells previously 
exposed to 50 µM of H2O2 and then incubated with EuL5 and EuL4 at concentration of 
1 µM, 10 µM and 10 0µM, were used to measure the fluorescence intensity of EuL5 and 
EuL4 in the presence of high levels of ROS generated by H2O2 (Figure 88). In this assay 
another 96 well plate was filled as described above but replacing the H2O2 with 150 µM 
of tBHP. The fluorescence intensity of EuL5 and EuL4 was recorded using a microplate 
reader and each measurement was made in triplicate. The fluorescence intensity of 
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EuL5 and EuL4 was recorded by monitoring the excitation at 390 nm and the emission 
at 645 nm. This choice was made taking into account the filters available with the 
microplate reader used for the measurements and by selecting among the available 
wavelengths the ones closest to the excitation and emission wavelengths of EuL5 and 
EuL4. The excitation wavelengths of EuL5 and EuL4 were 340 nm and 300 nm 
respectively (see chapter 4 for more explanation), while the emission wavelength was 
615 nm, which corresponds to the most emissive band ΔJ = 2 of the Eu(III) emission 
(see the chapter 4 for more explanation). The comparison between the fluorescence 
intensity of EuL5 and EuL4 recorded from the wells containing the cells previously 
incubated with H2O2 and tBHP and those containing the cells that were not incubated 
with H2O2 and tBHP allowed to evaluate whether or not EuL5 and EuL4 were able to 
detect the variation of ROS levels. The fluorescence intensity of EuL5 and EuL4 was 
measured before washing all the wells twice with the medium and after washing the 
wells, while the fluorescence intensity of the MitoSOX control was only recorded after 
washing according to the protocol. The fluorescence intensity recorded after washing the 
wells enabled the calculation of the fluorescence intensity of EuL5 and EuL4 that entered 
the cells and eliminate the interferences of EuL5 and EuL4 that were probably present 
in the extracellular medium before washing. 
 
5.3.1 In vitro measurements of EuL5 and EuL4 fluorescence intensity obtained 
before washing the wells  
The figures 89 and 90 show the fluorescence intensity of EuL5 and EuL4 respectively, 
recorded upon exposure of the cells to tBHP as ROS generator and before washing the 
wells. In both cases the control was represented by the cells and medium. 
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Figure 89. Fluorescence intensity of EuL5 (CA) recorded upon exposure of cells to tBHP as ROS generator. 
The fluorescence intensity was recorded upon excitation at 390 nm and emission at 645 nm and before 
washing the wells. 
 
 
Figure 90. Fluorescence intensity of EuL4 (CB) recorded upon exposure of cells to tBHP as ROS generator. 
The fluorescence intensity was recorded upon excitation at 390 nm and emission at 645 nm and before 
washing the wells. 
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 As it is shown in the graphs of Figures 89 and 90, the fluorescence intensity of EuL5 
and EuL4 recorded from the wells containing the cells previously exposed to tBHP and 
from those containing the cells incubated with EuL5 and EuL4 but not exposed to tBHP, 
were approximately the same. This was observed for all the concentrations of EuL5 and 
EuL4, namely 1 µM, 10 µM and 100 µM. This indicated that no significant EuL5 and 
EuL4 fluorescence changes took place upon exposure of the cells to tBHP, meaning that 
EuL5 and EuL4 were not responsive to high ROS levels generated by tBHP. Figures 91 
and 92 show the fluorescence intensity of EuL5 and EuL4 respectively, recorded upon 
exctitation at 390 nm and emission at 645 nm when H2O2 was employed as ROS 
generator. Again in these cases the control was represented by the cells and medium. 
 
Figure 91. Fluorescence intensity of EuL5 (CA) recorded upon exposure of cells to H2O2 as ROS generator. 
The fluorescence intensity was recorded upon excitation at 390 nm and emission at 645 nm and before 
washing the wells. 
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Figure 92. Fluorescence intensity of EuL4 (CB) recorded upon exposure of cells to H2O2 as ROS generator. 
The fluorescence intensity was recorded upon excitation at 39 0nm and emission at 645 nm and before 
washing the wells. 
 
A decrease in the fluorescence intensity of both EuL5 and EuL4 was observed upon 
exposure of the cells to H2O2. Although a decrease in fluorescence intesity was observed 
for EuL5 and EuL4 at all concentrations they were tested, namely 1 µM, 10 µM and 100 
µM, this effect was particularly pronounced for 100 µM EuL5 (Figure 91). This  indicated 
that EuL5 and EuL4 were responsive to high ROS levels generated by H2O2 and 100 
µM EuL5 was the most responsive. It is interestingly to note how the fluorescence 
intensity of EuL5 (Figure 91) and EuL4 (Figure 92) measured upon exposure the cells 
to H2O2 were approximately the same independently from the concentration they were 
tested. This indicated that the fluorescence of EuL5 and EuL4 was completely quenched 
by H2O2 or by other ROS species, such as OH∙. 
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5.3.1.1 ROS sensing ability of EuL5 in vitro and cuvette when H2O2 was used as 
ROS generator  
The quenching of EuL5 fluorescence observed in vitro could be due to a direct Eu(III) 
quenching caused H2O2, OH∙ or other ROS species or changes of the photophysical 
properties of the sensitizer antennae used in EuL5, namely the coumarin 151, as 
consequence of its interaction with ROS species generated by H2O2. The EuL5 
fluorescence quenching observed in vitro was consinstent with the results obtained with 
the photophysical test performed on EuL5 in the presence of H2O2 and Fe(II) perchlorate 
(chapter 4, section 4.4), where a decrease of the Eu(III) luminescence was observed 
upon H2O2 and Fe(II) perchlorate addition. Therefore the EuL5 quencing observed in 
vitro could support the hypothesis that the hydroxylation of the coumarin 151 by OH∙ 
could cause changes in its photophysical properties thus preventing it to act efficiently 
as sensitizer toward Eu(III), and as consequence no emission from the Eu(III) could be 
achieved. However it could not be excluded a direct quenching of Eu(III) and/or the 
sensitizer antenna by other ROS species present in the cells.  
5.3.1.2 ROS sensing ability of EuL4 in vitro and cuvette when H2O2 was used as 
ROS generator 
By contrast the quenching of the EuL4 fluorescence observed in vitro was not consistent 
with the the results obtained with the photophysical test performed on EuL4 in the 
presence of H2O2 and Fe(II) perchlorate, where an increase of the Eu(III) luminescence 
was indeed observed upon H2O2 and Fe(II) perchlorate addition. These inconsistent 
results could be due to the fact that, whilst the increase of the Eu(III) luminescence 
observed with EuL4 in solution could be attributable to the hydroxylation of the coumarin 
3 carboxylic acid by OH∙ generated in situ by H2O2 and Fe(II) perchlorate, the quenching 
of EuL4 fluorescence in vitro could be due to a direct Eu(III) quenching exerted by, and/or 
to the reaction of coumarinn 3 carboxylic acid with other types of ROS species generated 
within the cells upon H2O2 exsposure. 
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5.3.1.3 Differences in EuL5 and EuL4 responses to high ROS levels generated by 
tBHP and H2O2 
A plausible explanation to the absence of response by EuL5 and EuL4 to high ROS 
levels generated by tBHP while a response was observed when H2O2 was used as ROS 
generator could be that different sets of ROS are generated by H2O2 and tBHP. Exposure 
of cells to tBHP leads to an oxidative stress mainly caused by the production of peroxyl 
and alkoxyl radicals via cytochrome P450 [106], [108]. On the other hand, the oxidative 
stress generated within the cells treated with H2O2 is mainly attributable to the formation 
of OH● as consequence of the Haber-Weiss reaction [9]. Therefore it may be that the 
absence of response by EuL5 and EuL4 to high ROS levels generated by tBHP could 
be attributable to the fact that the products of tBHP transformation, namely the peroxyl 
and alkoxyl radicals, were not able to react with the antennae used in EuL5 and EuL4, 
so that to affect their ability to act as Eu(III) sensitizers, or were not able to cause a direct 
quenching of Eu(III) emission. Although the results related to the EuL5 and EuL4 
fluorescence intensity measurements discussed so far provide important information 
about their photophysical properties in vitro, they cannot be considered fully 
representative of their photophysical behaviour in a cellular environment. That is 
because the fluorescence intensity measured for EuL5 and EuL4 could be affected by 
the presence of EuL5 and EuL4 that did not enter the cells and remained into the 
extracellular medium. In order to measure the fluorescence intensity of EuL5 and EuL4 
without having any interference form by the amount that did not enter the cells, all the 
wells were washed twice with medium in order to eliminate traces of EuL5 and EuL4 
that remained in the extracellular medium. In the next section, the fluorescence intensity 
of EuL5 and EuL4 recorded after washing the wells are described together with the 
fluorescence intensity of the MitoSOX ROS positive control. 
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5.3.2 In vitro measurements of EuL5 and EuL4 fluorescence intensity obtained 
after washing the wells 
Figures 93 and 94  show the fluorescence intensity of EuL5 and EuL4 respectively 
recorded upon excitation at 390 nm and emission at 645 nm and upon washing all the 
wells twice with HBSS (balanced salt solution) medium. The control consisted of the cells 
just incubated with medium. 
 
 
Figure 93. Fluorescence intensity of EuL5 (CA) recorded upon exposure of cells to tBHP as ROS generator. 
The fluorescence intensity was recorded upon excitation at 390 nm and emission at 645 nm and after 
washing the wells. 
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Figure 94. Fluorescence intensity of EuL4 (CB) recorded upon exposure of cells to tBHP as ROS generator. 
The fluorescence intensity was recorded upon excitation at 390 nm and emission at 645 nm and after 
washing the wells. 
 
As shown in Figures 93 and 94, no changes of EuL5 and EuL4 photophysical properties 
were observed when they were incubated in the cells previously exposed to tBHP, 
indicating that these compounds were not responsive to high ROS levels generated by 
tBHP. The absence of response by EuL5 and EuL4 to high ROS levels generated by 
tBHP was observed for all concentrations at which these compounds were tested, 
namely 1 µM, 10 µM and 100 µM. These results were aligned with the results related to 
the fluorescence intensity measurements obtained with EuL5 and EuL4 before washing 
all wells. Figures 95 and 96 show the fluorescence intensity measurements of EuL5 and 
EuL4 respectively recorded upon excitation at 390 nm and emission at 645 nm and upon 
exposure of cells to H2O2. 
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Figure 95. Fluorescence intensity of EuL5 (CA) recorded upon exposure of cells to H2O2 as ROS generator. 
The fluorescence intensity was recorded upon excitation at 390 nm and emission at 645 nm and after 
washing the wells. 
 
 
 
Figure 96. Fluorescence intensity of EuL4 (CB) recorded upon exposure of cells to H2O2 as ROS generator. 
The fluorescence intensity was recorded upon excitation at 390 nm and emission at 645 nm and after 
washing the wells. 
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As it is possible to note in Figure 95, while no significant decrease of 1 μM EuL5 and 10 
μM EuL5 fluorescence intensity were observed when EuL5 was injected into the cells 
that were previously exposed to H2O2, a significant decrease at 100 μM EuL5 was indeed 
observed. These results were only partially aligned with the results related to the 
fluorescence intensity measurements of EuL5 recorded before washing all the wells. In 
fact, although a strong decrease of the fluorescence intensity of 100 μM EuL5 was 
measured both before and after washing the wells, the decrease of fluorescence intensity 
of 1 µM EuL5 and 10 µM EuL5 was more significant before washing the wells compared 
to after washing the wells. This could be explained by the fact that the fluorescence 
intensity of EuL5 recorded before washing the wells were affected by the presence of 
EuL5 in the extracellular medium that was removed after washing. Similarly to EuL5, 
also EuL4 showed a similar behaviour as some differences between the fluorescence 
intensity recorded before and after washing the wells were observed. A lower decrease 
of 1 µM EuL4 and 10 µM EuL4 fluorescence intensity was observed after washing the 
wells compared to the decrease of 1 µM EuL4 and 10 µM EuL4 observed before washing 
the wells. In addition, inconsistent results were observed for 100 µM EuL4 before and 
after washing. While a decrease of 100 µM EuL4 fluorescence intensity was observed 
before washing the wells (Figure 92), a slight increase of 100 µM EuL4 fluorescence 
intensity was observed after washing the wells (Figure 96). If the fluorescence intensity 
of 1µM, 10 µM and 100 µM of EuL4 recorded in the wells containing the cells incubated 
with EuL4 are considered (Figure 96), an increase in the fluorescence intensity was 
expected as the EuL4 concentration increased. However, a decrease of the EuL4 
fluorescence intensity was observed as the concentration increased implying the 
washing process may adversely affect the concentration of the complex in the cells. This 
hypothesis can be supported by the results obtained with the MitoSOX positive control 
fluorescence intensity measurements. According to the protocol, the MitoSOX 
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fluorescence intensity was only recorded after washing and upon excitation at 544 nm at 
and emission at 590 nm. Figures 97 and 98 show the fluorescence intensity related to 
MitoSOX recorded upon exposure of the cells to H2O2 and tBHP respectively. 
 
 
Figure 97. Fluorescence intensity of MitoSOX recorded upon exposure of cells to H 2O2. The fluorescence 
intensity was recorded upon excitation at 544 nm and emission at 590 nm and after washing the wells. 
 
 
246 
 
 
Figure 98. Fluorescence intensity of MitoSOX recorded upon exposure of cells to tBHP. The fluorescence 
intensity was recorded upon excitation at 544 nm and emission at 590 nm and after washing the wells.  
 
Although an increase of MitoSOX fluorescence intensity was observed both when H2O2 
and tBHP were used as ROS generators, the magnitude of this increase was not so huge 
as expected from a compound known for its ability to detect variation of ROS levels within 
the cells.  This could be due to that fact that washing all wells twice with the medium 
affected in some way the fluorescence intensity measurement. It may be that washing 
all wells one time may improve the fluorescence intensity measurements thus avoiding 
inconsistent results.  
The two tests assessing the impact on the mitochondrial function showed the complexes 
EuL4 and TbL4 to have moderate to no effect on the cells suggesting they are potentially 
useful as sensors for mitochondrial function. The two complexes that showed useful 
Ln(III) based emission (EuL5 and EuL4) were tested in cell cultures and the cells 
tolerated these complexes allowing Eu(III) emission and responses to ROS to be 
recorded. Qualitatively EuL5 and EuL4 showed a response to ROS however there was 
a potential impact on washing the cells. 
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6. Conclusion and Future Work 
 
The aim of this project was to synthesise lanthanide complexes based on asymmetrically 
substituted cyclen ligands in order to produce luminescent molecular sensors able to 
signal the presence of ROS species. A series of lanthanide complexes based on 
asymmetrically substituted cyclen ligands were designed. This was achieved by the 
asymmetrical functionalisation of the cyclen ring with four pendant arms. Two arms, each 
containing a triphenylphosphonium derivative, were incorporated on the cyclen ring in 
order to target the complexes to mitochondria as they are the main source of ROS. The 
other two arms of the cyclen ring contained an organic chromophore and a carboxylic 
function protected with a benzyl ester group respectively. The chromophore antenna was 
used to sensitize the Ln(III) emission via an antenna effect and in the meantime to react 
with ROS species. Changes in the photophysical properties of the chromophore antenna 
caused by ROS were responsible for changes in the Ln(III) emission. The carbonyl 
function present on the arm containing the benzyl ester group, together with the four 
nitrogen atoms of the cyclen ring and two carbonyl functions present on the 
triphenylphosphonium containing moieties, were involved in the Ln(III) coordination. 
 
6.1 The synthesis  
The first unsuccessful synthetic strategy was based on the direct and selective N-
alkylation of four pendant arms on the cyclen ring. This synthetic approach required that 
the pendant arms had to be synthesised separately and then could be used for the direct 
N-alkylation. Two arms containing an N-methyl-L-glucamine derivative were chosen in 
order to increase the hydrophilicity of the ligand due to the presence of ten hydroxyl 
functions that would have made the ligand an amphiphilic molecule thus providing it with 
similar properties of plasma and mitochondria membranes and facilitating its diffusion 
through these systems of membranes. 
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Although the pendant arms that had to be incorporated on the cyclen ring by direct N-
alkylation reaction were successfully synthesised and two of them were successfully 
incorporated on the cyclen ring to obtain the 1-N-Boc-ethylmine-4-coumarin 2 
acetamide-1,4,7,10-tetraazacyclododecane (24), it was not possible to introduce the two 
arms containing the N-methyl-L-glucamine derivatives via direct N-alkylation reaction. 
This could be due to the instability of N-methyl-L-glucamine pentaactetate bromoacetate 
(26) under the reflux conditions used for the direct N-alkylation, or to their steric 
hindrance, which could in some way prevent the N-alkylation reaction of the 1-4 
disubstituted cyclen (24) from taking place, or to a combination of both. Based on the 
hypothesis that the N-methyl-L-glucamine pentaactetate bromoacetate (26) was not 
stable under the reflux conditions used for the direct N-alkylation, it was replaced by 
another moiety, which was thought to be stable under reflux conditions. In particular, two 
moieties, each containing a lipophilic triphenylphosphonium cation, were used as 
mitochondria-targeted molecules to replace the two molecules of N-methyl-L-glucamine 
pentaactetate bromoacetate (26). The net positive charge present on the 
triphenylphosphonium cation was expected to target the compound to the negatively 
charged mitochondria.  
Based on the hypothesis that the steric hindrance of the two N-methyl-L-glucamine 
pentaactetate bromoacetate (26) moieties could be responsible for the failure of the 
direct N-alkylation reaction, a second, successful synthetic approach for the synthesis of 
the asymmetrically substituted cyclen-based ligands was used. It involved the synthesis 
of an intermediate ligand, the 1-N-Boc ethylamine-4,7-diallyl acetate-10-benzyl acetate-
1,4,7,10-tetraazacyclododecane (DABBC) (36), which was called “the generic ligand” 
since it possesses a generic chemical structure that could be modified in many ways in 
order to produce different types of ligands. The generic ligand was designed and 
synthesised by exploiting an orthogonal protection strategy. The generic ligand was 
designed in a way that it contained three different protecting groups, used for masking 
the reactivity of carboxyl and amino functions. These protecting groups could be 
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selectively and sequentially removed allowing inserting different pendant arms on the 
cyclen ring. The sequential attachment of different pendant arms to the cyclen ring, after 
that each protecting group was removed, could allow to obtain an asymmetrically 
substituted cyclen-based ligand and could be achieved using a peptide coupling reaction. 
Three protecting groups were chosen for the synthesis of the general ligand: one Boc 
group to protect the primary amino function, two allyl ester groups and one benzyl ester 
group to protect three carboxylic functions. The synthetic route involving the orthogonal 
deprotection strategy allowed the issues encountered with the direct N-alkylation 
strategy to be overcome and the synthesis of different types of ligands, based on 
asymmetrically substituted cyclen. In fact, starting from the generic ligand and selectively 
removing the protecting groups attached to it, it was possible to successfully synthesise 
different types of asymmetrically substituted cyclen based ligands, which were 
complexed with Ln(III) ions. 
 
6.2 Future work: the synthesis 
As discussed in the section 3.2.3, four ligands (L1, L2, L3 and L4), based on 
symmetrically substituted cyclen and bearing two pendant arms containing a 
triphenylphosphonium cation as mitochondria targeting moiety and one pendant arm 
containing a sensitizer antenna that in the meantime could react with ROS species, were 
successfully synthesized in this project. However it was not possible to introduce a 
further antenna that would have generated a reversible system of antennae described in 
the section 3.1. This was due to the fact that one step of the multistep orthogonal 
deprotection strategy, which starting from the DABBC (36) led to the synthesis of L1, L2, 
L3 and L4, was unsuccessful after various reaction conditions. In future work, the 
introduction of a second antenna replacing the benzyl ester group could be achieved in 
two ways:  
1. By changing the order by which the protecting groups are removed from the 
generic ligand. The allyl ester groups’ cleavage can be followed by the Boc group 
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removal rather than the benzyl ester group removal. Then the benzyl ester group 
can be removed under strong acidic conditions, using for example hydrogen 
bromide, rather than reduction conditions via catalytic hydrogenation. However 
this procedure can be applied only if the pendant arms to be incorporated on the 
cyclen ring after each deprotection are stable not only under mild acidic 
conditions used for the Boc group removal but also under the strong acidic 
conditions used for the benzyl ester group removal. 
2.  By optimising the reactions conditions used for the benzyl ester group removal 
via catalytic hydrogenation. The catalytic hydrogenation can be performed under 
high H2 pressure by using an autoclave rather than a glass round bottom flask. 
The autoclave may improve the efficiency of the catalytic hydrogenation as a 
higher concentration of H2 in solution can be achieved in such a hermetically 
closed and pressurised system. 
The orthogonal deprotection strategy involving the synthesis of the intermediate generic 
ligand proved to be a very versatile synthetic route since starting from the same 
molecule, the generic ligand, it was possible to obtain different types of asymmetrically 
substituted cyclen base-ligands. The versatility of the new synthetic route can be 
exploited in future works to produce other types of Ln3+ complexes based on 
asymmetrically substituted cyclen-based ligands targeted to different cellular organelles. 
This can be achieved by replacing the two arms containing the mitochondria targeting 
molecules, namely the triphenylphosphonium derivatives, with two arms containing 
different types of targeting molecules, such as peptide sequences, carbohydrates or 
antibodies.  
 
6.3 Photophysical studies 
All ligands synthesised in this project were complexed with trivalent lanthanide ions, 
giving rise to eleven lanthanide complexes of Eu(III), Tb(III), Nd(III) and Yb(III). Since 
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NdL3 and YbL3 were complexed with the near infrared emitting Nd(III) and Yb(III), it was 
not possible to measure their photophysical properties using the fluorimeter available at 
the Open University due to the inability of the instrument to record the emission profiles 
falling in the near infrared region. The photophysical studies performed on EuL2, TbL2 
and EuL6, where the coumarin 343 was used as sensitizer antenna towards Eu(III) and 
Tb(III), demonstrated that it was not possible to achieve the Ln3+ sensitization using the 
coumarin 343 as sensitizer antenna since the characteristic L3+-based luminescence was 
not observed upon exciting the coumarin 343 antenna. The absorption properties studies 
performed on EuL1, TbL1 and EuL7, where the dihydrofluorescein diacetate was used 
as Eu(III) and Tb(III) sensitizer antenna, revealed that the dihydrofluorecein diacetate 
lost the acetate groups, as it was shown by the presence of a peak between 490 and 
500 nm on the absorption spectra of EuL1, TbL1 and EuL7. The emission studies 
performed on EuL1, TbL1 and EuL7 demonstrated that the dihydrofluorescein sensitizer 
antenna, formed upon acetate groups’ cleavage, was not able to sensitize the Eu(III) and 
Tb(III) emission since the characteristic Ln3+-based emission was not observed upon 
excitation of the dihydrofluorescein antenna at around 500 nm. On the other hand, 
according to the data reported in literature by Steemers et al. [83], the dihydrofluorescein 
diacetate can be a suitable Eu(III) and Tb(III) sensitizer if the acetate groups are not 
cleaved off during the complexation reaction, as its longest-wavelength absorption peak 
falls at 280 nm.  
The photophysical studies performed on EuL4 and EuL5 demonstrated that the 
sensitisation of the Eu(III) emission could be achieved using the coumarin 3 carboxylic 
and coumarin 151 respectively as sensitizer antennae since the characteristic Eu(III) 
emission profile was observed upon excitation of the coumarin 3 carboxylic acid and the 
coumarin 151. The difference between EuL4 and EuL5 absorption and excitation spectra 
was indicative of a partial energy transfer process from the coumarin 3 carboxylic acid 
and coumarin 151 antennae to the Eu(III). In conclusion, EuL4 and EuL5 were the only 
complexes among those synthesised in this project to exhibit the characteristic Eu(III) 
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based luminescence. For this reason they were selected among all complexes to be 
evaluated for their response to the presence of ROS species. EuL4 and EuL5 
photophysical properties were measured in the presence of H2O2 and Fe(II) perchlorate 
by using emission spectroscopy. A dose dependent increase of the Eu(III)-based 
emission intensity in EuL4 was observed upon the addition H2O2, while no changes in 
the Eu(III) emission profile form were observed, indicating that there were no changes of 
that the Eu(III) coordination environment. A slight dose dependent decrease of the 
Eu(III)-based emission intensity in EuL5 was observed upon the addition H2O2, while no 
changes in the Eu(III) emission profile form were observed, indicating that, similarly to 
EuL4, there were no changes of that the Eu(III) coordination environment.  
 
6.4 Future work: photophysical studies 
Future works based on the photophysical studies include: 
1. Testing the lanthanide complexes containing the coumarin 343 as sensitizer 
antenna, namely EuL2, TbL2 and EuL6, in order to assess if they would be able 
to sense the presence of ROS species. In particular the emission of EuL2, TbL2 
and EuL6 will be recorded in absence and presence of hydroxyl radicals in order 
to see if the hydroxylation of the coumarin 343 by hydroxyl radicals generated in 
situ in the Fenton reaction catalysed by Fe(II) perchlorate could cause changes 
in its photophysical properties such that a switching on of the Ln3+ emission can 
be achieved. 
2. Optimise the reactions conditions related to the complexation reaction of the 
ligands containing the dihydrofluorescein as Eu(III) and Tb(III) sensitizer with the 
Ln3+ in order to prevent the acetate group’s cleavage. This would allow the 
synthesis of luminescent Eu(III) and Tb(III) complexes based on switch on/off 
mechanism. In this systems the sensitisation of the Eu(III) or Tb(III) luminescence 
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achieved using the dihydrofluorescein diacetate as sensitizer antenna should be 
switched off upon antenna oxidation by ROS species.  
 
 
6.5 Biological studies 
A mitochondrial stress test (MST) was performed on EuL1, TbL1, EuL2, TbL2, NdL3, 
YbL3, EuL4 and TbL4 to assess how test compounds affect various components of the 
mitochondrial electron transport chain with the aim to identify compounds that exhibit a 
potential mitochondrial and/or cellular toxicity [87]. A calcium loading capacity assay was 
performed on the same lanthanide complexes tested with the MST with the aim of 
investigating their effect on the mitochondrial capability to uptake and internalize Ca2+.  
A cellular ROS assay, was performed on the lanthanide complexes EuL4 and EuL5 to 
evaluate whether or not these complexes were responsive to ROS species, such as H2O2 
and OH∙, in a cellular environment by measuring changes in their luminescence intensity 
eventually caused by increased ROS levels. EuL4 and EuL5 were tested with the cellular 
ROS since they were the only complexes among those synthesised in this project that 
exhibited the characteristic lanthanide-based luminescence. 
 
6.5.1 Mitochondrial Stress Test 
A mitochondrial stress test (MST) was performed on the lanthanide complexes to verify 
if these complexes exhibit a potential mitochondrial and/or cellular toxicity. All complexes 
were tested at concentrations of 200 µM, 50 µM, 12.5 µM, 3.1 μM and 0.8 μM and their 
related OCR and ECAR profiles were recorded in presence and absence of cells (HepG2 
liver cancer cell line). The OCR (pmol/min) was recorded in real time upon the sequential 
injection of oligomycin (ATP synthase inhibitor), FCCP (mitochondrial uncoupler), and 
rotenone/antimycin A/gluocose (complex I and III inhibitors), whilst the The ECAR 
254 
 
profiles were recorded in order to measure the compounds’ effect on the glycolytic 
activity of the cells. When considering the MST data for each complex in its entirety it 
can be concluded that: 
 EuL1 and TbL1 had a gradual effect on the oxygen fluorophore or could remove 
oxygen from the system on its own.  
 EuL1 and TbL1 had an immediate and dose dependent effect on the pH fluorophore.  
 EuL1 and TbL1 appeared to be non-toxic to cells at the two lowest doses of 3.1 and 
0.8 µM, however exact interpretation of an effect/no effect level was difficult.  
 EuL2 and TbL2 had a negative effect on basal and maximal respiration at the top 
two doses. 
 EuL2 and TbL2 appeared to have no effect on oxygen consumption or mitochondrial 
function at 12.5, 3.1 and 0.8 µM and, whilst the pH fluorophore saturation rendered 
interpretation difficult, cells recovered glycolysis at 3.1 and 0.8 µM. 
 200, 50 and 12.5 µM of NdL3 and YbL3 had a deleterious effect on maximal 
respiration following FCCP injection. 
 NdL3 and YbL3 showed a recovery of glycolysis up to 50 µM suggesting that NdL3 
and YbL3 are not overtly cytotoxic and whilst a possible dose response remained it 
could be due to a dose related response of the compound on the pH fluorophore.  
 The ECAR and OCR results obtained with EuL4 and TbL4 demonstrated that they 
did not exhibit any mitochondrial and cellular toxicity with the slight exception of 200 
µM, which showed a small erosion of oxygen consumption at basal and maximal 
respiration. 
 The MST data  for EuL4 and TbL4 demonstarted a far superior mitochondrial and 
cellular toxicty profile and represent the most promising compounds for future 
development. Whilst the interpretation of the other complexes was complicated by 
the various effects on the pH and oxygen flurophores, it appeared clear that they all 
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caused imapirment of mitochondrial and cellular function at lower levels than EuL4 
and TbL4. 
 
6.5.2 Calcium Loading Capacity Test 
The calcium loading capacity profiles related to EuL1, TbL1, EuL2, TbL2, NdL3, YbL3, 
EuL4 and TbL4, showed that these complexes were responsible for a significant erosion 
of the mitochondrial CLC. The significant CLC erosion caused by these complexes could 
be due to several factors. The significant erosion of the CLC caused by EuL1-TbL4 could 
be due to mitochondrial toxicity or complete inhibition of mitochondrial calcium uptake. 
Whilst all compounds demonstrated inhibition of mitochondrial calcium loading, EuL4 
and TbL4 demonstrated a degree of calcium loading compared to the other 6 complexes 
even at 250 µM and appeared to slightly less potent in their effects on calcium loading. 
This was in correlation with the MST data that suggested that EuL4 and TbL4 showed 
the lowest toxicity and are the most promising complexes for future development.  
 
6.5.3 Cellular ROS assay 
The aim of this test was to evaluate whether or not these complexes could sense high 
ROS levels in a cellular environment by measuring changes in their fluorescence 
intensity. EuL4 and EuL5 were tested at concentration of 1 µM, 10 µM and 100 µM. H2O2 
(tested at concentration of 50 µM) and tBHP (tested at concentration of 150 µM) were 
used as ROS generator compounds, since they are able to induce an oxidative stress 
within the cells by increasing the ROS production [103]. MitoSOX, which is a fluorogenic 
ROS-sensing dye that is targeted to mitochondria in live cells, was used as probe positive 
control. The comparison between the fluorescence intensity of EuL4 and EuL5 recorded 
from the wells containing the cells previously incubated with H2O2 and tBHP and those 
containing the cells that were not incubated with H2O2 and tBHP allowed to evaluate 
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whether or not EuL4 and EuL5 were able to detect the variation of ROS levels. The 
results of the Cellular ROS assay can be summarised as follows: 
 The fluorescence intensity of EuL4 and EuL5 recorded from the wells containing 
the cells previously exposed to tBHP and from those containing the cells 
incubated with EuL4 and EuL5 but not exposed to tBHP, were approximately the 
same. This indicated that EuL4 and EuL5 were not responsive to high ROS 
levels generated by tBHP.  
 A complete quenching of EuL4 and EuL5 fluorescence was observed upon 
exposure of the cells to H2O2 indicating that EuL4 and EuL5 were responsive to 
high ROS levels generated by H2O2. 
 The quenching of EuL5 fluorescence observed in vitro was consistent with 
photophysical test performed on EuL5 in the presence of H2O2 and Fe(II) 
perchlorate, where a decrease of the Eu(III) luminescence was observed upon 
H2O2 and Fe(II) perchlorate addition. By contrast the quenching of the EuL4 
fluorescence observed in vitro was not consistent with the the results obtained 
with the photophysical test performed on EuL4 in the presence of H2O2 and Fe(II) 
perchlorate, where an increase of the Eu(III) luminescence was indeed observed 
upon H2O2 and Fe(II) perchlorate addition. 
  In order to measure the fluorescence intensity of EuL4 and EuL5 without having 
any interference form by the amount that did not enter the cells, all the wells were 
washed twice with medium in order to eliminate traces of EuL4 and EuL5 that 
remained in the extracellular medium.  
 Although a strong decrease of the fluorescence intensity of 100 μM EuL5 was 
measured both before and after washing the wells, the decrease of fluorescence 
intensity of 1 µM and 10 µM EuL5 was more significant before washing the wells 
compared to the one observed after washing the wells. 
  A lower decrease of 1 µM EuL4 and 10 µM EuL4 fluorescence intensity was 
observed after washing the wells compared to the decrease of 1 µM EuL4 and 
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10 µM EuL4 observed before washing the wells. In addition, while a decrease of 
100 µM EuL4 fluorescence intensity was observed before washing the wells, a 
slight increase of 100 µM EuL4 fluorescence intensity was observed after 
washing the wells. This inconsistent result could be due to the fact that probably 
wells’ washing twice caused the release of a certain amount of compound that 
had previously entered the cells thus reducing its concentration within the cells.  
 This hypothesis can be supported by the results obtained with the MitoSOX 
positive control fluorescence intensity measurements. According to the protocol, 
the MitoSOX fluorescence intensity was only recorded after washing. Although 
an increase of MitoSOX fluorescence intensity was observed both when H2O2 
and tBHP were used as ROS generators and for, the magnitude of this increase 
was not so huge as expected from a compound known for its ability to detect 
variation of ROS levels within the cells. 
 
6.6 Future work: biological studies 
Although the lanthanide complexes EuL4 and EuL5 demonstrated to be able to act as 
ROS sensors, the small variation of the signal generated by them when tested in 
presence of ROS species makes these complexes not applicable to further in vitro and 
in vivo studies. However, taking advantages from the feasibility and versatility of the 
synthetic route developed in this project it will be possible to synthesise other types of 
Ln3+ complexes, based on asymmetrically substituted cyclen ligands, more responsive 
to the presence of ROS species by using different types of sensitizer antennae that allow 
a better sensitization and control of the Ln3+ luminescence, and in the meantime a major 
selectivity and reactivity towards ROS species.  
Although a working ROS sensor was not successfully developed, this work has shown it 
is achievable. The synthetic strategy is broadly adaptable to a wide variety of ligands 
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that should produce more response in complexes and the protocol for the ROS assay 
can be modified to develop a quantifiable response. 
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Appendix 
 
 
Appendix A.1 - MST data of TbL1, EuL2, TbL2, NdL3, YbL3, EuL4  and TbL4. 
 
Appendix A.1.1 - TbL1 MST data 
 
 
 
Figure 99. OCR RATE of cells measured during the MST performed on TbL1. Injection 1 corresponds to 
TbL1 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
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Figure 100. TbL1 OCR rate measured during the MST in absence of cells. Injection 1 corresponds to TbL1 
injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection and 
injection 4 corresponds to rotenone/antimycin A injection.  
 
 
Figure 101. TbL1 OCR LEVEL measured during the MST in absence of cells. Injection 1 corresponds to 
TbL1 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
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Figure 102. TbL1 ECAR  LEVEL measured during the MST in absence and presence of cells. Injection 1 
corresponds to TbL1 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to 
FCCP injection and injection 4 corresponds to rotenone/antimycin A injection. 
 
 
Figure 103. C2 ECAR  RATE measured during the MST in presence of cells. Injection 1 corresponds to 
TbL1 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection. 
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Appendix A.1.2 – EuL2 and TbL2 MST data 
 
 
Figure 104. OCR RATE of cells measured during the MST performed on EuL2. Injection 1 corresponds to 
EuL2 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
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Figure 105. EuL2 OCR RATE measured during the MST in absence of cells. Injection 1 corresponds to 
EuL2 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
 
Figure 106. EuL2 ECAR LEVEL measured during the MST in absence of cells. Injection 1 corresponds to 
EuL2 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
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Figure 107. EuL2 ECAR RATE measured during the MST in presence of cells. Injection 1 corresponds to 
EuL2 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
 
 
 
Figure 108. OCR RATE of cells measured during the MST performed on  TbL2. Injection 1 corresponds to 
TbL2 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
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Figure 109. TbL2 OCR RATE measured during the MST in absence of cells. Injection 1 corresponds to 
TbL2 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
 
 
Figure 110. TbL2 ECAR LEVEL measured during the MST in absence of cells. Injection 1 corresponds to 
TbL2 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
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Figure 111. TbL2 ECAR RATE measured during the MST in presence of cells. Injection 1 corresponds to 
TbL2 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
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Appendix A.1.3 – NdL3 and YbL3 MST data 
 
 
 
Figure 112. OCR RATE of cells measured during the MST performed on NdL3. Injection 1 corresponds to 
NdL3 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
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Figure 113. NdL3 OCR RATE measured during the MST in absence of cells. Injection 1 corresponds to 
NdL3 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
 
 
Figure 114. NdL3 OCR LEVEL measured during the MST in absence of cells. Injection 1 corresponds to 
NdL3 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
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Figure 115. NdL3 ECAR  LEVEL measured during the MST in absence of cells. Injection 1 corresponds to 
NdL3 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection. 
 
Figure116. NdL3 ECAR  RATE measured during the MST in presence of cells. Injection 1 corresponds to 
NdL3 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection. 
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Figure 117. OCR RATE of cells measured during the MST performed on  YbL3. Injection 1 corresponds to 
YbL3 njection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
 
 
 
Figure 118. YbL3 OCR RATE measured during the MST in absence of cells. Injection 1 corresponds to 
YbL3 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
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Figure 119. YbL3 OCR LEVEL measured during the MST in absence of cells. Injection 1 corresponds to 
YbL3 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
 
 
 
 
Figure 120. YbL3 ECAR  LEVEL measured during the MST in absence of cells. Injection 1 corresponds to 
YbL3 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection. 
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Figure 121. YbL3 ECAR  RATE measured during the MST in presence of cells. Injection 1 corresponds to 
YbL3 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection. 
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Appendix A.1.4 – EuL4 and TbL4 MST data 
 
 
Figure 122. OCR RATE of cells measured during the MST performed on  EuL4. Injection 1 corresponds to 
EuL4 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
 
Figure 123. EuL4 ECAR  LEVEL measured during the MST in absence of cells. Injection 1 corresponds to 
EuL4 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection. 
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Figure 124. EuL4 ECAR  RATE measured during the MST in presence of cells. Injection 1 corresponds to 
EuL4 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection. 
 
 
 
Figure 125. OCR RATE of cells measured during the MST performed on TbL4. Injection 1 corresponds to 
TbL4 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection.  
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Figure 126. TbL4 ECAR  LEVEL measured during the MST in absence of cells. Injection 1 corresponds to 
TbL4 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection. 
 
 
 
Figure 127. TbL4 ECAR  RATE measured during the MST in presence of cells. Injection 1 corresponds to 
TbL4 injection, injection 2 corresponds to oligomicyn injection, injection 3 corresponds to FCCP injection 
and injection 4 corresponds to rotenone/antimycin A injection. 
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Appendix A.2 - Calcium loading capacity profiles of TbL1, EuL2, TbL2, NdL3 
and YbL3. 
 
 
Figure 128. Calcium loading capacity profile of TbL1. 
 
 
Figure 129. Calcium loading capacity profile of EuL2. 
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Figure 130. Calcium loading capacity profile of TbL2.  
 
 
Figure 131. Calcium loading capacity profile of NdL3. 
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Figure 132. Calcium loading capacity profile of YbL3. 
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Appendix A.3 - Calcium chelation of TbL1, EuL2, TbL2, NdL3, YbL3, EuL4 
and TbL4. 
 
 
Figure 133. Calcium chelation of TbL1. 
 
 
 
Figure 134. Calcium chelation of EuL2. 
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Figure 135. Calcium chelation of TbL2. 
 
 
 
Figure 136. Calcium chelation of NdL3. 
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Figure 137. Calcium chelation of YbL3. 
 
 
Figure 138. Calcium chelation of EuL4. 
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Figure 139. Calcium chelation of TbL4. 
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